https://openbiodx.com/2026-07-09daily1.0 https://openbiodx.com/library/2026-07-09weekly0.9 https://openbiodx.com/archive/2026-07-09daily0.7 https://openbiodx.com/molecular/2026-07-09weekly0.8 https://openbiodx.com/biomarkers/2026-07-09weekly0.8 https://openbiodx.com/liquid-biopsy/2026-07-09weekly0.8 https://openbiodx.com/point-of-care/2026-07-09weekly0.8 https://openbiodx.com/ai-data/2026-07-09weekly0.8 https://openbiodx.com/regulatory/2026-07-09weekly0.8 https://openbiodx.com/lab-medicine/2026-07-09weekly0.8 https://openbiodx.com/about/2026-07-09monthly0.5 https://openbiodx.com/2026/04/01/novel-hla-a-32-202-allele-identified-by-ngs-and-nanopore-sequencing/2026-07-09monthly0.6 https://openbiodx.com/2026/04/01/ai-powered-urine-test-reduces-unnecessary-prostate-biopsies-by-up-to-23/2026-07-09monthly0.6 https://openbiodx.com/2026/03/25/nine-rna-binding-proteins-form-prognostic-model-for-breast-cancer-survival/2026-07-09monthly0.6 https://openbiodx.com/2026/03/24/keratin-7-staining-reveals-disease-progression-markers-in-fatty-liver-disease-bi/2026-07-09monthly0.6 https://openbiodx.com/2026/03/24/ai-foundation-models-extract-quantitative-mri-biomarkers-for-knee-osteoarthritis/2026-07-09monthly0.6 https://openbiodx.com/2026/03/24/donor-age-and-sex-shape-msc-secretome-signalling-a-framework-for-potency-testing/2026-07-09monthly0.6 https://openbiodx.com/2026/03/24/proenkephalin-predicts-worsening-renal-function-in-sepsis-patients/2026-07-09monthly0.6 https://openbiodx.com/2026/03/24/occupational-alcohol-exposure-causes-false-positive-etg-immunoassay-results-via-/2026-07-09monthly0.6 https://openbiodx.com/2026/03/24/genomic-analysis-maps-species-specific-polymyxin-heteroresistance-in-e-coli-and-/2026-07-09monthly0.6 https://openbiodx.com/2026/03/24/liquid-biopsy-workflow-enables-single-cell-telomere-profiling-of-myeloma-ctcs-fr/2026-07-09monthly0.6 https://openbiodx.com/2026/03/24/crispr-cas12a-biosensor-detects-cardiac-mirna-133a-at-femtomolar-sensitivity/2026-07-09monthly0.6 https://openbiodx.com/2026/03/24/rb-immunohistochemistry-detects-cdk4-6-inhibitor-resistance-missed-by-ngs-in-met/2026-07-09monthly0.6 https://openbiodx.com/2026/03/24/explainable-ai-in-oncology-methods-to-open-the-black-box/2026-07-09monthly0.6 https://openbiodx.com/2026/03/24/phage-derived-binding-protein-enables-rapid-culture-free-detection-of-a-baumanni/2026-07-09monthly0.6 https://openbiodx.com/2026/03/24/european-physicians-prioritise-rapid-fever-tests-for-immunocompromised-patients-/2026-07-09monthly0.6 https://openbiodx.com/2026/03/24/same-day-hepatitis-c-test-and-treat-model-trialled-using-antibody-only-screening/2026-07-09monthly0.6 https://openbiodx.com/2026/03/24/pleural-fluid-biomarkers-show-promise-for-diagnosing-malignant-effusions-and-gui/2026-07-09monthly0.6 https://openbiodx.com/2026/03/23/ceftobiprole-susceptibility-testing-mic-strips-reliable-disk-diffusion-depends-o/2026-07-09monthly0.6 https://openbiodx.com/2026/03/23/plasma-metabolomics-classifier-detects-glioma-via-seven-metabolite-liquid-biopsy/2026-07-09monthly0.6 https://openbiodx.com/2026/03/23/crispr-magnetic-microbots-enable-liquid-biopsy-cancer-subtyping-via-extracellula/2026-07-09monthly0.6 https://openbiodx.com/2026/03/23/manganese-powered-cas12a-enables-amplification-free-rna-detection-at-femtomolar-/2026-07-09monthly0.6 https://openbiodx.com/2026/03/23/crispr-cas13a-assay-detects-salmonella-in-under-60-minutes-across-large-clinical/2026-07-09monthly0.6 https://openbiodx.com/2026/03/23/one-pot-crispr-cas12a-assay-with-ultrashort-hda-detects-respiratory-pathogens-at/2026-07-09monthly0.6 https://openbiodx.com/2026/03/23/genetic-testing-reshapes-the-diagnostic-workup-for-childhood-nystagmus/2026-07-09monthly0.6 https://openbiodx.com/2026/03/23/50-gene-ngs-panel-achieves-15-diagnostic-yield-for-hereditary-breast-and-ovarian/2026-07-09monthly0.6 https://openbiodx.com/2026/03/23/melanomas-in-blue-nevi-lack-tert-promoter-mutations-and-carry-uniformly-low-tumo/2026-07-09monthly0.6 https://openbiodx.com/2026/03/23/landscape-analysis-of-14-digital-pathology-platforms-offers-selection-guide-for-/2026-07-09monthly0.6 https://openbiodx.com/2026/03/23/deep-learning-system-diagnoses-and-predicts-recurrence-of-jaw-tumours/2026-07-09monthly0.6 https://openbiodx.com/2026/03/23/ultra-sensitive-ctdna-assay-predicts-treatment-response-65-days-before-imaging-i/2026-07-09monthly0.6 https://openbiodx.com/2026/03/22/mitochondrial-lipidomics-reveals-arachidonic-acid-deficiency-as-targetable-featu/2026-07-09monthly0.6 https://openbiodx.com/2026/03/21/pan-cancer-lymph-node-ai-achieves-100-sensitivity-with-built-in-uncertainty-safe/2026-07-09monthly0.6 https://openbiodx.com/2026/03/20/six-gene-ddpcr-panel-achieves-100-sensitivity-for-thyroid-cancer-detection-in-fn/2026-07-09monthly0.6 https://openbiodx.com/2026/03/20/global-interlaboratory-study-exposes-significant-variability-in-myositis-autoant/2026-07-09monthly0.6 https://openbiodx.com/2026/03/20/nanopore-full-rrna-operon-sequencing-improves-fungal-identification-in-ocular-in/2026-07-09monthly0.6 https://openbiodx.com/2026/03/20/lancet-microbe-review-maps-the-expanding-toolkit-for-isoniazid-resistant-tb-diag/2026-07-09monthly0.6 https://openbiodx.com/2026/03/20/ai-based-pathologic-response-assessment-in-lung-cancer-after-neoadjuvant-therapy/2026-07-09monthly0.6 https://openbiodx.com/2026/03/20/discarded-malaria-rapid-tests-repurposed-for-arbovirus-surveillance-in-haiti/2026-07-09monthly0.6 https://openbiodx.com/2026/03/20/ctdna-misses-lung-and-surgical-bed-recurrences-after-pancreatic-cancer-resection/2026-07-09monthly0.6 https://openbiodx.com/2026/03/20/iq-consortium-reviews-human-mass-balance-study-designs-including-microtracer-and/2026-07-09monthly0.6 https://openbiodx.com/2026/03/19/irregular-borders-in-fibroadenomas-are-common-and-should-not-be-confused-with-ph/2026-07-09monthly0.6 https://openbiodx.com/2026/03/19/comprehensive-review-of-metrological-traceability-tools-for-urine-albumin-standa/2026-07-09monthly0.6 https://openbiodx.com/2026/03/19/crispr-based-lipid-lowering-redefines-laboratory-medicine-s-role-in-gene-editing/2026-07-09monthly0.6 https://openbiodx.com/2026/03/19/nxtag-respiratory-pathogen-panel-v2-demonstrates-high-accuracy-across-five-us-cl/2026-07-09monthly0.6 https://openbiodx.com/2026/03/19/lip-ms-molecular-fishing-identifies-therapeutic-targets-for-a-traditional-chines/2026-07-09monthly0.6 https://openbiodx.com/2026/03/19/intraoperative-mri-volumetrics-predict-survival-in-lower-grade-glioma-especially/2026-07-09monthly0.6 https://openbiodx.com/2026/03/19/collaborative-framework-proposed-to-streamline-ldt-validation-across-us-hospital/2026-07-09monthly0.6 https://openbiodx.com/2026/03/19/crispr-based-point-of-care-tests-push-toward-practical-h-pylori-screening/2026-07-09monthly0.6 https://openbiodx.com/2026/03/19/rapid-diagnostics-and-opportunistic-infections-drive-mortality-in-advanced-hiv-c/2026-07-09monthly0.6 https://openbiodx.com/2026/03/19/ai-model-predicts-druggable-mutation-probability-before-genomic-profiling-in-lun/2026-07-09monthly0.6 https://openbiodx.com/2026/03/19/ai-and-molecular-biomarkers-converge-to-reshape-lung-cancer-diagnostics/2026-07-09monthly0.6 https://openbiodx.com/2026/03/19/tumour-informed-copy-number-analysis-detects-ctdna-down-to-0-2-tumour-fraction/2026-07-09monthly0.6 https://openbiodx.com/2026/03/19/ctdna-emerges-as-powerful-non-invasive-biomarker-across-all-stages-of-bladder-ca/2026-07-09monthly0.6 https://openbiodx.com/2026/03/18/updated-clsi-guidance-brings-carbapenemase-testing-back-to-the-clinical-lab/2026-07-09monthly0.6 https://openbiodx.com/2026/03/18/genomic-epidemiology-reveals-complex-vre-dynamics-behind-germany-s-vanb-surge-an/2026-07-09monthly0.6 https://openbiodx.com/2026/03/18/non-fumigatus-aspergillus-species-cause-treatable-lung-disease-but-current-diagn/2026-07-09monthly0.6 https://openbiodx.com/2026/03/18/in-memoriam-davise-honig-larone-pioneering-clinical-mycologist/2026-07-09monthly0.6 https://openbiodx.com/2026/03/18/maldi-tof-ms-and-pcr-panel-enable-rapid-ntm-identification-directly-from-blood-c/2026-07-09monthly0.6 https://openbiodx.com/2026/03/18/real-world-adjuvant-therapy-patterns-after-chemoimmunotherapy-in-early-triple-ne/2026-07-09monthly0.6 https://openbiodx.com/2026/03/18/modified-viscoelastic-tests-show-promise-for-rapid-doac-detection-at-point-of-ca/2026-07-09monthly0.6 https://openbiodx.com/2026/03/18/portable-biosensor-combines-two-thalassemia-screening-assays-with-90-concordance/2026-07-09monthly0.6 https://openbiodx.com/2026/03/17/quantitative-hepatitis-b-surface-antigen-assays-show-troubling-inter-method-vari/2026-07-09monthly0.6 https://openbiodx.com/2026/03/17/new-insights-into-the-epstein-barr-virus-link-to-systemic-lupus-erythematosus/2026-07-09monthly0.6 https://openbiodx.com/2026/03/17/spark-seq-could-transform-clinical-laboratory-diagnostics-beyond-traditional-aff/2026-07-09monthly0.6 https://openbiodx.com/2026/03/17/companion-diagnostics-cut-oncology-drug-development-time-by-nearly-a-year-fda-an/2026-07-09monthly0.6 https://openbiodx.com/2026/03/16/review-wastewater-surveillance-methods-for-sars-cov-2-variant-tracking-and-beyon/2026-07-09monthly0.6 https://openbiodx.com/2026/03/16/cxcl1-qpcr-assay-validated-as-potential-companion-diagnostic-for-bladder-cancer-/2026-07-09monthly0.6 https://openbiodx.com/2026/03/16/six-biomarker-panel-predicts-lung-cancer-relapse-after-curative-radiotherapy-wit/2026-07-09monthly0.6 https://openbiodx.com/2026/03/15/dynamic-open-source-digital-twin-of-taqman-pcr-enables-in-silico-assay-optimisat/2026-07-09monthly0.6 https://openbiodx.com/2026/03/14/tiered-genomic-testing-achieves-48-diagnostic-yield-in-3-353-chinese-children-wi/2026-07-09monthly0.6 https://openbiodx.com/2026/03/12/aml-with-kmt2a-ptd-frequently-mimics-myelodysplasia-related-disease/2026-07-09monthly0.6 https://openbiodx.com/2026/03/12/polaris-ai-classifier-reliably-triages-colorectal-polyps-validated-on-10-000-sli/2026-07-09monthly0.6 https://openbiodx.com/2026/03/12/eln-2025-mrd-update-introduces-risk-stratified-response-categories-and-ngs-stand/2026-07-09monthly0.6 https://openbiodx.com/2026/03/11/crispr-cas-and-isothermal-amplification-platforms-advance-toward-field-deployabl/2026-07-09monthly0.6 https://openbiodx.com/2026/03/10/ctdna-in-nsclc-review-maps-current-evidence-for-mrd-detection-and-treatment-moni/2026-07-09monthly0.6 https://openbiodx.com/2026/03/09/full-dpyd-sequencing-catches-26-more-clinically-relevant-variants-than-targeted-/2026-07-09monthly0.6 https://openbiodx.com/2026/03/09/co-occurring-tertp-and-tp53-mutations-predict-worse-survival-in-bladder-cancer/2026-07-09monthly0.6 https://openbiodx.com/2026/03/09/mngs-and-genexpert-crack-a-complex-case-of-infantile-endobronchial-tuberculosis/2026-07-09monthly0.6 https://openbiodx.com/2026/03/07/100-of-journal-submissions-contain-gene-variant-nomenclature-errors/2026-07-09monthly0.6 https://openbiodx.com/2026/03/07/atrial-fibrillation-in-2026-wearable-detection-integrated-care-and-evolving-abla/2026-07-09monthly0.6 https://openbiodx.com/2026/03/06/crispr1-system-linked-to-virulence-and-resistance-in-dominant-neonatal-gbs-linea/2026-07-09monthly0.6 https://openbiodx.com/2026/03/05/endogenous-lithium-levels-explored-as-potential-link-to-alzheimer-disease/2026-07-09monthly0.6 https://openbiodx.com/2026/03/05/commentary-on-unexplained-salicylate-elevation-lessons-for-the-clinical-lab/2026-07-09monthly0.6 https://openbiodx.com/2026/03/05/unexpected-salicylate-elevation-in-a-patient-denying-aspirin-use/2026-07-09monthly0.6 https://openbiodx.com/2026/03/05/ifcc-framework-for-implementing-high-sensitivity-cardiac-troponin-point-of-care-/2026-07-09monthly0.6 https://openbiodx.com/2026/03/04/autoimmune-conditions-in-cmml-patients-linked-to-reduced-leukaemic-transformatio/2026-07-09monthly0.6 https://openbiodx.com/2026/03/04/kinetic-model-offers-rational-design-framework-for-amplification-free-crispr-dia/2026-07-09monthly0.6 https://openbiodx.com/2026/03/04/pre-existing-hiv-resistance-mutations-do-not-compromise-dolutegravir-efficacy-in/2026-07-09monthly0.6 https://openbiodx.com/2026/03/03/whole-genome-sequencing-links-microglandular-adenosis-to-genomic-instability-in-/2026-07-09monthly0.6 https://openbiodx.com/2026/03/01/italian-multicentre-study-tackles-mrd-harmonisation-in-myeloma-using-ngf-and-ngs/2026-07-09monthly0.6 https://openbiodx.com/2026/03/01/self-attention-network-achieves-over-90-cancer-classification-accuracy-from-pane/2026-07-09monthly0.6 https://openbiodx.com/2026/03/01/ai-in-neuropathology-from-methylation-classifiers-to-intraoperative-raman-histol/2026-07-09monthly0.6 https://openbiodx.com/2026/03/01/companion-diagnostics-in-oncology-comprehensive-review-of-platforms-challenges-a/2026-07-09monthly0.6 https://openbiodx.com/2026/03/01/liquid-biopsy-for-early-gi-cancer-detection-multi-analyte-platforms-near-clinica/2026-07-09monthly0.6 https://openbiodx.com/2026/02/28/liquid-biopsy-in-non-metastatic-prostate-cancer-ctdna-outperforms-ctcs-for-risk-/2026-07-09monthly0.6 https://openbiodx.com/2026/02/27/molecular-screening-tools-for-colorectal-cancer-from-tissue-mutations-to-multi-o/2026-07-09monthly0.6 https://openbiodx.com/2026/02/27/obicetrapib-lowers-ldl-c-by-36-in-familial-hypercholesterolaemia-brooklyn-trial-/2026-07-09monthly0.6 https://openbiodx.com/2026/02/25/deep-learning-triage-cuts-breast-biopsy-turnaround-by-38-in-simulation/2026-07-09monthly0.6 https://openbiodx.com/2026/02/25/ai-powered-computational-pathology-enters-the-companion-diagnostic-arena/2026-07-09monthly0.6 https://openbiodx.com/2026/02/24/digital-pcr-outperforms-conventional-methods-for-ctdna-based-mrd-tracking-in-col/2026-07-09monthly0.6 https://openbiodx.com/2026/02/23/liquid-biopsy-meets-mutational-signatures-a-framework-for-longitudinal-cancer-mo/2026-07-09monthly0.6 https://openbiodx.com/2026/02/23/liquid-biopsy-and-radiomics-show-promise-for-lung-cancer-screening-beyond-ct/2026-07-09monthly0.6 https://openbiodx.com/2026/02/20/review-molecular-pathology-platforms-converge-toward-integrative-multi-omics-dia/2026-07-09monthly0.6 https://openbiodx.com/2026/02/20/hybrid-imaging-molecular-surveillance-proposed-for-post-resection-cholangiocarci/2026-07-09monthly0.6 https://openbiodx.com/2026/02/19/multiplex-csf-pcr-co-detects-hsv-1-in-pneumococcal-meningitis-interpreting-molec/2026-07-09monthly0.6 https://openbiodx.com/2026/02/19/hpv-16-18-genotyping-by-real-time-pcr-provides-clear-risk-stratification-in-wome/2026-07-09monthly0.6 https://openbiodx.com/2026/02/18/two-nodule-hepatocellular-carcinoma-without-satellites-has-outcomes-similar-to-s/2026-07-09monthly0.6 https://openbiodx.com/2026/02/17/nipah-virus-diagnostics-advance-with-rapid-molecular-tests-and-field-deployable-/2026-07-09monthly0.6 https://openbiodx.com/2026/02/14/double-hit-myeloma-with-1q21-and-t-4-14-triple-agent-induction-improves-mrd-nega/2026-07-09monthly0.6 https://openbiodx.com/2026/02/13/choosing-wisely-canada-publishes-seven-evidence-based-recommendations-for-point-/2026-07-09monthly0.6 https://openbiodx.com/2026/02/12/early-relapse-within-12-months-predicts-poor-survival-in-nodal-mature-t-cell-lym/2026-07-09monthly0.6 https://openbiodx.com/2026/02/11/exosomes-in-prostate-cancer-dual-role-as-tumour-promoters-and-diagnostic-biomark/2026-07-09monthly0.6 https://openbiodx.com/2026/02/03/pecarn-prediction-rule-validated-for-identifying-low-risk-febrile-neonates-missi/2026-07-09monthly0.6 https://openbiodx.com/2026/02/03/multiplex-droplet-digital-pcr-covers-10-npm1-mutations-for-aml-measurable-residu/2026-07-09monthly0.6 https://openbiodx.com/2026/02/02/csf-proteomics-identifies-candidate-biomarkers-for-distinguishing-meningitis-typ/2026-07-09monthly0.6 https://openbiodx.com/2026/02/01/blinatumomab-shows-strong-short-term-efficacy-in-paediatric-relapsed-refractory-/2026-07-09monthly0.6 https://openbiodx.com/2026/02/01/precision-psychiatry-tools-move-toward-primary-care-rna-biomarkers-pharmacogenom/2026-07-09monthly0.6 https://openbiodx.com/2026/02/01/autoantibody-testing-in-neuromuscular-disease-assays-interpretation-and-clinical/2026-07-09monthly0.6 https://openbiodx.com/2026/02/01/postoperative-ctdna-predicts-celecoxib-benefit-in-stage-iii-colon-cancer/2026-07-09monthly0.6 https://openbiodx.com/2026/01/30/polish-society-of-pathologists-issues-national-guidelines-for-digital-pathology-/2026-07-09monthly0.6 https://openbiodx.com/2026/01/30/minocycline-improves-functional-outcomes-after-acute-ischaemic-stroke-in-phase-i/2026-07-09monthly0.6 https://openbiodx.com/2026/01/29/mendelian-randomisation-identifies-24-immune-cell-phenotypes-causally-linked-to-/2026-07-09monthly0.6 https://openbiodx.com/2026/01/29/nomogram-predicts-prolonged-hospitalisation-after-gastrointestinal-perforation-s/2026-07-09monthly0.6 https://openbiodx.com/2026/01/29/five-year-uti-pathogen-surveillance-in-suzhou-reveals-alarming-carbapenem-resist/2026-07-09monthly0.6 https://openbiodx.com/2026/01/29/metagenomic-ngs-outperforms-standard-pcr-for-atypical-hsv-2-encephalitis-diagnos/2026-07-09monthly0.6 https://openbiodx.com/2026/01/28/presepsin-shows-promise-as-neurological-prognostic-marker-after-cardiac-arrest/2026-07-09monthly0.6 https://openbiodx.com/2026/01/26/hierarchical-pyramid-transformer-achieves-84-accuracy-for-automated-breast-cance/2026-07-09monthly0.6 https://openbiodx.com/2026/01/20/jama-meta-analysis-sglt2-inhibitors-reduce-kidney-progression-and-death-regardle/2026-07-09monthly0.6 https://openbiodx.com/2026/01/20/sglt2-inhibitors-protect-kidneys-regardless-of-baseline-gfr-or-albuminuria-in-70/2026-07-09monthly0.6 https://openbiodx.com/2026/01/20/fingerstick-hepatitis-b-dna-testing-with-xpert-assay-enables-decentralised-viral/2026-07-09monthly0.6 https://openbiodx.com/2026/01/19/upath-her2-dual-ish-image-analysis-algorithm-validated-for-automated-her2-testin/2026-07-09monthly0.6 https://openbiodx.com/2026/01/15/ngs-panel-validates-ims-imwg-consensus-genomic-risk-classification-in-6-528-myel/2026-07-09monthly0.6 https://openbiodx.com/2026/01/13/oral-pcsk9-inhibitor-enlicitide-slashes-ldl-c-by-58-in-familial-hypercholesterol/2026-07-09monthly0.6 https://openbiodx.com/2026/01/12/cell-free-dna-model-detects-pancreatic-cancer-up-to-298-days-before-clinical-dia/2026-07-09monthly0.6 https://openbiodx.com/2026/01/08/eu-notified-body-perspective-on-mdr-and-ivdr-conformity-assessment/2026-07-09monthly0.6 https://openbiodx.com/2026/01/08/review-highlights-ctdna-as-a-promising-risk-stratification-tool-in-marginal-zone/2026-07-09monthly0.6 https://openbiodx.com/2026/01/07/edaravone-dexborneol-improves-functional-independence-after-thrombectomy-in-acut/2026-07-09monthly0.6 https://openbiodx.com/2026/01/07/castle-basket-trial-cd19-car-t-achieves-remission-across-three-autoimmune-diseas/2026-07-09monthly0.6 https://openbiodx.com/2026/01/07/antimicrobial-resistance-mechanisms-in-m-tuberculosis-a-translational-framework/2026-07-09monthly0.6 https://openbiodx.com/2026/01/06/ai-and-machine-learning-transform-predictive-biomarker-discovery-in-oncology/2026-07-09monthly0.6 https://openbiodx.com/2026/01/02/machine-learning-meets-genomics-convergence-for-precision-oncology-at-the-point-/2026-07-09monthly0.6 https://openbiodx.com/2026/01/01/icos-position-statement-on-immune-checkpoint-inhibitor-cardiovascular-toxicity/2026-07-09monthly0.6 https://openbiodx.com/2026/01/01/meta-analysis-of-10-000-patients-defines-optimal-androgen-deprivation-duration-f/2026-07-09monthly0.6 https://openbiodx.com/2025/12/30/from-pku-to-genomics-six-decades-of-newborn-screening-evolution/2026-07-09monthly0.6 https://openbiodx.com/2025/12/29/multiplex-serology-assay-distinguishes-mpox-infection-from-vaccinia-vaccination-/2026-07-09monthly0.6 https://openbiodx.com/2025/12/18/dual-target-measles-pcr-on-panther-fusion-differentiates-wild-type-from-vaccine-/2026-07-09monthly0.6 https://openbiodx.com/2025/12/18/pet-ct-combined-with-flow-cytometry-mrd-improves-prognostic-stratification-in-my/2026-07-09monthly0.6 https://openbiodx.com/2025/12/16/ai-led-diabetes-prevention-programme-matches-human-coaching-in-phase-3-rct/2026-07-09monthly0.6 https://openbiodx.com/2025/12/12/antimicrobial-resistance-in-2025-global-landscape-new-antibiotics-and-the-promis/2026-07-09monthly0.6 https://openbiodx.com/2025/12/11/zoliflodacin-non-inferior-to-ceftriaxone-azithromycin-for-uncomplicated-urogenit/2026-07-09monthly0.6 https://openbiodx.com/2025/12/11/three-key-practice-updates-in-non-hodgkin-lymphoma-classification-for-2026/2026-07-09monthly0.6 https://openbiodx.com/2025/12/11/whole-genome-sequencing-for-amr-surveillance-methodologies-validation-and-standa/2026-07-09monthly0.6 https://openbiodx.com/2025/12/10/nature-medicine-review-positions-liquid-biopsy-across-the-full-cancer-care-conti/2026-07-09monthly0.6 https://openbiodx.com/2025/12/09/global-burden-of-disease-2023-intimate-partner-violence-and-sexual-violence-agai/2026-07-09monthly0.6 https://openbiodx.com/2025/12/08/base-edited-universal-car-t-cells-induce-complete-remission-in-relapsed-t-cell-a/2026-07-09monthly0.6 https://openbiodx.com/2025/12/06/fixed-duration-venetoclax-combinations-are-non-inferior-to-continuous-ibrutinib-/2026-07-09monthly0.6 https://openbiodx.com/2025/12/05/hoxa-gene-dysregulation-in-aml-from-molecular-mechanisms-to-menin-inhibitor-resi/2026-07-09monthly0.6 https://openbiodx.com/2025/12/03/infectious-disease-lessons-from-the-2024-southern-brazil-floods-leptospirosis-di/2026-07-09monthly0.6 https://openbiodx.com/2025/12/02/analytical-bias-in-troponin-assays-affects-rule-out-rates-more-than-diagnostic-s/2026-07-09monthly0.6 https://openbiodx.com/2025/12/02/precision-oncology-2025-in-review-new-targets-liquid-biopsy-and-ai-driven-insigh/2026-07-09monthly0.6 https://openbiodx.com/2025/12/02/individualized-blood-pressure-targets-during-major-surgery-do-not-improve-postop/2026-07-09monthly0.6 https://openbiodx.com/2025/12/01/distant-disease-free-survival-validated-as-surrogate-for-overall-survival-in-neo/2026-07-09monthly0.6 https://openbiodx.com/2025/12/01/expert-consensus-routine-ngs-not-warranted-in-all-sarcoma-patients-expert-center/2026-07-09monthly0.6 https://openbiodx.com/2025/12/01/sysucc-001-ten-year-update-metronomic-capecitabine-benefits-triple-negative-brea/2026-07-09monthly0.6 https://openbiodx.com/2025/12/01/focused-ultrasound-plus-temozolomide-achieves-31-month-median-survival-in-gliobl/2026-07-09monthly0.6 https://openbiodx.com/2025/12/01/non-operative-management-after-total-neoadjuvant-therapy-preserves-organs-in-rec/2026-07-09monthly0.6 https://openbiodx.com/2025/11/29/lancet-review-non-invasive-cardiac-imaging-and-ai-for-chronic-coronary-artery-di/2026-07-09monthly0.6 https://openbiodx.com/2025/11/27/biomarker-first-drug-development-strategy-demonstrated-for-iga-driven-autoimmune/2026-07-09monthly0.6 https://openbiodx.com/2025/11/27/computational-pathology-for-colorectal-cancer-bridging-the-gap-between-ai-resear/2026-07-09monthly0.6 https://openbiodx.com/2025/11/27/biomarker-driven-therapy-in-urothelial-cancer-from-fgfr3-mutations-to-ctdna-moni/2026-07-09monthly0.6 https://openbiodx.com/2025/11/27/epcoritamab-plus-r2-achieves-88-complete-response-and-86-mrd-negativity-in-relap/2026-07-09monthly0.6 https://openbiodx.com/2025/11/26/machine-learning-on-maldi-tof-spectra-predicts-antimicrobial-resistance-but-requ/2026-07-09monthly0.6 https://openbiodx.com/2025/11/25/lung-cancer-in-never-smokers-ngs-driven-genomic-profiling-guides-targeted-therap/2026-07-09monthly0.6 https://openbiodx.com/2025/11/14/capillary-blood-sampling-for-core-laboratories-promise-standardisation-gaps-and-/2026-07-09monthly0.6 https://openbiodx.com/2025/11/11/comprehensive-review-maps-egfr-tki-resistance-mechanisms-and-ctdna-guided-adapti/2026-07-09monthly0.6 https://openbiodx.com/2025/11/10/pro-grp-as-a-complementary-biomarker-for-medullary-thyroid-carcinoma-high-specif/2026-07-09monthly0.6 https://openbiodx.com/2025/11/08/crispr-gene-editing-of-angptl3-achieves-up-to-80-lipid-target-reduction-in-phase/2026-07-09monthly0.6 https://openbiodx.com/2025/11/06/ai-in-hematology-diagnostic-accuracy-risk-stratification-and-the-road-to-clinica/2026-07-09monthly0.6 https://openbiodx.com/2025/11/06/asap-trial-genetic-risk-not-remission-status-predicts-transplant-outcomes-in-aml/2026-07-09monthly0.6 https://openbiodx.com/2025/11/05/mass-spectrometry-poised-to-replace-electrophoresis-for-m-protein-detection-in-c/2026-07-09monthly0.6 https://openbiodx.com/2025/11/04/drug-resistant-tuberculosis-rapid-diagnostics-and-shorter-oral-regimens-offer-ne/2026-07-09monthly0.6 https://openbiodx.com/2025/11/01/integrated-biomedical-innovations-in-hiv-and-sti-prevention-diagnostics-and-serv/2026-07-09monthly0.6 https://openbiodx.com/2025/11/01/ai-rapno-review-current-state-and-future-directions-for-ai-in-paediatric-neuro-o/2026-07-09monthly0.6 https://openbiodx.com/2025/11/01/ai-rapno-part-2-recommendations-for-clinical-translation-of-ai-in-paediatric-neu/2026-07-09monthly0.6 https://openbiodx.com/2025/11/01/cyclone-2-cdk4-6-inhibitor-abemaciclib-plus-abiraterone-does-not-improve-pfs-in-/2026-07-09monthly0.6 https://openbiodx.com/2025/11/01/psa-variability-is-high-22-of-elevated-results-normalise-within-a-year/2026-07-09monthly0.6 https://openbiodx.com/2025/10/30/psa-screening-cuts-prostate-cancer-deaths-by-13-after-23-years-of-follow-up/2026-07-09monthly0.6 https://openbiodx.com/2025/10/29/cobas-liat-poc-naat-delivers-lab-grade-sti-detection-for-chlamydia-gonorrhoea-an/2026-07-09monthly0.6 https://openbiodx.com/2025/10/28/troponin-variation-interpretation-reference-change-values-versus-analytical-perf/2026-07-09monthly0.6 https://openbiodx.com/2025/10/28/review-maps-the-case-for-enhanced-point-of-care-diagnostics-in-deep-space-missio/2026-07-09monthly0.6 https://openbiodx.com/2025/10/21/single-dose-lysergide-mm120-shows-dose-dependent-anxiety-reduction-in-gad-trial/2026-07-09monthly0.6 https://openbiodx.com/2025/10/20/dynamic-iii-ctdna-guided-therapy-de-escalation-reduces-oxaliplatin-use-in-stage-/2026-07-09monthly0.6 https://openbiodx.com/2025/10/20/neoadjuvant-immunotherapy-achieves-26-response-rate-in-mismatch-repair-proficien/2026-07-09monthly0.6 https://openbiodx.com/2025/10/20/imvigor011-ctdna-guided-adjuvant-atezolizumab-improves-survival-in-muscle-invasi/2026-07-09monthly0.6 https://openbiodx.com/2025/10/17/cefazolin-non-inferior-to-cloxacillin-for-mssa-bacteraemia-with-better-tolerabil/2026-07-09monthly0.6 https://openbiodx.com/2025/10/17/nordic-consensus-recommendations-for-clinical-bioinformatics-in-whole-genome-seq/2026-07-09monthly0.6 https://openbiodx.com/2025/10/11/il-6-receptor-blockade-with-tocilizumab-reduces-monocyte-mediated-myocardial-inj/2026-07-09monthly0.6 https://openbiodx.com/2025/10/09/multicenter-validation-of-clonit-toxoplasma-pcr-kit-shows-94-7-clinical-sensitiv/2026-07-09monthly0.6 https://openbiodx.com/2025/10/09/review-positions-ctdna-based-mrd-monitoring-as-key-to-personalising-unresectable/2026-07-09monthly0.6 https://openbiodx.com/2025/10/09/follicular-lymphoma-review-envisions-ctdna-replacing-imaging-for-treatment-monit/2026-07-09monthly0.6 https://openbiodx.com/2025/10/08/extracellular-vesicles-as-cancer-diagnostics-and-therapeutics-clinical-translati/2026-07-09monthly0.6 https://openbiodx.com/2025/10/07/amplitude-trial-niraparib-plus-abiraterone-improves-rpfs-in-hrr-deficient-castra/2026-07-09monthly0.6 https://openbiodx.com/2025/10/01/international-consensus-on-pathological-response-assessment-after-neoadjuvant-th/2026-07-09monthly0.6 https://openbiodx.com/2025/10/01/twenty-years-of-human-bocavirus-from-diagnostic-puzzle-to-confirmed-respiratory-/2026-07-09monthly0.6 https://openbiodx.com/2025/09/30/triverity-mrna-blood-test-diagnoses-bacterial-vs-viral-infection-and-predicts-se/2026-07-09monthly0.6 https://openbiodx.com/2025/09/29/prediabetes-remission-without-weight-loss-prevents-type-2-diabetes-via-visceral-/2026-07-09monthly0.6 https://openbiodx.com/2025/09/29/clinical-exome-and-genome-sequencing-yields-39-diagnostic-rate-in-2-700-adults/2026-07-09monthly0.6 https://openbiodx.com/2025/09/29/new-core-score-outperforms-fib-4-for-predicting-10-year-cirrhosis-risk-using-rou/2026-07-09monthly0.6 https://openbiodx.com/2025/09/25/nejm-crispr-cas9-gene-editing-achieves-92-sustained-ttr-reduction-in-hereditary-/2026-07-09monthly0.6 https://openbiodx.com/2025/09/25/lancet-rct-crp-point-of-care-decision-tool-safely-cuts-pediatric-antibiotic-pres/2026-07-09monthly0.6 https://openbiodx.com/2025/09/24/permethrin-treated-baby-wraps-cut-childhood-malaria-incidence-by-66-in-ugandan-r/2026-07-09monthly0.6 https://openbiodx.com/2025/09/24/dna-methylation-markers-znf582-and-ascl1-predict-progression-to-anal-cancer-in-h/2026-07-09monthly0.6 https://openbiodx.com/2025/09/19/achromobacter-infections-10-year-multicenter-analysis-of-1-598-isolates-reveals-/2026-07-09monthly0.6 https://openbiodx.com/2025/09/19/metagenomic-sequencing-for-tb-diagnosis-promise-and-practical-barriers/2026-07-09monthly0.6 https://openbiodx.com/2025/09/17/2024-mcdonald-ms-criteria-endorse-kappa-free-light-chains-as-csf-biomarker/2026-07-09monthly0.6 https://openbiodx.com/2025/09/11/acalabrutinib-obinutuzumab-delivers-durable-survival-benefit-in-treatment-naive-/2026-07-09monthly0.6 https://openbiodx.com/2025/09/11/methylcobalamin-halves-severe-hand-foot-syndrome-during-capecitabine-therapy/2026-07-09monthly0.6 https://openbiodx.com/2025/09/09/18-gene-signature-predicts-survival-in-gastric-cancer-via-lymphatic-endothelial-/2026-07-09monthly0.6 https://openbiodx.com/2025/09/03/rapid-phenotypic-ast-technologies-a-comprehensive-review-of-commercial-systems-f/2026-07-09monthly0.6 https://openbiodx.com/2025/09/03/enteric-fever-blood-culture-remains-the-diagnostic-standard-despite-performance-/2026-07-09monthly0.6 https://openbiodx.com/2025/09/03/mutant-kras-ctdna-at-160-copies-ml-predicts-survival-in-pancreatic-cancer/2026-07-09monthly0.6 https://openbiodx.com/2025/09/02/a-laboratorian-s-guide-to-billing-and-reimbursement-for-molecular-microbiology-t/2026-07-09monthly0.6 https://openbiodx.com/2025/09/02/default-mailed-fit-kit-outperforms-active-choice-strategies-for-colorectal-scree/2026-07-09monthly0.6 https://openbiodx.com/2025/09/02/targeting-dormant-tumour-cells-with-everolimus-and-hydroxychloroquine-depletes-m/2026-07-09monthly0.6 https://openbiodx.com/2025/09/01/pcsk9-inhibition-does-not-prevent-saphenous-vein-graft-failure-after-cabg-despit/2026-07-09monthly0.6 https://openbiodx.com/2025/08/29/lancet-review-frames-heart-failure-prevention-within-cardiovascular-kidney-metab/2026-07-09monthly0.6 https://openbiodx.com/2025/08/28/updated-review-of-cardiac-troponin-biology-reframes-myocardial-injury-and-infarc/2026-07-09monthly0.6 https://openbiodx.com/2025/08/28/multimodal-eyecare-foundation-model-improves-diagnostic-accuracy-in-randomized-c/2026-07-09monthly0.6 https://openbiodx.com/2025/08/28/revumenib-shows-meaningful-responses-in-npm1-mutated-relapsed-refractory-aml/2026-07-09monthly0.6 https://openbiodx.com/2025/08/27/deep-learning-predicts-axillary-pathological-complete-response-in-breast-cancer-/2026-07-09monthly0.6 https://openbiodx.com/2025/08/27/crispr-engineered-allogeneic-car-t-cells-induce-remission-in-refractory-lupus/2026-07-09monthly0.6 https://openbiodx.com/2025/08/25/senolytics-combined-with-anti-pd-1-therapy-show-promise-in-head-and-neck-cancer/2026-07-09monthly0.6 https://openbiodx.com/2025/08/21/checkpoint-inhibitor-exposure-before-allogeneic-transplant-improves-pfs-in-hodgk/2026-07-09monthly0.6 https://openbiodx.com/2025/08/21/combined-pet-and-ctdna-response-predicts-early-progression-in-follicular-lymphom/2026-07-09monthly0.6 https://openbiodx.com/2025/08/20/ai-system-diagnoses-acute-aortic-syndrome-from-non-contrast-ct-cutting-time-to-d/2026-07-09monthly0.6 https://openbiodx.com/2025/08/20/non-diphtheriae-corynebacterium-an-underestimated-clinical-pathogen-requiring-ma/2026-07-09monthly0.6 https://openbiodx.com/2025/08/13/laboratory-diagnostics-for-emergency-bleeding-a-core-panel-for-rapid-clinical-de/2026-07-09monthly0.6 https://openbiodx.com/2025/08/11/equipment-validation-for-sterility-testing-in-clinical-labs-iq-oq-pq-framework-e/2026-07-09monthly0.6 https://openbiodx.com/2025/08/09/vmat2-inhibitors-in-movement-disorders-pharmacogenetics-shapes-personalised-dosi/2026-07-09monthly0.6 https://openbiodx.com/2025/08/07/clsi-m100-updates-new-ast-breakpoints-and-reporting-guidance-for-clinical-labora/2026-07-09monthly0.6 https://openbiodx.com/2025/08/07/sustained-mrd-negativity-by-ngs-is-the-optimal-endpoint-for-treatment-cessation-/2026-07-09monthly0.6 https://openbiodx.com/2025/08/05/lorundrostat-a-novel-aldosterone-synthase-inhibitor-significantly-lowers-blood-p/2026-07-09monthly0.6 https://openbiodx.com/2025/08/05/emerging-molecular-targets-in-breast-cancer-from-ngs-and-liquid-biopsy-to-spatia/2026-07-09monthly0.6 https://openbiodx.com/2025/08/04/cancer-of-unknown-primary-molecular-profiling-transforms-a-diagnostic-dead-end/2026-07-09monthly0.6 https://openbiodx.com/2025/08/01/early-ctdna-response-predicts-immunotherapy-outcomes-in-msi-high-metastatic-colo/2026-07-09monthly0.6 https://openbiodx.com/2025/08/01/high-dose-aumolertinib-shows-durable-cns-response-in-egfr-mutant-nsclc-with-brai/2026-07-09monthly0.6 https://openbiodx.com/2025/07/23/ai-driven-crop-improvement-integrating-genome-editing-protein-design-and-multi-o/2026-07-09monthly0.6 https://openbiodx.com/2025/07/22/panecho-ai-system-achieves-complete-echocardiography-interpretation-across-39-me/2026-07-09monthly0.6 https://openbiodx.com/2025/07/18/vitek-mitube-enables-direct-maldi-tof-identification-of-gram-negative-bacteria-f/2026-07-09monthly0.6 https://openbiodx.com/2025/07/15/belantamab-mafodotin-triplet-shows-overall-survival-benefit-and-doubled-mrd-nega/2026-07-09monthly0.6 https://openbiodx.com/2025/07/14/ai-xenotransplantation-and-regenerative-medicine-are-converging-to-address-the-o/2026-07-09monthly0.6 https://openbiodx.com/2025/07/11/blood-culture-contamination-across-52-us-hospitals-variability-in-definitions-im/2026-07-09monthly0.6 https://openbiodx.com/2025/07/11/qiastat-dx-gi-panel-2-detects-17-enteric-pathogens-with-over-90-agreement-in-mul/2026-07-09monthly0.6 https://openbiodx.com/2025/07/10/comprehensive-review-frames-mrd-as-a-powerful-but-incompletely-standardised-biom/2026-07-09monthly0.6 https://openbiodx.com/2025/07/10/brecadd-preserves-fertility-significantly-better-than-ebeacopp-in-advanced-hodgk/2026-07-09monthly0.6 https://openbiodx.com/2025/07/07/eha-emn-guidelines-integrate-mrd-and-mass-spectrometry-monitoring-for-multiple-m/2026-07-09monthly0.6 https://openbiodx.com/2025/07/03/international-study-reveals-distinct-mutational-patterns-in-early-onset-colorect/2026-07-09monthly0.6 https://openbiodx.com/2025/07/03/personalised-cancer-vaccines-ngs-guided-neoantigen-targeting-enters-pivotal-tria/2026-07-09monthly0.6 https://openbiodx.com/2025/07/03/isatuximab-carfilzomib-quadruplet-induction-achieves-63-mrd-negativity-in-newly-/2026-07-09monthly0.6 https://openbiodx.com/2025/07/02/virtual-ihc-staining-from-h-e-in-breast-cancer-a-benchmark-of-deep-generative-mo/2026-07-09monthly0.6 https://openbiodx.com/2025/07/02/somatic-mosaicism-network-maps-mutations-across-19-tissue-types-to-build-a-human/2026-07-09monthly0.6 https://openbiodx.com/2025/07/02/cobas-liat-poc-rt-pcr-for-sars-cov-2-and-influenza-shows-over-98-agreement-with-/2026-07-09monthly0.6 https://openbiodx.com/2025/07/02/tumor-infiltrating-lymphocytes-gain-ground-as-a-cost-effective-breast-cancer-bio/2026-07-09monthly0.6 https://openbiodx.com/2025/07/01/lancet-series-precision-monitoring-and-ai-driven-diagnostics-are-reshaping-trans/2026-07-09monthly0.6 https://openbiodx.com/2025/07/01/second-large-validation-study-confirms-blood-based-ctdna-test-detects-79-of-colo/2026-07-09monthly0.6 https://openbiodx.com/2025/06/27/laboratory-medicine-central-to-ckd-mbd-management-pth-vitamin-d-and-bone-turnove/2026-07-09monthly0.6 https://openbiodx.com/2025/06/25/mast-cell-heterogeneity-predicts-anti-pd-1-response-in-triple-negative-breast-ca/2026-07-09monthly0.6 https://openbiodx.com/2025/06/24/grape-deep-learning-enables-large-scale-gastric-cancer-screening-from-non-contra/2026-07-09monthly0.6 https://openbiodx.com/2025/06/23/capsule-sponge-biomarker-panel-stratifies-barrett-s-oesophagus-risk-and-could-re/2026-07-09monthly0.6 https://openbiodx.com/2025/06/23/isup-consensus-refines-reporting-standards-for-prostate-cancer-precursor-lesions/2026-07-09monthly0.6 https://openbiodx.com/2025/06/19/lancet-energize-trial-mitapivat-raises-haemoglobin-in-non-transfusion-dependent-/2026-07-09monthly0.6 https://openbiodx.com/2025/06/18/blood-based-biomarkers-for-neurological-disorders-from-simoa-to-clinical-impleme/2026-07-09monthly0.6 https://openbiodx.com/2025/06/17/cascade-reporting-of-ast-results-stewardship-tool-or-surveillance-blind-spot/2026-07-09monthly0.6 https://openbiodx.com/2025/06/17/korean-society-for-laboratory-medicine-publishes-standardized-venous-blood-colle/2026-07-09monthly0.6 https://openbiodx.com/2025/06/16/asm-guideline-rapid-diagnostics-on-positive-blood-cultures-reduce-time-to-therap/2026-07-09monthly0.6 https://openbiodx.com/2025/06/15/mrd-guided-ibrutinib-venetoclax-achieves-94-five-year-pfs-in-first-line-cll/2026-07-09monthly0.6 https://openbiodx.com/2025/06/13/contact-02-final-analysis-cabozantinib-atezolizumab-improves-pfs-but-not-os-in-m/2026-07-09monthly0.6 https://openbiodx.com/2025/06/13/multi-cancer-early-detection-via-liquid-biopsy-promises-pitfalls-and-what-comes-/2026-07-09monthly0.6 https://openbiodx.com/2025/06/12/plasma-ptau217-abeta42-ratio-outperforms-individual-biomarkers-for-detecting-bra/2026-07-09monthly0.6 https://openbiodx.com/2025/06/11/embodied-ai-in-ophthalmology-from-perception-to-autonomous-clinical-action/2026-07-09monthly0.6 https://openbiodx.com/2025/06/06/new-colorectal-cancer-screening-methods-cfdna-blood-tests-and-improved-stool-bio/2026-07-09monthly0.6 https://openbiodx.com/2025/06/05/microrna-based-risk-score-stratifies-type-1-diabetes-risk-across-global-populati/2026-07-09monthly0.6 https://openbiodx.com/2025/06/05/acute-rheumatic-fever-molecular-poc-tests-and-biomarker-discovery-could-transfor/2026-07-09monthly0.6 https://openbiodx.com/2025/06/05/murano-final-analysis-shows-7-year-durability-of-mrd-guided-venetoclax-rituximab/2026-07-09monthly0.6 https://openbiodx.com/2025/06/04/impassion031-final-results-ctdna-dynamics-add-prognostic-value-beyond-pathologic/2026-07-09monthly0.6 https://openbiodx.com/2025/06/03/meta-analysis-finds-no-meaningful-difference-between-hs-ctni-and-hs-ctnt-for-car/2026-07-09monthly0.6 https://openbiodx.com/2025/06/03/first-ai-designed-drug-reaches-phase-2a-rentosertib-shows-lung-function-improvem/2026-07-09monthly0.6 https://openbiodx.com/2025/06/03/acquired-therapy-resistance-in-cancer-a-roadmap-for-ai-driven-prediction-and-pre/2026-07-09monthly0.6 https://openbiodx.com/2025/06/03/ai-and-molecular-biomarkers-drive-precision-diagnosis-in-lupus-nephritis/2026-07-09monthly0.6 https://openbiodx.com/2025/06/03/mrd-guided-consolidation-in-myeloma-midas-trial-tests-personalised-treatment-int/2026-07-09monthly0.6 https://openbiodx.com/2025/06/03/post-neoadjuvant-breast-pathology-current-reporting-standards-and-biomarker-test/2026-07-09monthly0.6 https://openbiodx.com/2025/06/03/novel-methylglyoxal-albumin-biomarker-predicts-new-onset-diabetes-in-prediabetic/2026-07-09monthly0.6 https://openbiodx.com/2025/06/02/liaison-plex-yeast-blood-culture-assay-identifies-16-fungal-pathogens-with-100-s/2026-07-09monthly0.6 https://openbiodx.com/2025/06/02/neoadjuvant-nivolumab-plus-chemotherapy-delivers-five-year-overall-survival-bene/2026-07-09monthly0.6 https://openbiodx.com/2025/06/01/ctdna-detected-esr1-mutations-guide-first-line-switch-to-camizestrant-in-advance/2026-07-09monthly0.6 https://openbiodx.com/2025/05/29/venetoclax-decitabine-non-inferior-to-intensive-chemotherapy-in-young-aml-patien/2026-07-09monthly0.6 https://openbiodx.com/2025/05/29/extended-ibrutinib-venetoclax-schedule-achieves-53-undetectable-mrd-in-relapsed-/2026-07-09monthly0.6 https://openbiodx.com/2025/05/28/circulating-forms-of-cardiac-troponin-implications-for-immunoassay-design-and-cl/2026-07-09monthly0.6 https://openbiodx.com/2025/05/28/primary-renal-ewing-sarcoma-24-case-series-identifies-rare-ewsr1-etv4-fusion/2026-07-09monthly0.6 https://openbiodx.com/2025/05/27/ai-in-breast-pathology-from-her2-quantification-to-novel-biomarker-discovery/2026-07-09monthly0.6 https://openbiodx.com/2025/05/27/multiomics-tumour-profiling-guides-personalized-melanoma-treatment-in-prospectiv/2026-07-09monthly0.6 https://openbiodx.com/2025/05/27/ctdna-fraction-predicts-psma-targeted-radioligand-therapy-response-in-metastatic/2026-07-09monthly0.6 https://openbiodx.com/2025/05/20/reinforcement-learning-model-recommends-earlier-vasopressin-in-septic-shock-asso/2026-07-09monthly0.6 https://openbiodx.com/2025/05/15/noninvasive-prenatal-testing-for-red-blood-cell-and-platelet-antigens-enters-cli/2026-07-09monthly0.6 https://openbiodx.com/2025/05/10/six-inflammatory-biomarkers-compared-for-infection-diagnosis-in-the-emergency-de/2026-07-09monthly0.6 https://openbiodx.com/2025/05/09/equant-system-enables-same-day-disk-diffusion-ast-directly-from-positive-blood-c/2026-07-09monthly0.6 https://openbiodx.com/2025/05/08/flt3-itd-mrd-levels-predict-relapse-and-guide-gilteritinib-maintenance-after-tra/2026-07-09monthly0.6 https://openbiodx.com/2025/05/07/lancet-phase-3-tandem-trial-obicetrapib-ezetimibe-combination-cuts-ldl-cholester/2026-07-09monthly0.6 https://openbiodx.com/2025/05/05/next-generation-high-sensitivity-cardiac-troponin-assays-expanding-the-diagnosti/2026-07-09monthly0.6 https://openbiodx.com/2025/05/05/pharmacogenomic-testing-in-practice-who-when-and-which-model-to-use/2026-07-09monthly0.6 https://openbiodx.com/2025/05/01/antimicrobial-resistance-up-to-three-times-higher-in-outpatients-with-cancer-tha/2026-07-09monthly0.6 https://openbiodx.com/2025/04/29/large-language-models-in-precision-oncology-from-screening-to-treatment-recommen/2026-07-09monthly0.6 https://openbiodx.com/2025/04/29/first-in-human-crispr-knockout-of-intracellular-checkpoint-cish-in-til-therapy-f/2026-07-09monthly0.6 https://openbiodx.com/2025/04/29/advancing-anaerobic-microbial-cultivation-to-complement-ngs-based-microbiome-res/2026-07-09monthly0.6 https://openbiodx.com/2025/04/24/eflm-conference-maps-new-frontiers-in-preanalytical-quality-from-ai-to-liquid-bi/2026-07-09monthly0.6 https://openbiodx.com/2025/04/21/presepsin-cut-off-of-713-ng-l-shows-good-accuracy-for-late-onset-sepsis-in-criti/2026-07-09monthly0.6 https://openbiodx.com/2025/04/17/large-uk-cohort-maps-kras-mutation-landscape-in-non-small-cell-lung-cancer/2026-07-09monthly0.6 https://openbiodx.com/2025/04/17/who-5th-edition-genomics-driven-reclassification-of-myeloid-neoplasms/2026-07-09monthly0.6 https://openbiodx.com/2025/04/15/gwas-identifies-first-genetic-locus-for-drug-resistant-focal-epilepsy/2026-07-09monthly0.6 https://openbiodx.com/2025/04/15/ddpcr-based-ctdna-predicts-recurrence-in-resected-stage-iii-melanoma-on-combi-ad/2026-07-09monthly0.6 https://openbiodx.com/2025/04/10/structural-interventions-and-rapid-diagnostics-key-to-controlling-bacterial-sti-/2026-07-09monthly0.6 https://openbiodx.com/2025/04/10/sclc-heterogeneity-and-phenotypic-plasticity-demand-new-biomarker-strategies/2026-07-09monthly0.6 https://openbiodx.com/2025/04/09/amie-google-s-diagnostic-ai-outperforms-primary-care-physicians-in-blinded-text-/2026-07-09monthly0.6 https://openbiodx.com/2025/04/07/broad-324-gene-panel-identifies-more-matched-therapies-but-no-outcome-gain-in-ad/2026-07-09monthly0.6 https://openbiodx.com/2025/04/07/her2-testing-evolves-from-companion-diagnostic-to-precision-quantification/2026-07-09monthly0.6 https://openbiodx.com/2025/04/07/review-maps-opportunities-and-barriers-for-mrd-guided-treatment-in-multiple-myel/2026-07-09monthly0.6 https://openbiodx.com/2025/04/02/pharmacogenomic-testing-evolves-from-targeted-genotyping-toward-sequencing-based/2026-07-09monthly0.6 https://openbiodx.com/2025/04/01/talapro-2-hrr-deficient-cohort-parp-ar-combination-delays-symptom-deterioration-/2026-07-09monthly0.6 https://openbiodx.com/2025/04/01/talapro-2-all-comers-talazoparib-enzalutamide-preserves-quality-of-life-in-mcrpc/2026-07-09monthly0.6 https://openbiodx.com/2025/03/31/selux-next-generation-phenotyping-system-enables-same-day-ast-directly-from-posi/2026-07-09monthly0.6 https://openbiodx.com/2025/03/31/solbinsiran-sirna-targeting-angptl3-reduces-apob-in-mixed-dyslipidaemia-phase-2-/2026-07-09monthly0.6 https://openbiodx.com/2025/03/31/urine-based-hpv-testing-by-real-time-pcr-achieves-82-sensitivity-in-meta-analysi/2026-07-09monthly0.6 https://openbiodx.com/2025/03/28/integrating-high-sensitivity-troponin-into-emergency-chest-pain-evaluation/2026-07-09monthly0.6 https://openbiodx.com/2025/03/27/bmj-living-guideline-recommends-against-routine-ai-assisted-polyp-detection-duri/2026-07-09monthly0.6 https://openbiodx.com/2025/03/27/fit-based-colorectal-screening-non-inferior-to-colonoscopy-for-cancer-mortality-/2026-07-09monthly0.6 https://openbiodx.com/2025/03/26/multimodal-generative-ai-for-automated-medical-image-reporting-progress-and-clin/2026-07-09monthly0.6 https://openbiodx.com/2025/03/25/rapid-cns2-nanopore-based-platform-delivers-intraoperative-molecular-brain-tumou/2026-07-09monthly0.6 https://openbiodx.com/2025/03/24/comprehensive-review-maps-ctdna-treatment-monitoring-across-lung-colorectal-and-/2026-07-09monthly0.6 https://openbiodx.com/2025/03/22/european-liquid-biopsy-society-issues-consensus-guidelines-for-ctdna-test-report/2026-07-09monthly0.6 https://openbiodx.com/2025/03/21/exemestane-cross-reacts-with-all-androstenedione-immunoassays-causing-falsely-el/2026-07-09monthly0.6 https://openbiodx.com/2025/03/20/zanubrutinib-venetoclax-obinutuzumab-achieves-85-undetectable-mrd-in-relapsed-cl/2026-07-09monthly0.6 https://openbiodx.com/2025/03/19/sustainable-surgical-pathology-carbon-footprint-reduction-through-digital-pathol/2026-07-09monthly0.6 https://openbiodx.com/2025/03/18/out-of-hospital-cardiac-arrest-in-young-adults-troponin-central-to-the-diagnosti/2026-07-09monthly0.6 https://openbiodx.com/2025/03/17/metabolomic-biomarkers-show-promise-for-breast-cancer-diagnosis-and-prognosis/2026-07-09monthly0.6 https://openbiodx.com/2025/03/17/adaura-mrd-analysis-ctdna-detects-recurrence-4-7-months-before-imaging-in-resect/2026-07-09monthly0.6 https://openbiodx.com/2025/03/14/review-using-ctdna-to-map-resistance-mechanisms-to-targeted-therapy-in-nsclc/2026-07-09monthly0.6 https://openbiodx.com/2025/03/13/multicenter-aieop-bfm-study-standardizes-flow-cytometry-mrd-assessment-in-pediat/2026-07-09monthly0.6 https://openbiodx.com/2025/03/12/systematic-review-professional-use-glucometers-meet-iso-15197-accuracy-standards/2026-07-09monthly0.6 https://openbiodx.com/2025/03/12/adding-a-return-deadline-to-fit-invitation-letters-boosts-colorectal-screening-u/2026-07-09monthly0.6 https://openbiodx.com/2025/03/07/dynamic-trial-5-year-data-validate-ctdna-guided-adjuvant-chemotherapy-de-escalat/2026-07-09monthly0.6 https://openbiodx.com/2025/03/04/comprehensive-review-maps-the-cfdna-fragmentome-as-a-multi-feature-platform-for-/2026-07-09monthly0.6 https://openbiodx.com/2025/03/03/laboratory-reference-ranges-for-transgender-patients-on-gender-affirming-hormone/2026-07-09monthly0.6 https://openbiodx.com/2025/03/01/urinary-dna-methylation-test-achieves-89-sensitivity-for-high-grade-bladder-canc/2026-07-09monthly0.6 https://openbiodx.com/2025/03/01/molecular-testing-now-indispensable-for-who-classification-of-cns-tumors/2026-07-09monthly0.6 https://openbiodx.com/2025/03/01/genomic-signatures-may-enable-personalized-radiotherapy-decisions-in-breast-canc/2026-07-09monthly0.6 https://openbiodx.com/2025/02/28/poc-glucose-metre-matches-blood-gas-analyser-accuracy-across-all-neonatal-gestat/2026-07-09monthly0.6 https://openbiodx.com/2025/02/26/mass-spectrometry-proteomics-reaches-single-cell-resolution-and-clinical-scale/2026-07-09monthly0.6 https://openbiodx.com/2025/02/25/adapt-sepsis-trial-procalcitonin-guided-antibiotic-stewardship-safely-reduces-tr/2026-07-09monthly0.6 https://openbiodx.com/2025/02/14/high-steacs-pathway-most-efficient-for-early-mi-rule-out-using-siemens-hs-ctni/2026-07-09monthly0.6 https://openbiodx.com/2025/02/14/ai-guided-catheter-ablation-proves-superior-to-standard-pulmonary-vein-isolation/2026-07-09monthly0.6 https://openbiodx.com/2025/02/13/molecular-profiling-defines-high-risk-mantle-cell-lymphoma-and-guides-therapy-se/2026-07-09monthly0.6 https://openbiodx.com/2025/02/12/digital-pathology-in-2025-an-update-on-clinical-diagnosis-telepathology-educatio/2026-07-09monthly0.6 https://openbiodx.com/2025/02/12/predictive-model-identifies-children-with-vasovagal-syncope-who-will-respond-to-/2026-07-09monthly0.6 https://openbiodx.com/2025/02/11/digital-pathology-ai-faces-a-reality-check-progress-and-barriers-to-clinical-ado/2026-07-09monthly0.6 https://openbiodx.com/2025/02/07/high-sensitivity-cardiac-troponin-from-subclinical-risk-to-poc-emergency-diagnos/2026-07-09monthly0.6 https://openbiodx.com/2025/02/05/gpt-4-improves-physician-performance-on-clinical-management-reasoning-tasks/2026-07-09monthly0.6 https://openbiodx.com/2025/02/05/cepheus-trial-daratumumab-vrd-quadruplet-sets-new-standard-in-transplant-ineligi/2026-07-09monthly0.6 https://openbiodx.com/2025/02/05/personalised-neoantigen-vaccine-targets-driver-mutations-and-prevents-recurrence/2026-07-09monthly0.6 https://openbiodx.com/2025/02/01/deep-learning-from-h-e-slides-predicts-immunotherapy-response-in-advanced-nsclc/2026-07-09monthly0.6 https://openbiodx.com/2025/01/31/practical-guide-for-implementing-dpyd-genotyping-in-fluoropyrimidine-prescribing/2026-07-09monthly0.6 https://openbiodx.com/2025/01/30/chemo-free-boven-triplet-meets-efficacy-endpoint-in-tp53-mutant-mantle-cell-lymp/2026-07-09monthly0.6 https://openbiodx.com/2025/01/22/largest-bipolar-disorder-gwas-identifies-298-risk-loci-and-implicates-gabaergic-/2026-07-09monthly0.6 https://openbiodx.com/2025/01/20/ctdna-in-early-and-locally-advanced-nsclc-evidence-review-and-clinical-readiness/2026-07-09monthly0.6 https://openbiodx.com/2025/01/18/lancet-review-multidrug-resistant-gram-negative-infections-demand-rapid-diagnost/2026-07-09monthly0.6 https://openbiodx.com/2025/01/17/tucatinib-trastuzumab-shows-42-response-rate-in-her2-mutated-her2-negative-breas/2026-07-09monthly0.6 https://openbiodx.com/2025/01/16/daratumumab-lenalidomide-maintenance-doubles-mrd-negative-conversion-after-trans/2026-07-09monthly0.6 https://openbiodx.com/2025/01/15/baseline-ctdna-level-and-early-clearance-predict-survival-in-locally-advanced-re/2026-07-09monthly0.6 https://openbiodx.com/2025/01/13/ca-125-screening-offers-a-12-month-window-for-early-stage-ovarian-cancer-detecti/2026-07-09monthly0.6 https://openbiodx.com/2025/01/09/frontline-large-b-cell-lymphoma-trials-increasingly-leverage-ctdna-for-response-/2026-07-09monthly0.6 https://openbiodx.com/2025/01/08/tripod-llm-first-reporting-guideline-for-large-language-models-in-healthcare-res/2026-07-09monthly0.6 https://openbiodx.com/2025/01/07/multicenter-validation-of-the-maglumi-high-sensitivity-cardiac-troponin-i-assay-/2026-07-09monthly0.6 https://openbiodx.com/2025/01/07/real-world-ai-supported-mammography-screening-detects-17-6-more-cancers-without-/2026-07-09monthly0.6 https://openbiodx.com/2025/01/06/anatomy-of-an-eqa-cycle-from-sample-distribution-to-performance-assessment/2026-07-09monthly0.6 https://openbiodx.com/2025/01/06/eqa-sample-design-homogeneity-stability-and-clinically-relevant-targets/2026-07-09monthly0.6 https://openbiodx.com/2025/01/06/inside-external-quality-assessment-structure-lifecycle-and-stakeholder-impact-of/2026-07-09monthly0.6 https://openbiodx.com/2025/01/06/immunotherapy-advances-in-squamous-lung-cancer-biomarker-challenges-and-emerging/2026-07-09monthly0.6 https://openbiodx.com/2025/01/06/eqa-beyond-the-lab-how-external-quality-assessment-supports-regulators-ivd-surve/2026-07-09monthly0.6 https://openbiodx.com/2025/01/06/eqa-benefits-for-laboratories-from-ivd-verification-to-staff-competence-monitori/2026-07-09monthly0.6 https://openbiodx.com/2025/01/06/novel-diagnostics-for-urinary-tract-infections-molecular-methods-and-ngs-enter-t/2026-07-09monthly0.6 https://openbiodx.com/2025/01/03/polygenic-risk-scores-poised-to-reshape-precision-medicine-across-diseases/2026-07-09monthly0.6 https://openbiodx.com/2025/01/02/ai-driven-ultrasound-outperforms-expert-examiners-in-ovarian-cancer-detection-ac/2026-07-09monthly0.6 https://openbiodx.com/2025/01/02/managing-post-immunotherapy-relapse-in-b-all-antigen-escape-and-lineage-switch/2026-07-09monthly0.6 https://openbiodx.com/2025/01/02/philadelphia-chromosome-like-all-ngs-guided-targeted-therapy-strategies/2026-07-09monthly0.6 https://openbiodx.com/2025/01/02/expert-review-redefines-etp-all-management-with-mrd-guided-risk-stratification/2026-07-09monthly0.6 https://openbiodx.com/2025/01/01/precision-imaging-in-oncology-bridging-the-gap-between-liquid-biopsy-and-treatme/2026-07-09monthly0.6 https://openbiodx.com/2024/12/24/digital-health-intervention-reduces-childhood-obesity-in-diverse-population-gree/2026-07-09monthly0.6 https://openbiodx.com/2024/12/22/deep-learning-for-tumour-purity-estimation-outperforms-pathologist-review-and-mo/2026-07-09monthly0.6 https://openbiodx.com/2024/12/20/her2-fish-proficiency-testing-in-china-reveals-persistent-standardisation-gaps/2026-07-09monthly0.6 https://openbiodx.com/2024/12/19/review-examines-mrd-monitoring-and-molecular-biomarkers-for-risk-stratification-/2026-07-09monthly0.6 https://openbiodx.com/2024/12/17/two-transcript-signature-distinguishes-sfts-viral-infection-from-bacterial-sepsi/2026-07-09monthly0.6 https://openbiodx.com/2024/12/16/patient-derived-xenograft-models-for-functional-precision-oncology-in-the-ai-era/2026-07-09monthly0.6 https://openbiodx.com/2024/12/15/plasma-proteomics-identifies-mortality-associated-protein-signatures-in-sepsis/2026-07-09monthly0.6 https://openbiodx.com/2024/12/11/pi-hub-international-initiative-maps-the-complete-human-proteome-for-precision-m/2026-07-09monthly0.6 https://openbiodx.com/2024/12/06/rethinking-uti-diagnostics-the-case-for-rapid-culture-independent-testing/2026-07-09monthly0.6 https://openbiodx.com/2024/12/06/deepgem-deep-learning-predicts-gene-mutations-from-routine-histology-slides-in-l/2026-07-09monthly0.6 https://openbiodx.com/2024/12/05/point-of-care-testing-cuts-emergency-department-decision-time-by-75-minutes-in-m/2026-07-09monthly0.6 https://openbiodx.com/2024/12/05/prenatal-cfdna-screening-incidentally-detects-occult-maternal-cancer-in-nearly-h/2026-07-09monthly0.6 https://openbiodx.com/2024/12/04/wearable-biosensors-for-body-fluid-analysis-from-sweat-to-interstitial-fluid-mon/2026-07-09monthly0.6 https://openbiodx.com/2024/12/04/cas12-and-tnpb-variants-expanding-the-crispr-toolkit-for-editing-and-diagnostics/2026-07-09monthly0.6 https://openbiodx.com/2024/12/03/synthetic-lethality-from-parp-inhibitors-to-a-new-generation-of-targeted-cancer-/2026-07-09monthly0.6 https://openbiodx.com/2024/12/02/mass-spectrometry-transforms-clinical-immunoglobulin-analysis-and-m-protein-dete/2026-07-09monthly0.6 https://openbiodx.com/2024/11/28/pantel-and-alix-panabieres-outline-how-ctdna-guided-mrd-detection-could-enable-c/2026-07-09monthly0.6 https://openbiodx.com/2024/11/26/managing-measurement-bias-in-the-metrological-traceability-era-from-ivd-surveill/2026-07-09monthly0.6 https://openbiodx.com/2024/11/23/integrating-cardiac-biomarkers-with-ct-coronary-angiography-for-coronary-heart-d/2026-07-09monthly0.6 https://openbiodx.com/2024/11/20/balance-trial-7-day-antibiotic-treatment-is-noninferior-to-14-days-for-bloodstre/2026-07-09monthly0.6 https://openbiodx.com/2024/11/19/angioimmunoblastic-t-cell-lymphoma-diagnostic-pathology-and-molecular-landscape/2026-07-09monthly0.6 https://openbiodx.com/2024/11/18/managing-difficult-to-treat-acinetobacter-infections-from-mic-guided-therapy-to-/2026-07-09monthly0.6 https://openbiodx.com/2024/11/18/aav9-gene-therapy-for-danon-disease-restores-cardiac-lamp2-expression-at-up-to-5/2026-07-09monthly0.6 https://openbiodx.com/2024/11/17/tirzepatide-reduces-blood-volume-inflammation-and-cardiac-biomarkers-in-obesity-/2026-07-09monthly0.6 https://openbiodx.com/2024/11/16/crispr-cas9-ttr-gene-editing-achieves-90-transthyretin-reduction-in-attr-cardiom/2026-07-09monthly0.6 https://openbiodx.com/2024/11/15/hybridization-bait-capture-target-enrichment-advances-public-health-microbiology/2026-07-09monthly0.6 https://openbiodx.com/2024/11/13/fastglioma-foundation-model-detects-brain-tumour-infiltration-in-under-10-second/2026-07-09monthly0.6 https://openbiodx.com/2024/11/11/standardised-nomenclature-proposed-for-human-and-animal-fungal-pathogens-and-dis/2026-07-09monthly0.6 https://openbiodx.com/2024/11/09/oncolytic-virus-plus-nivolumab-achieves-42-complete-response-in-bladder-cancer-g/2026-07-09monthly0.6 https://openbiodx.com/2024/11/08/global-eqa-for-semen-analysis-34-years-of-inconsistency-and-high-inter-laborator/2026-07-09monthly0.6 https://openbiodx.com/2024/11/06/large-prospective-study-leads-to-fda-clearance-of-cepheid-xpert-xpress-cov-2-plu/2026-07-09monthly0.6 https://openbiodx.com/2024/11/04/asm-guidelines-evidence-based-interventions-cut-blood-culture-contamination-by-4/2026-07-09monthly0.6 https://openbiodx.com/2024/11/04/ai-based-pathology-tool-validated-for-mash-scoring-in-clinical-trials/2026-07-09monthly0.6 https://openbiodx.com/2024/11/01/ai-rano-part-2-standardisation-and-validation-recommendations-for-ai-in-neuro-on/2026-07-09monthly0.6 https://openbiodx.com/2024/11/01/ai-rano-part-1-ai-for-diagnosis-prediction-and-response-assessment-in-neuro-onco/2026-07-09monthly0.6 https://openbiodx.com/2024/11/01/oral-serd-camizestrant-outperforms-fulvestrant-in-er-positive-advanced-breast-ca/2026-07-09monthly0.6 https://openbiodx.com/2024/11/01/cystatin-c-as-a-gfr-biomarker-adoption-challenges-and-standardisation-gaps/2026-07-09monthly0.6 https://openbiodx.com/2024/11/01/multiplexed-tissue-imaging-poised-to-transform-precision-oncology-workflows/2026-07-09monthly0.6 https://openbiodx.com/2024/11/01/beyond-pcr-residual-disease-biology-and-ctdna-refine-post-neoadjuvant-strategy-i/2026-07-09monthly0.6 https://openbiodx.com/2024/11/01/cfdna-fragmentome-blood-test-validated-for-augmenting-lung-cancer-screening/2026-07-09monthly0.6 https://openbiodx.com/2024/10/31/treatment-landscape-for-nodal-peripheral-t-cell-lymphomas-moving-toward-biomarke/2026-07-09monthly0.6 https://openbiodx.com/2024/10/31/triple-epigenetic-immunotherapy-overcomes-anti-pd-1-resistance-in-hodgkin-lympho/2026-07-09monthly0.6 https://openbiodx.com/2024/10/29/valemetostat-dual-ezh-inhibitor-shows-55-response-rate-in-relapsed-non-hodgkin-l/2026-07-09monthly0.6 https://openbiodx.com/2024/10/24/phase-2-trial-confirms-crispr-based-ntla-2002-reduces-hereditary-angioedema-atta/2026-07-09monthly0.6 https://openbiodx.com/2024/10/21/early-cancer-biology-emerging-models-and-multi-omics-tools-for-detecting-precanc/2026-07-09monthly0.6 https://openbiodx.com/2024/10/21/home-based-transcranial-direct-current-stimulation-shows-efficacy-in-major-depre/2026-07-09monthly0.6 https://openbiodx.com/2024/10/15/molecular-diagnostics-in-csf-comprehensive-review-of-pcr-methods-for-cns-infecti/2026-07-09monthly0.6 https://openbiodx.com/2024/10/14/lancet-commission-global-health-2050-strategy-highlights-diagnostics-as-key-to-h/2026-07-09monthly0.6 https://openbiodx.com/2024/10/09/first-reported-primary-adenocarcinoma-of-the-spermatic-cord-with-smarcb1-deficie/2026-07-09monthly0.6 https://openbiodx.com/2024/10/03/doxycycline-post-exposure-prophylaxis-enriches-tetracycline-resistance-genes-in-/2026-07-09monthly0.6 https://openbiodx.com/2024/10/01/expert-framework-calls-for-standardized-neoadjuvant-biopsy-trials-in-glioma-drug/2026-07-09monthly0.6 https://openbiodx.com/2024/09/30/diagnostic-stewardship-in-microbiology-regulatory-foundations-and-the-laboratory/2026-07-09monthly0.6 https://openbiodx.com/2024/09/30/standing-platform-proposed-for-ctdna-guided-cancer-drug-development-in-molecular/2026-07-09monthly0.6 https://openbiodx.com/2024/09/26/quickmic-microfluidic-system-delivers-rapid-ast-from-positive-blood-cultures-in-/2026-07-09monthly0.6 https://openbiodx.com/2024/09/26/nejm-review-neuroleptic-malignant-syndrome-diagnosis-and-management/2026-07-09monthly0.6 https://openbiodx.com/2024/09/23/beacon-crc-biomarker-analysis-reveals-resistance-mechanisms-to-braf-targeted-the/2026-07-09monthly0.6 https://openbiodx.com/2024/09/13/tinivo-2-trial-ici-rechallenge-fails-to-improve-pfs-in-post-checkpoint-renal-cel/2026-07-09monthly0.6 https://openbiodx.com/2024/09/09/rsv-in-children-molecular-poc-testing-and-new-prevention-strategies-reshape-clin/2026-07-09monthly0.6 https://openbiodx.com/2024/09/04/chief-foundation-model-outperforms-existing-methods-by-up-to-36-across-19-cancer/2026-07-09monthly0.6 https://openbiodx.com/2024/09/02/ai-guided-screening-with-digital-stethoscope-doubles-detection-of-peripartum-car/2026-07-09monthly0.6 https://openbiodx.com/2024/09/02/high-sensitivity-troponin-i-point-of-care-assay-matches-lab-performance-in-mi-ru/2026-07-09monthly0.6 https://openbiodx.com/2024/09/01/capivasertib-fulvestrant-maintains-quality-of-life-while-improving-pfs-in-hr-pos/2026-07-09monthly0.6 https://openbiodx.com/2024/09/01/brca1-2-testing-in-males-demands-greater-clinical-attention-given-expanding-ther/2026-07-09monthly0.6 https://openbiodx.com/2024/09/01/systematic-review-validates-undetectable-mrd-as-pfs-surrogate-in-cll-treated-wit/2026-07-09monthly0.6 https://openbiodx.com/2024/08/29/peripheral-blood-mass-spectrometry-provides-non-invasive-mrd-assessment-in-post-/2026-07-09monthly0.6 https://openbiodx.com/2024/08/28/plasma-cell-free-dna-sequencing-now-detects-antimicrobial-resistance-markers-dir/2026-07-09monthly0.6 https://openbiodx.com/2024/08/27/adenovirus-diagnostics-lag-behind-clinical-labs-hold-untapped-research-potential/2026-07-09monthly0.6 https://openbiodx.com/2024/08/26/automated-mri-system-predicts-axillary-complete-response-to-neoadjuvant-chemothe/2026-07-09monthly0.6 https://openbiodx.com/2024/08/22/seven-year-follow-up-confirms-durable-remissions-with-venetoclax-ibrutinib-in-ma/2026-07-09monthly0.6 https://openbiodx.com/2024/08/21/network-meta-analysis-high-dose-psilocybin-outperforms-placebo-for-depression-bu/2026-07-09monthly0.6 https://openbiodx.com/2024/08/20/probio-platform-trial-uses-ctdna-to-guide-treatment-selection-in-metastatic-pros/2026-07-09monthly0.6 https://openbiodx.com/2024/08/19/updated-guidance-for-processing-cf-respiratory-samples-in-the-cftr-modulator-era/2026-07-09monthly0.6 https://openbiodx.com/2024/08/19/copeptin-reviewed-as-surrogate-biomarker-for-vasopressin-in-pediatric-diseases/2026-07-09monthly0.6 https://openbiodx.com/2024/08/13/pharmvar-defines-14-novel-cyp4f2-star-alleles-affecting-warfarin-and-vitamin-k-m/2026-07-09monthly0.6 https://openbiodx.com/2024/08/08/cardiac-mri-shows-myocardial-fibrosis-reversal-after-stem-cell-transplant-in-you/2026-07-09monthly0.6 https://openbiodx.com/2024/08/03/comprehensive-review-maps-liquid-biopsy-landscape-across-pediatric-solid-tumors/2026-07-09monthly0.6 https://openbiodx.com/2024/08/01/postoperative-ctdna-positivity-strongly-predicts-recurrence-in-resectable-pancre/2026-07-09monthly0.6 https://openbiodx.com/2024/08/01/tepotinib-plus-osimertinib-achieves-50-response-rate-in-met-amplified-egfr-mutan/2026-07-09monthly0.6 https://openbiodx.com/2024/07/25/pharmvar-genefocus-cyp2a6-nomenclature-for-nicotine-metabolism-and-drug-interact/2026-07-09monthly0.6 https://openbiodx.com/2024/07/25/antiviral-resistance-testing-in-2024-shifting-from-phenotypic-to-genotypic-metho/2026-07-09monthly0.6 https://openbiodx.com/2024/07/25/fda-aligned-meta-analysis-validates-mrd-negativity-as-surrogate-endpoint-in-myel/2026-07-09monthly0.6 https://openbiodx.com/2024/07/25/blinatumomab-added-to-chemotherapy-improves-survival-in-mrd-negative-adult-all/2026-07-09monthly0.6 https://openbiodx.com/2024/07/24/standardised-cobas-ebv-and-bkv-assays-dramatically-reduce-inter-laboratory-varia/2026-07-09monthly0.6 https://openbiodx.com/2024/07/24/emerging-technologies-in-paediatric-laboratory-medicine-from-microassays-to-mach/2026-07-09monthly0.6 https://openbiodx.com/2024/07/18/obinutuzumab-outperforms-rituximab-in-mantle-cell-lymphoma-with-better-mrd-clear/2026-07-09monthly0.6 https://openbiodx.com/2024/07/18/ctdna-outperforms-flow-cytometry-for-early-relapse-detection-in-cll-triple-combi/2026-07-09monthly0.6 https://openbiodx.com/2024/07/16/spatial-immune-infiltrate-mapping-predicts-outcomes-in-high-risk-soft-tissue-sar/2026-07-09monthly0.6 https://openbiodx.com/2024/07/11/precision-public-health-integrating-genomics-big-data-and-ai-for-population-leve/2026-07-09monthly0.6 https://openbiodx.com/2024/07/08/ai-guided-triage-to-supplemental-mri-detects-cancers-missed-by-mammography-at-fo/2026-07-09monthly0.6 https://openbiodx.com/2024/07/05/laboratory-testing-for-prenatal-substance-exposure-methods-matrices-and-interpre/2026-07-09monthly0.6 https://openbiodx.com/2024/07/04/small-cell-lung-cancer-molecular-subtypes-open-new-diagnostic-and-therapeutic-wi/2026-07-09monthly0.6 https://openbiodx.com/2024/07/01/cpic-guideline-cyp2d6-genotyping-for-metoprolol-dose-adjustment/2026-07-09monthly0.6 https://openbiodx.com/2024/07/01/ctdna-guided-tki-de-escalation-in-advanced-nsclc-enables-median-9-month-treatmen/2026-07-09monthly0.6 https://openbiodx.com/2024/06/28/phase-1-trial-live-bacterial-supplementation-boosts-response-rate-to-cabozantini/2026-07-09monthly0.6 https://openbiodx.com/2024/06/27/car-t-outcomes-vary-by-race-and-ethnicity-real-world-data-from-1-290-lbcl-patien/2026-07-09monthly0.6 https://openbiodx.com/2024/06/26/neonatal-sepsis-a-lancet-seminar-on-diagnosis-treatment-and-the-urgent-need-for-/2026-07-09monthly0.6 https://openbiodx.com/2024/06/25/blood-self-sampling-devices-poised-to-transform-laboratory-diagnostics/2026-07-09monthly0.6 https://openbiodx.com/2024/06/25/prosper-trial-perioperative-nivolumab-fails-to-improve-recurrence-free-survival-/2026-07-09monthly0.6 https://openbiodx.com/2024/06/20/five-drug-vipor-regimen-achieves-durable-remissions-in-molecular-subtypes-of-rel/2026-07-09monthly0.6 https://openbiodx.com/2024/06/19/computational-framework-proposed-to-bridge-rna-seq-signatures-into-pcr-based-cli/2026-07-09monthly0.6 https://openbiodx.com/2024/06/19/urinary-angiogenin-confirmed-as-reliable-biomarker-for-early-bladder-cancer-dete/2026-07-09monthly0.6 https://openbiodx.com/2024/06/19/multi-centre-italian-study-validates-in-house-hrd-testing-as-reliable-alternativ/2026-07-09monthly0.6 https://openbiodx.com/2024/06/19/bfast-trial-validates-liquid-biopsy-guided-entrectinib-for-ros1-positive-lung-ca/2026-07-09monthly0.6 https://openbiodx.com/2024/06/17/expert-consensus-on-point-of-care-testing-balancing-speed-and-accuracy-in-modern/2026-07-09monthly0.6 https://openbiodx.com/2024/06/15/persistent-physical-symptoms-biomarker-gaps-in-somatic-symptom-disorders/2026-07-09monthly0.6 https://openbiodx.com/2024/06/15/cassiopeia-long-term-follow-up-confirms-daratumumab-maintenance-benefit-with-mrd/2026-07-09monthly0.6 https://openbiodx.com/2024/06/11/population-level-prognostic-value-of-troponin-nt-probnp-and-crp-for-cardiovascul/2026-07-09monthly0.6 https://openbiodx.com/2024/06/11/ai-outperforms-radiologists-in-detecting-clinically-significant-prostate-cancer-/2026-07-09monthly0.6 https://openbiodx.com/2024/06/11/hospital-at-home-programs-expose-gaps-in-decentralized-laboratory-support/2026-07-09monthly0.6 https://openbiodx.com/2024/06/11/cpic-finds-insufficient-evidence-to-change-methadone-dosing-based-on-cyp2b6-geno/2026-07-09monthly0.6 https://openbiodx.com/2024/06/05/eflm-updates-european-urinalysis-guideline-with-new-performance-standards/2026-07-09monthly0.6 https://openbiodx.com/2024/06/04/ponatinib-doubles-mrd-negative-complete-remission-rate-versus-imatinib-in-ph-all/2026-07-09monthly0.6 https://openbiodx.com/2024/06/03/multiomics-profiling-of-circulating-tumor-cells-reveals-metastatic-biology-and-c/2026-07-09monthly0.6 https://openbiodx.com/2024/06/03/benefit-trial-isatuximab-vrd-quadruplet-doubles-mrd-negativity-in-transplant-ine/2026-07-09monthly0.6 https://openbiodx.com/2024/06/03/vimseltinib-achieves-40-response-rate-in-tenosynovial-giant-cell-tumour-phase-3-/2026-07-09monthly0.6 https://openbiodx.com/2024/06/03/adagrasib-plus-cetuximab-shows-34-response-rate-in-krasg12c-mutated-colorectal-c/2026-07-09monthly0.6 https://openbiodx.com/2024/06/02/destiny-breast03-long-term-data-confirm-t-dxd-superiority-over-t-dm1-in-her2-pos/2026-07-09monthly0.6 https://openbiodx.com/2024/06/02/donor-derived-cell-free-dna-validates-as-noninvasive-biomarker-for-kidney-transp/2026-07-09monthly0.6 https://openbiodx.com/2024/06/01/radiotherapy-innovation-for-low-income-settings-ai-deep-phenotyping-and-real-tim/2026-07-09monthly0.6 https://openbiodx.com/2024/06/01/radiopharmaceutical-sciences-in-oncology-advances-in-theranostics-radionuclide-p/2026-07-09monthly0.6 https://openbiodx.com/2024/06/01/first-in-human-kat6a-b-inhibitor-shows-durable-activity-in-er-positive-breast-ca/2026-07-09monthly0.6 https://openbiodx.com/2024/06/01/mri-integration-in-prostate-cancer-screening-halves-unnecessary-biopsies-without/2026-07-09monthly0.6 https://openbiodx.com/2024/06/01/venetoclax-obinutuzumab-combinations-show-superior-4-year-pfs-over-chemoimmunoth/2026-07-09monthly0.6 https://openbiodx.com/2024/06/01/belantamab-mafodotin-combination-triples-progression-free-survival-in-relapsed-m/2026-07-09monthly0.6 https://openbiodx.com/2024/06/01/ctdna-dynamics-reveal-distinct-response-patterns-to-immunotherapy-vs-chemotherap/2026-07-09monthly0.6 https://openbiodx.com/2024/05/30/medical-ai-and-human-values-navigating-ethics-equity-and-trust-in-clinical-deplo/2026-07-09monthly0.6 https://openbiodx.com/2024/05/29/orfan-study-ai-enhanced-coronary-inflammation-score-predicts-cardiac-events-in-p/2026-07-09monthly0.6 https://openbiodx.com/2024/05/28/mindray-cl1200i-high-sensitivity-troponin-i-assay-meets-analytical-validation-cr/2026-07-09monthly0.6 https://openbiodx.com/2024/05/27/ai-powered-cardiovascular-risk-assessment-a-scoping-review-of-machine-learning-a/2026-07-09monthly0.6 https://openbiodx.com/2024/05/25/felzartamab-resolves-antibody-mediated-kidney-transplant-rejection-in-phase-2-tr/2026-07-09monthly0.6 https://openbiodx.com/2024/05/23/tackling-amr-requires-integrated-investment-in-antibiotics-vaccines-and-diagnost/2026-07-09monthly0.6 https://openbiodx.com/2024/05/17/practical-guide-to-using-digital-slides-in-histopathology-education/2026-07-09monthly0.6 https://openbiodx.com/2024/05/16/practical-guide-to-ai-for-cancer-researchers-image-analysis-nlp-and-drug-discove/2026-07-09monthly0.6 https://openbiodx.com/2024/05/14/ai-matches-expert-dermatologists-but-significantly-outperforms-generalists-in-sk/2026-07-09monthly0.6 https://openbiodx.com/2024/05/14/destiny-gastric01-biomarker-analysis-reveals-ctdna-and-her2-heterogeneity-challe/2026-07-09monthly0.6 https://openbiodx.com/2024/05/08/brief-case-diagnostic-challenge-in-clinical-microbiology/2026-07-09monthly0.6 https://openbiodx.com/2024/05/08/ethical-and-regulatory-challenges-of-patient-self-testing-and-near-patient-diagn/2026-07-09monthly0.6 https://openbiodx.com/2024/05/07/three-step-psa-kallikrein-mri-protocol-detects-more-aggressive-prostate-cancers-/2026-07-09monthly0.6 https://openbiodx.com/2024/05/06/brilliance-trial-in-vivo-crispr-gene-editing-improves-vision-in-inherited-retina/2026-07-09monthly0.6 https://openbiodx.com/2024/05/04/ai-in-digital-pathology-shows-high-accuracy-but-pervasive-risk-of-bias-across-10/2026-07-09monthly0.6 https://openbiodx.com/2024/05/04/liquid-biopsy-with-mirna-and-ctdna-shows-promise-for-gastric-cancer-screening-an/2026-07-09monthly0.6 https://openbiodx.com/2024/05/02/laboratory-diagnostics-for-endocrine-hypertension-from-current-biomarkers-to-omi/2026-07-09monthly0.6 https://openbiodx.com/2024/05/01/metrological-traceability-for-ivd-standardisation-needs-rigorous-implementation-/2026-07-09monthly0.6 https://openbiodx.com/2024/05/01/ai-in-oncology-current-clinical-integration-across-detection-diagnosis-and-treat/2026-07-09monthly0.6 https://openbiodx.com/2024/05/01/validated-candida-auris-pcr-screening-assay-cuts-turnaround-from-days-to-hours/2026-07-09monthly0.6 https://openbiodx.com/2024/04/30/neoadjuvant-nivolumab-plus-relatlimab-is-feasible-and-safe-before-lung-cancer-su/2026-07-09monthly0.6 https://openbiodx.com/2024/04/29/ai-enabled-ecg-alert-reduces-90-day-all-cause-mortality-by-17-in-hospitalized-pa/2026-07-09monthly0.6 https://openbiodx.com/2024/04/25/elara-update-tisagenlecleucel-shows-durable-responses-at-29-months-in-relapsed-f/2026-07-09monthly0.6 https://openbiodx.com/2024/04/19/automated-neumodx-mpox-assay-differentiates-clade-i-from-clade-ii-with-99-sensit/2026-07-09monthly0.6 https://openbiodx.com/2024/04/13/meta-analysis-ctdna-based-mrd-detection-strongly-predicts-recurrence-across-rese/2026-07-09monthly0.6 https://openbiodx.com/2024/04/10/understanding-clinical-impact-of-ai-errors-in-histopathology-beyond-technical-pe/2026-07-09monthly0.6 https://openbiodx.com/2024/04/08/analytical-performance-specifications-and-their-role-in-metrological-traceabilit/2026-07-09monthly0.6 https://openbiodx.com/2024/04/04/lancet-prostate-cancer-commission-projected-case-surge-demands-diagnostic-capaci/2026-07-09monthly0.6 https://openbiodx.com/2024/03/29/ai-in-neuro-oncology-advances-in-glioma-diagnosis-molecular-profiling-and-precis/2026-07-09monthly0.6 https://openbiodx.com/2024/03/27/deep-learning-in-cancer-genomics-and-histopathology-applications-biases-and-futu/2026-07-09monthly0.6 https://openbiodx.com/2024/03/27/future-of-valvular-heart-disease-ai-digital-twins-pharmacological-targets-and-bi/2026-07-09monthly0.6 https://openbiodx.com/2024/03/27/t-cell-receptor-therapy-afami-cel-achieves-durable-responses-in-mage-a4-positive/2026-07-09monthly0.6 https://openbiodx.com/2024/03/26/lancet-oncology-largest-cmmrd-cohort-reveals-90-cancer-incidence-by-age-18-and-g/2026-07-09monthly0.6 https://openbiodx.com/2024/03/20/microbiologic-diagnosis-of-implant-associated-infections-from-culture-to-ngs/2026-07-09monthly0.6 https://openbiodx.com/2024/03/19/neoadjuvant-immunotherapy-in-esophageal-cancer-ctdna-clearance-reflects-neoantig/2026-07-09monthly0.6 https://openbiodx.com/2024/03/15/sars-cov-2-testing-four-years-on-lessons-learned-and-current-use-cases/2026-07-09monthly0.6 https://openbiodx.com/2024/03/14/shield-blood-test-achieves-83-sensitivity-for-colorectal-cancer-in-eclipse-scree/2026-07-09monthly0.6 https://openbiodx.com/2024/03/11/promise-epi-poc-viral-load-guided-infant-prophylaxis-reduces-postnatal-hiv-trans/2026-07-09monthly0.6 https://openbiodx.com/2024/03/08/cefazolin-surrogacy-for-oral-cephalosporin-susceptibility-in-urinary-tract-infec/2026-07-09monthly0.6 https://openbiodx.com/2024/03/08/neural-antibody-testing-for-autoimmune-cns-disorders-assays-panels-and-clinical-/2026-07-09monthly0.6 https://openbiodx.com/2024/03/07/microplastics-detected-in-carotid-plaques-linked-to-elevated-cardiovascular-risk/2026-07-09monthly0.6 https://openbiodx.com/2024/03/04/at-home-respiratory-virus-testing-regulatory-landscape-and-performance-after-the/2026-07-09monthly0.6 https://openbiodx.com/2024/03/04/triple-combination-of-anti-pd-1-hdac-inhibitor-and-anti-vegf-active-in-mss-color/2026-07-09monthly0.6 https://openbiodx.com/2024/03/02/ifcc-guidance-on-reporting-low-cardiac-troponin-concentrations-in-accelerated-di/2026-07-09monthly0.6 https://openbiodx.com/2024/03/01/deep-learning-enables-10x-mri-acceleration-while-preserving-oncological-biomarke/2026-07-09monthly0.6 https://openbiodx.com/2024/02/29/campylobacter-fetus-susceptibility-patterns-gentamicin-and-meropenem-show-favour/2026-07-09monthly0.6 https://openbiodx.com/2024/02/27/llms-in-diagnostic-medicine-scoping-review-maps-key-barriers-for-digital-patholo/2026-07-09monthly0.6 https://openbiodx.com/2024/02/22/ai-in-breast-cancer-pathology-comprehensive-review-of-diagnostic-grading-and-pre/2026-07-09monthly0.6 https://openbiodx.com/2024/02/22/behcet-s-syndrome-diagnostic-challenges-without-pathognomonic-biomarkers/2026-07-09monthly0.6 https://openbiodx.com/2024/02/19/niacin-metabolites-2py-and-4py-linked-to-cardiovascular-disease-risk-via-vascula/2026-07-09monthly0.6 https://openbiodx.com/2024/02/19/polygenic-risk-scores-near-clinical-use-but-equity-and-standardisation-lag-behin/2026-07-09monthly0.6 https://openbiodx.com/2024/02/19/macroscopic-specimen-handling-in-urological-pathology-needs-a-rethink/2026-07-09monthly0.6 https://openbiodx.com/2024/02/16/preemptive-pharmacogenomic-testing-cuts-psychiatric-adverse-events-and-costs-in-/2026-07-09monthly0.6 https://openbiodx.com/2024/02/14/validating-biological-age-biomarkers-from-epigenetic-clocks-to-multi-omics-predi/2026-07-09monthly0.6 https://openbiodx.com/2024/02/08/micronuclei-as-cancer-biomarkers-from-chromosomal-instability-to-clinical-applic/2026-07-09monthly0.6 https://openbiodx.com/2024/02/07/urine-albumin-measurement-standardization-critical-for-ckd-diagnosis/2026-07-09monthly0.6 https://openbiodx.com/2024/02/05/auc-guided-vancomycin-tdm-with-bayesian-forecasting-recommended-for-all-paediatr/2026-07-09monthly0.6 https://openbiodx.com/2024/02/01/single-dose-in-vivo-crispr-editing-of-klkb1-reduces-angioedema-attacks-by-up-to-/2026-07-09monthly0.6 https://openbiodx.com/2024/02/01/neopact-anthracycline-free-chemoimmunotherapy-shows-promise-in-triple-negative-b/2026-07-09monthly0.6 https://openbiodx.com/2024/01/29/eflm-survey-reveals-pfas-dependency-in-ivd-technologies-and-uncertain-end-of-lif/2026-07-09monthly0.6 https://openbiodx.com/2024/01/23/blood-based-biomarkers-are-transforming-alzheimer-s-disease-diagnostics/2026-07-09monthly0.6 https://openbiodx.com/2024/01/22/ewsr1-nfatc2-round-cell-sarcoma-a-four-case-series-supports-classification-as-a-/2026-07-09monthly0.6 https://openbiodx.com/2024/01/22/expanded-prenatal-cfdna-screening-detects-aneuploidies-microdeletions-and-monoge/2026-07-09monthly0.6 https://openbiodx.com/2024/01/17/multiplex-immune-profiling-of-tumors-translational-framework-from-the-internatio/2026-07-09monthly0.6 https://openbiodx.com/2024/01/15/clinical-practice-guideline-establishes-standards-for-blood-based-ctdna-assays/2026-07-09monthly0.6 https://openbiodx.com/2024/01/13/anti-egfr-antibody-sct200-shows-promise-in-refractory-colorectal-cancer-ctdna-cl/2026-07-09monthly0.6 https://openbiodx.com/2024/01/12/adding-dihydroartemisinin-piperaquine-to-co-trimoxazole-cuts-malaria-risk-by-55-/2026-07-09monthly0.6 https://openbiodx.com/2024/01/09/molecular-susceptibility-testing-for-h-pylori-enables-resistance-guided-therapy-/2026-07-09monthly0.6 https://openbiodx.com/2024/01/09/kras-targeted-amphiphile-vaccine-induces-t-cell-responses-and-ctdna-clearance-in/2026-07-09monthly0.6 https://openbiodx.com/2024/01/06/cfdna-based-precar-score-doubles-early-hepatocellular-carcinoma-detection-sensit/2026-07-09monthly0.6 https://openbiodx.com/2024/01/05/ctdna-reveals-kit-mutation-dependent-drug-sensitivity-in-gist-intrigue-trial-bio/2026-07-09monthly0.6 https://openbiodx.com/2024/01/04/microbiome-derived-metabolites-show-promise-for-pancreatic-cancer-risk-assessmen/2026-07-09monthly0.6 https://openbiodx.com/2024/01/04/systematic-review-of-multi-cancer-early-detection-tests-high-specificity-variabl/2026-07-09monthly0.6 https://openbiodx.com/2024/01/04/blood-based-biomarkers-for-lung-cancer-screening-proteins-mirna-cfdna-and-methyl/2026-07-09monthly0.6 https://openbiodx.com/2024/01/04/practical-guide-to-interpreting-ctdna-in-gastrointestinal-cancer-management/2026-07-09monthly0.6 https://openbiodx.com/2024/01/04/review-identifies-critical-preanalytical-and-analytical-variables-in-ctdna-liqui/2026-07-09monthly0.6 https://openbiodx.com/2024/01/04/extracellular-vesicle-biomarker-assays-roadmap-from-discovery-to-clinical-implem/2026-07-09monthly0.6 https://openbiodx.com/2024/01/04/circulating-tumour-cells-in-breast-cancer-current-clinical-validity-and-emerging/2026-07-09monthly0.6 https://openbiodx.com/2024/01/04/circulating-tumor-cells-from-metastatic-biology-to-precision-medicine-applicatio/2026-07-09monthly0.6 https://openbiodx.com/2023/12/28/inspires-trial-dual-antiplatelet-therapy-effective-up-to-72-hours-after-ischaemi/2026-07-09monthly0.6 https://openbiodx.com/2023/12/19/biased-ai-models-reduce-clinician-diagnostic-accuracy-and-explanations-do-not-mi/2026-07-09monthly0.6 https://openbiodx.com/2023/12/19/ctdna-implementation-challenges-from-early-detection-to-immunotherapy-monitoring/2026-07-09monthly0.6 https://openbiodx.com/2023/12/12/cannabis-exposure-in-pregnancy-linked-to-placental-dysfunction-by-lc-ms-ms-confi/2026-07-09monthly0.6 https://openbiodx.com/2023/12/07/sorafenib-plus-chemotherapy-does-not-improve-event-free-survival-in-flt3-itd-aml/2026-07-09monthly0.6 https://openbiodx.com/2023/12/05/selux-next-generation-phenotyping-system-delivers-rapid-ast-results-in-under-6-h/2026-07-09monthly0.6 https://openbiodx.com/2023/12/05/blood-culture-contamination-rate-reporting-asm-subcommittee-recommendations-for-/2026-07-09monthly0.6 https://openbiodx.com/2023/12/05/divarasib-plus-cetuximab-achieves-63-response-rate-in-kras-g12c-positive-colorec/2026-07-09monthly0.6 https://openbiodx.com/2023/12/01/ai-models-show-strong-performance-across-urinalysis-applications/2026-07-09monthly0.6 https://openbiodx.com/2023/12/01/immunoassay-vs-lc-ms-for-androgen-measurement-pitfalls-and-clinical-guidance/2026-07-09monthly0.6 https://openbiodx.com/2023/12/01/neoadjuvant-immunotherapy-achieves-up-to-100-response-in-mismatch-repair-deficie/2026-07-09monthly0.6 https://openbiodx.com/2023/12/01/eucast-wild-type-mic-distributions-provide-the-reference-point-for-resistance-de/2026-07-09monthly0.6 https://openbiodx.com/2023/11/24/ai-driven-digital-pathology-and-ctdna-converge-to-personalise-adjuvant-therapy-i/2026-07-09monthly0.6 https://openbiodx.com/2023/11/20/panda-deep-learning-detects-pancreatic-cancer-on-non-contrast-ct-with-92-9-sensi/2026-07-09monthly0.6 https://openbiodx.com/2023/11/14/multitarget-stool-rna-test-significantly-outperforms-fit-for-colorectal-cancer-a/2026-07-09monthly0.6 https://openbiodx.com/2023/11/10/cardiac-troponin-and-bnp-show-untapped-potential-for-cardiovascular-risk-assessm/2026-07-09monthly0.6 https://openbiodx.com/2023/11/08/ai-based-digital-pathology-predicts-immunotherapy-response-in-hepatocellular-car/2026-07-09monthly0.6 https://openbiodx.com/2023/11/03/meta-analysis-regional-node-radiotherapy-reduces-breast-cancer-mortality-in-mode/2026-07-09monthly0.6 https://openbiodx.com/2023/11/02/ai-chatbots-in-clinical-laboratory-medicine-capabilities-limitations-and-path-fo/2026-07-09monthly0.6 https://openbiodx.com/2023/11/02/review-envisions-mrd-as-future-coprimary-endpoint-and-treatment-adaptation-tool-/2026-07-09monthly0.6 https://openbiodx.com/2023/11/01/systematic-review-finds-health-inequality-impacts-largely-ignored-in-antimicrobi/2026-07-09monthly0.6 https://openbiodx.com/2023/11/01/creatinine-vs-cystatin-c-a-practical-guide-to-renal-biomarkers-and-egfr-equation/2026-07-09monthly0.6 https://openbiodx.com/2023/10/31/dual-her2-blockade-with-pyrotinib-trastuzumab-docetaxel-doubles-pfs-in-metastati/2026-07-09monthly0.6 https://openbiodx.com/2023/10/26/systemic-lupus-erythematosus-autoantibody-panels-and-molecular-diagnostics-in-sl/2026-07-09monthly0.6 https://openbiodx.com/2023/10/25/biofire-joint-infection-panel-detects-39-targets-in-synovial-fluid-in-about-one-/2026-07-09monthly0.6 https://openbiodx.com/2023/10/23/ifcc-leap-checklist-sets-new-standard-for-reporting-method-evaluation-in-lab-med/2026-07-09monthly0.6 https://openbiodx.com/2023/10/17/sequential-cd19-and-cd22-car-t-therapy-achieves-97-response-and-durable-mrd-nega/2026-07-09monthly0.6 https://openbiodx.com/2023/10/16/molecular-tumor-boards-evolving-role-in-precision-oncology-and-biomarker-interpr/2026-07-09monthly0.6 https://openbiodx.com/2023/10/14/how-to-measure-clinical-utility-of-diagnostic-tests-a-methods-review-for-lab-pro/2026-07-09monthly0.6 https://openbiodx.com/2023/10/09/biofilm-antimicrobial-susceptibility-testing-bridging-the-gap-between-in-vitro-m/2026-07-09monthly0.6 https://openbiodx.com/2023/10/09/early-vs-delayed-blood-pressure-lowering-shows-no-benefit-in-acute-ischaemic-str/2026-07-09monthly0.6 https://openbiodx.com/2023/10/09/br-36-trial-validates-ctdna-molecular-response-at-cycle-3-as-predictor-of-pembro/2026-07-09monthly0.6 https://openbiodx.com/2023/10/05/gut-microbiota-emerges-as-diagnostic-biomarker-and-therapeutic-target-in-diabete/2026-07-09monthly0.6 https://openbiodx.com/2023/10/04/us-clinical-breakpoint-updates-closing-the-gap-between-revision-and-laboratory-i/2026-07-09monthly0.6 https://openbiodx.com/2023/10/04/defining-clinical-utility-a-framework-for-evaluating-whether-diagnostic-tests-im/2026-07-09monthly0.6 https://openbiodx.com/2023/10/03/ai-in-diagnostic-pathology-from-whole-slide-imaging-to-fda-approved-clinical-too/2026-07-09monthly0.6 https://openbiodx.com/2023/10/02/phase-2-trial-chemo-immunotherapy-enables-bladder-sparing-in-43-of-muscle-invasi/2026-07-09monthly0.6 https://openbiodx.com/2023/09/29/machine-learning-for-personalized-drug-dosing-systematic-review-finds-high-poten/2026-07-09monthly0.6 https://openbiodx.com/2023/09/28/clsi-m100-tables-1-overhaul-modernising-ast-reporting-for-antimicrobial-stewards/2026-07-09monthly0.6 https://openbiodx.com/2023/09/28/pharmvar-tutorial-standardises-cyp2d6-structural-variant-detection-and-reporting/2026-07-09monthly0.6 https://openbiodx.com/2023/09/20/alinity-m-cmv-assay-delivers-precise-rapid-viral-load-monitoring-with-sub-3-hour/2026-07-09monthly0.6 https://openbiodx.com/2023/09/20/ai-derived-biomarker-from-deep-brain-stimulation-tracks-depression-recovery-in-r/2026-07-09monthly0.6 https://openbiodx.com/2023/09/20/platelet-distribution-width-emerges-as-prognostic-marker-in-covid-19-severity-an/2026-07-09monthly0.6 https://openbiodx.com/2023/09/19/primary-brain-tumours-molecular-diagnostics-drive-the-who-2021-cns-classificatio/2026-07-09monthly0.6 https://openbiodx.com/2023/09/19/whole-genome-sequencing-finds-actionable-cancer-variants-in-15-of-patients-where/2026-07-09monthly0.6 https://openbiodx.com/2023/09/14/phase-iii-mdma-assisted-therapy-shows-significant-ptsd-symptom-reduction/2026-07-09monthly0.6 https://openbiodx.com/2023/09/14/egfr-and-met-expression-as-predictive-biomarkers-for-amivantamab-lazertinib-in-o/2026-07-09monthly0.6 https://openbiodx.com/2023/09/14/give-triple-combination-achieves-durable-remissions-in-high-risk-cll-with-del-17/2026-07-09monthly0.6 https://openbiodx.com/2023/09/13/qiastat-dx-meningitis-encephalitis-panel-matches-biofire-filmarray-in-multicente/2026-07-09monthly0.6 https://openbiodx.com/2023/09/01/rna-based-molecular-subtypes-of-colorectal-liver-metastases-validated-in-phase-3/2026-07-09monthly0.6 https://openbiodx.com/2023/09/01/tumor-treating-fields-plus-standard-therapy-improves-survival-in-metastatic-nscl/2026-07-09monthly0.6 https://openbiodx.com/2023/08/31/ai-in-ovarian-cancer-histopathology-systematic-review-reveals-universal-risk-of-/2026-07-09monthly0.6 https://openbiodx.com/2023/08/24/phase-1-trial-of-kras-g12c-inhibitor-divarasib-shows-durable-responses-with-seri/2026-07-09monthly0.6 https://openbiodx.com/2023/08/23/international-working-group-identifies-key-pitfalls-in-ml-based-til-assessment-f/2026-07-09monthly0.6 https://openbiodx.com/2023/08/23/spatial-immune-cell-analysis-in-cancer-methods-compendium-and-path-to-clinical-u/2026-07-09monthly0.6 https://openbiodx.com/2023/08/17/pembrolizumab-maintenance-after-autologous-transplant-shows-promise-in-t-cell-ly/2026-07-09monthly0.6 https://openbiodx.com/2023/08/14/computational-pathology-promises-automation-but-faces-major-adoption-hurdles/2026-07-09monthly0.6 https://openbiodx.com/2023/08/08/ai-driven-tumour-microenvironment-analysis-from-digital-h-e-images-to-predict-pr/2026-07-09monthly0.6 https://openbiodx.com/2023/08/07/unlocking-ai-for-pathology-a-systematic-analysis-of-development-and-deployment-b/2026-07-09monthly0.6 https://openbiodx.com/2023/08/02/molecular-diagnostics-offer-faster-h-pylori-detection-and-resistance-prediction-/2026-07-09monthly0.6 https://openbiodx.com/2023/08/02/pathology-archive-management-cost-analysis-and-the-case-for-digital-tracking-sys/2026-07-09monthly0.6 https://openbiodx.com/2023/08/01/masai-trial-ai-supported-mammography-screening-matches-radiologist-accuracy-whil/2026-07-09monthly0.6 https://openbiodx.com/2023/08/01/ntrk-fusion-testing-in-thyroid-carcinoma-expert-consensus-on-a-diagnostic-algori/2026-07-09monthly0.6 https://openbiodx.com/2023/07/25/integrative-deep-learning-combining-pathology-clinical-and-genomic-data-improves/2026-07-09monthly0.6 https://openbiodx.com/2023/07/21/global-lung-cancer-burden-underscores-need-for-expanded-low-dose-ct-screening-pr/2026-07-09monthly0.6 https://openbiodx.com/2023/07/20/mixed-endocarditis-infection-a-diagnostic-microbiology-case-report/2026-07-09monthly0.6 https://openbiodx.com/2023/07/19/deep-learning-radiopathomics-distinguishes-luminal-from-non-luminal-breast-cance/2026-07-09monthly0.6 https://openbiodx.com/2023/07/14/lucerne-toolbox-2-european-consensus-on-axillary-lymph-node-management-in-early-/2026-07-09monthly0.6 https://openbiodx.com/2023/07/13/fungal-endocarditis-diagnostic-strategies-from-blood-culture-to-pet-ct-imaging/2026-07-09monthly0.6 https://openbiodx.com/2023/07/13/ai-against-infectious-disease-accelerating-diagnostics-drug-discovery-and-amr-su/2026-07-09monthly0.6 https://openbiodx.com/2023/07/13/hpv-testing-in-urine-blood-and-oral-specimens-gains-ground-for-cancer-screening-/2026-07-09monthly0.6 https://openbiodx.com/2023/07/11/gemini-trial-whole-genome-sequencing-doubles-diagnostic-yield-over-targeted-pane/2026-07-09monthly0.6 https://openbiodx.com/2023/07/06/new-genomic-and-liquid-biopsy-insights-illuminate-richter-syndrome-transformatio/2026-07-09monthly0.6 https://openbiodx.com/2023/07/03/machine-learning-image-analysis-is-beginning-to-transform-clinical-microbiology-/2026-07-09monthly0.6 https://openbiodx.com/2023/07/03/prophylactic-anakinra-reduces-severe-neurotoxicity-to-under-10-in-car-t-cell-the/2026-07-09monthly0.6 https://openbiodx.com/2023/07/01/liquid-biopsy-guided-anti-egfr-rechallenge-shows-benefit-in-refractory-ras-wild-/2026-07-09monthly0.6 https://openbiodx.com/2023/06/22/co-occurring-genomic-alterations-in-sarcomas-secondary-hits-that-drive-sarcomage/2026-07-09monthly0.6 https://openbiodx.com/2023/06/22/blood-neurofilament-light-predicts-progressive-ms-disability-after-anti-cd20-the/2026-07-09monthly0.6 https://openbiodx.com/2023/06/15/nci-match-trial-lessons-from-the-largest-tumour-agnostic-precision-oncology-stud/2026-07-09monthly0.6 https://openbiodx.com/2023/06/12/cell-free-rna-fragments-outperform-other-cfrna-types-for-early-hepatocellular-ca/2026-07-09monthly0.6 https://openbiodx.com/2023/06/05/camonsertib-atr-inhibitor-shows-activity-in-ddr-deficient-solid-tumours-guided-b/2026-07-09monthly0.6 https://openbiodx.com/2023/06/02/ifcc-consensus-recommendations-for-managing-point-of-care-testing-outside-hospit/2026-07-09monthly0.6 https://openbiodx.com/2023/06/01/nejm-trial-shows-point-of-care-ultrasound-is-non-inferior-to-radiography-for-pae/2026-07-09monthly0.6 https://openbiodx.com/2023/05/30/cpic-guideline-expands-pharmacogenomic-recommendations-for-serotonin-reuptake-in/2026-07-09monthly0.6 https://openbiodx.com/2023/05/25/biofire-bcid2-panel-achieves-98-9-sensitivity-for-pathogen-identification-from-p/2026-07-09monthly0.6 https://openbiodx.com/2023/05/25/nejm-review-the-current-and-future-state-of-ai-interpretation-of-medical-images/2026-07-09monthly0.6 https://openbiodx.com/2023/05/25/eu-ivdr-reshapes-companion-diagnostic-regulation-new-framework-new-challenges/2026-07-09monthly0.6 https://openbiodx.com/2023/05/24/direct-from-blood-pathogen-detection-molecular-technologies-challenge-the-blood-/2026-07-09monthly0.6 https://openbiodx.com/2023/05/20/anti-attr-antibody-ni006-shows-cardiac-amyloid-depletion-on-imaging-in-phase-1-t/2026-07-09monthly0.6 https://openbiodx.com/2023/05/18/adopting-ai-enabled-digital-pathology-in-resource-limited-settings-a-practical-f/2026-07-09monthly0.6 https://openbiodx.com/2023/05/18/isup-consensus-bladder-cancer-molecular-subtypes-not-yet-ready-for-routine-use/2026-07-09monthly0.6 https://openbiodx.com/2023/05/15/simplexa-congenital-cmv-direct-pcr-achieves-near-perfect-agreement-for-newborn-s/2026-07-09monthly0.6 https://openbiodx.com/2023/05/15/cholangiocarcinoma-cfdna-monitoring-emerges-alongside-fgfr2-and-idh1-targeted-th/2026-07-09monthly0.6 https://openbiodx.com/2023/05/12/review-highlights-challenges-in-developing-reliable-gastric-cancer-peritoneal-me/2026-07-09monthly0.6 https://openbiodx.com/2023/05/11/five-year-zuma-1-follow-up-43-of-refractory-lymphoma-patients-alive-after-axi-ce/2026-07-09monthly0.6 https://openbiodx.com/2023/05/10/vitek-2-receives-fda-clearance-for-automated-omadacycline-susceptibility-testing/2026-07-09monthly0.6 https://openbiodx.com/2023/05/10/regression-models-outperform-machine-learning-for-breast-cancer-mortality-predic/2026-07-09monthly0.6 https://openbiodx.com/2023/05/10/modelling-analysis-finds-modest-efficiency-gains-for-polygenic-risk-score-strati/2026-07-09monthly0.6 https://openbiodx.com/2023/05/01/triplet-vs-doublet-therapy-in-metastatic-prostate-cancer-living-network-meta-ana/2026-07-09monthly0.6 https://openbiodx.com/2023/04/28/lipid-testing-is-evolving-sampson-nih-equation-apob-and-lp-a-gain-ground-over-tr/2026-07-09monthly0.6 https://openbiodx.com/2023/04/27/ai-for-infectious-disease-surveillance-from-digital-epidemiology-to-outbreak-pre/2026-07-09monthly0.6 https://openbiodx.com/2023/04/21/lancet-rct-intravenous-ferric-carboxymaltose-did-not-reduce-anaemia-at-36-weeks-/2026-07-09monthly0.6 https://openbiodx.com/2023/04/21/functional-reference-limits-offer-new-physiological-insights-beyond-traditional-/2026-07-09monthly0.6 https://openbiodx.com/2023/04/21/ai-powered-point-of-care-testing-transforming-lateral-flow-microscopy-and-haemat/2026-07-09monthly0.6 https://openbiodx.com/2023/04/21/review-charts-genomic-and-epigenetic-advances-transforming-oesophageal-cancer-de/2026-07-09monthly0.6 https://openbiodx.com/2023/04/20/typhoid-fever-burden-in-india-prospective-cohort-reveals-incidence-up-to-1-622-p/2026-07-09monthly0.6 https://openbiodx.com/2023/04/18/broth-disk-elution-method-enables-practical-aztreonam-ceftazidime-avibactam-comb/2026-07-09monthly0.6 https://openbiodx.com/2023/04/13/genetics-of-human-infertility-expanding-demand-for-reproductive-genomic-testing/2026-07-09monthly0.6 https://openbiodx.com/2023/04/12/generalist-medical-ai-a-new-paradigm-for-multimodal-clinical-foundation-models/2026-07-09monthly0.6 https://openbiodx.com/2023/04/11/first-tp53-mutant-low-grade-papillary-schneiderian-carcinoma-documented-without-/2026-07-09monthly0.6 https://openbiodx.com/2023/04/05/blinded-rct-ai-cardiac-function-assessment-proves-non-inferior-to-sonographers/2026-07-09monthly0.6 https://openbiodx.com/2023/04/04/acute-myocarditis-troponin-and-cardiac-mri-as-diagnostic-cornerstones/2026-07-09monthly0.6 https://openbiodx.com/2023/04/04/whole-exome-sequencing-identifies-pten-hamartoma-syndrome-behind-colorectal-poly/2026-07-09monthly0.6 https://openbiodx.com/2023/03/31/belzutifan-plus-cabozantinib-shows-promising-activity-in-pretreated-clear-cell-r/2026-07-09monthly0.6 https://openbiodx.com/2023/03/27/rethinking-reference-methods-for-antibacterial-susceptibility-testing-beyond-bro/2026-07-09monthly0.6 https://openbiodx.com/2023/03/23/deepglioma-ai-based-rapid-molecular-classification-of-brain-tumours-in-under-90-/2026-07-09monthly0.6 https://openbiodx.com/2023/03/21/molecular-approaches-transform-discrimination-of-multiple-primary-vs-metastatic-/2026-07-09monthly0.6 https://openbiodx.com/2023/03/15/revumenib-in-kmt2a-rearranged-leukaemia-mrd-clearance-validates-menin-inhibition/2026-07-09monthly0.6 https://openbiodx.com/2023/03/06/etest-eravacycline-validated-for-susceptibility-testing-of-enterobacteriaceae-an/2026-07-09monthly0.6 https://openbiodx.com/2023/03/06/ai-model-detects-lymph-node-metastases-in-bladder-cancer-with-98-sensitivity-inc/2026-07-09monthly0.6 https://openbiodx.com/2023/03/01/clear-trial-extended-follow-up-confirms-durable-pfs-benefit-of-lenvatinib-pembro/2026-07-09monthly0.6 https://openbiodx.com/2023/02/27/metagenomic-sequencing-for-agnostic-viral-pathogen-detection-promise-and-barrier/2026-07-09monthly0.6 https://openbiodx.com/2023/02/22/ki67-in-breast-cancer-pragmatic-use-despite-persistent-scoring-challenges/2026-07-09monthly0.6 https://openbiodx.com/2023/02/13/large-individual-patient-data-analysis-quantifies-the-prognostic-cost-of-p16-hpv/2026-07-09monthly0.6 https://openbiodx.com/2023/02/06/why-crp-remains-the-most-requested-biomarker-in-clinical-laboratories/2026-07-09monthly0.6 https://openbiodx.com/2023/02/04/unified-framework-exposes-evidence-gaps-in-neurological-protein-biomarkers/2026-07-09monthly0.6 https://openbiodx.com/2023/02/04/landmark-prepare-trial-12-gene-pharmacogenetic-panel-cuts-adverse-drug-reactions/2026-07-09monthly0.6 https://openbiodx.com/2023/02/01/tucatinib-extends-survival-by-9-months-in-her2-positive-breast-cancer-brain-meta/2026-07-09monthly0.6 https://openbiodx.com/2023/02/01/systematic-review-maps-prognostic-biomarker-landscape-for-male-breast-cancer/2026-07-09monthly0.6 https://openbiodx.com/2023/01/31/iso-15189-can-satisfy-ivdr-requirements-for-laboratory-developed-tests-expert-an/2026-07-09monthly0.6 https://openbiodx.com/2023/01/24/daxx-atrx-and-alt-testing-refines-pancreatic-neuroendocrine-tumor-classification/2026-07-09monthly0.6 https://openbiodx.com/2023/01/19/tutorial-meta-analysis-of-diagnostic-test-accuracy-studies-with-bivariate-random/2026-07-09monthly0.6 https://openbiodx.com/2023/01/17/two-days-of-post-operative-antibiotics-non-inferior-to-five-days-for-complex-app/2026-07-09monthly0.6 https://openbiodx.com/2023/01/16/parathyroid-hormone-measurement-evolves-from-immunoassay-to-lc-ms-ms/2026-07-09monthly0.6 https://openbiodx.com/2023/01/12/atlas-trial-carfilzomib-lenalidomide-dexamethasone-maintenance-extends-progressi/2026-07-09monthly0.6 https://openbiodx.com/2023/01/10/removing-ethnicity-from-egfr-equations-rationale-impact-and-remaining-questions/2026-07-09monthly0.6 https://openbiodx.com/2023/01/04/fda-cleared-molecular-assays-transform-laboratory-detection-of-mycoplasma-genita/2026-07-09monthly0.6 https://openbiodx.com/2022/12/23/updated-uk-guidelines-for-her2-assessment-in-breast-cancer/2026-07-09monthly0.6 https://openbiodx.com/2022/12/22/rethinking-ivd-quality-control-a-two-component-iqc-model-tied-to-clinical-perfor/2026-07-09monthly0.6 https://openbiodx.com/2022/12/20/lung-cancer-screening-with-low-dose-ct-evidence-ai-integration-and-implementatio/2026-07-09monthly0.6 https://openbiodx.com/2022/12/20/hcv-core-antigen-test-shows-high-accuracy-for-screening-hiv-coinfected-patients/2026-07-09monthly0.6 https://openbiodx.com/2022/12/14/cytogenetic-risk-stratification-reveals-unmet-need-in-ultra-high-risk-myeloma-de/2026-07-09monthly0.6 https://openbiodx.com/2022/12/12/practical-guide-to-investigating-lead-mercury-and-arsenic-poisoning-in-general-p/2026-07-09monthly0.6 https://openbiodx.com/2022/12/09/circulating-tumour-cell-biology-reveals-new-cancer-vulnerabilities-and-liquid-bi/2026-07-09monthly0.6 https://openbiodx.com/2022/12/08/lc-ms-ms-in-clinical-diagnostics-a-primer-on-implementation-and-quality-manageme/2026-07-09monthly0.6 https://openbiodx.com/2022/12/07/destiny-breast03-her2-testing-underpins-landmark-adc-trial-results/2026-07-09monthly0.6 https://openbiodx.com/2022/12/06/troponin-i-and-t-show-distinct-kinetics-after-coronary-bypass-surgery-implicatio/2026-07-09monthly0.6 https://openbiodx.com/2022/12/06/cepheid-xpert-gbs-lb-xc-test-validated-in-multicenter-study-for-prenatal-gbs-scr/2026-07-09monthly0.6 https://openbiodx.com/2022/12/06/urinary-cell-free-dna-emerges-as-truly-non-invasive-alternative-for-cancer-liqui/2026-07-09monthly0.6 https://openbiodx.com/2022/12/01/practical-guide-to-using-circulating-tumor-dna-in-cancer-treatment-decisions/2026-07-09monthly0.6 https://openbiodx.com/2022/11/30/commercially-available-typhoid-rapid-tests-fall-short-of-diagnostic-accuracy-req/2026-07-09monthly0.6 https://openbiodx.com/2022/11/28/troponin-t-vs-troponin-i-in-stable-populations-different-biology-different-clini/2026-07-09monthly0.6 https://openbiodx.com/2022/11/28/the-central-role-of-laboratory-medicine-in-public-health-from-cardiac-biomarkers/2026-07-09monthly0.6 https://openbiodx.com/2022/11/24/ex-vivo-confocal-laser-microscopy-enables-real-time-digital-assessment-of-pancre/2026-07-09monthly0.6 https://openbiodx.com/2022/11/24/lot-to-lot-reagent-verification-a-critical-but-under-resourced-quality-challenge/2026-07-09monthly0.6 https://openbiodx.com/2022/11/23/copeptin-adds-no-value-to-high-sensitivity-troponin-at-limit-of-detection-thresh/2026-07-09monthly0.6 https://openbiodx.com/2022/11/15/uspstf-evidence-review-finds-uncertain-benefit-of-screening-for-obstructive-slee/2026-07-09monthly0.6 https://openbiodx.com/2022/11/14/deep-learning-on-ct-scans-predicts-major-pathological-response-to-neoadjuvant-ch/2026-07-09monthly0.6 https://openbiodx.com/2022/11/11/thyroid-cancer-biomarkers-from-thyroglobulin-and-calcitonin-harmonization-challe/2026-07-09monthly0.6 https://openbiodx.com/2022/11/10/non-viral-crispr-edited-neoantigen-specific-t-cells-traffic-to-tumours-in-first-/2026-07-09monthly0.6 https://openbiodx.com/2022/11/02/procalcitonin-in-clinical-practice-evidence-based-strategies-for-diagnosing-infe/2026-07-09monthly0.6 https://openbiodx.com/2022/11/01/lancet-seminar-reviews-precision-medicine-opportunities-in-type-2-diabetes-inclu/2026-07-09monthly0.6 https://openbiodx.com/2022/10/31/updated-review-nocardia-identification-transformed-by-maldi-tof-and-whole-genome/2026-07-09monthly0.6 https://openbiodx.com/2022/10/26/two-decades-of-clinical-mass-spectrometry-progress-from-neonatal-screening-to-pr/2026-07-09monthly0.6 https://openbiodx.com/2022/10/19/brief-case-proteus-mirabilis-coraliform-lithiasis-and-bacteremia-in-catheterized/2026-07-09monthly0.6 https://openbiodx.com/2022/10/19/proteus-mirabilis-coraliform-lithiasis-and-bacteremia-a-clinical-microbiology-ca/2026-07-09monthly0.6 https://openbiodx.com/2022/10/16/pet-imaging-biomarkers-predict-response-to-lutetium-psma-therapy-in-prostate-can/2026-07-09monthly0.6 https://openbiodx.com/2022/10/14/hba1c-and-diabetes-biomarkers-a-decade-of-analytical-and-clinical-progress/2026-07-09monthly0.6 https://openbiodx.com/2022/10/13/early-ctdna-reduction-predicts-survival-benefit-from-tebentafusp-in-uveal-melano/2026-07-09monthly0.6 https://openbiodx.com/2022/10/09/systematic-review-finds-most-pharmacogenomic-tests-are-cost-effective/2026-07-09monthly0.6 https://openbiodx.com/2022/10/06/mutation-enrichment-technologies-advance-low-frequency-variant-detection-for-liq/2026-07-09monthly0.6 https://openbiodx.com/2022/10/04/cefepime-enmetazobactam-shows-superiority-over-piperacillin-tazobactam-for-compl/2026-07-09monthly0.6 https://openbiodx.com/2022/09/30/cross-ancestry-stroke-gwas-identifies-89-risk-loci-and-highlights-drug-targets-i/2026-07-09monthly0.6 https://openbiodx.com/2022/09/29/fully-automated-eucast-rast-achieves-robust-performance-for-direct-blood-culture/2026-07-09monthly0.6 https://openbiodx.com/2022/09/29/pada-1-trial-switching-therapy-based-on-rising-blood-esr1-mutation-doubles-progr/2026-07-09monthly0.6 https://openbiodx.com/2022/09/27/ai-guided-ecg-screening-increases-atrial-fibrillation-detection-fivefold-in-high/2026-07-09monthly0.6 https://openbiodx.com/2022/09/27/multi-omics-machine-learning-classifies-endocrine-hypertension-subtypes-with-92-/2026-07-09monthly0.6 https://openbiodx.com/2022/09/24/cpic-guideline-g6pd-genotyping-to-classify-medication-induced-haemolysis-risk/2026-07-09monthly0.6 https://openbiodx.com/2022/09/17/poc-nucleic-acid-testing-dramatically-accelerates-hiv-treatment-in-infants/2026-07-09monthly0.6 https://openbiodx.com/2022/09/17/international-consensus-prioritizes-molecular-biomarkers-for-risk-stratification/2026-07-09monthly0.6 https://openbiodx.com/2022/09/14/hiv-1-drug-resistance-testing-from-proviral-dna-methods-dynamics-and-clinical-ut/2026-07-09monthly0.6 https://openbiodx.com/2022/09/05/temperature-challenges-for-i-stat-and-epoc-poc-blood-gas-devices-in-field-settin/2026-07-09monthly0.6 https://openbiodx.com/2022/09/01/expert-guidelines-established-for-covid-19-molecular-testing-in-mobile-laborator/2026-07-09monthly0.6 https://openbiodx.com/2022/09/01/synthetic-norovirus-rna-reference-materials-enable-quality-control-across-commer/2026-07-09monthly0.6 https://openbiodx.com/2022/09/01/lc-ms-ms-operations-guide-covers-validation-qa-and-troubleshooting-for-clinical-/2026-07-09monthly0.6 https://openbiodx.com/2022/09/01/systematic-review-establishes-best-practices-for-lc-ms-ms-calibration-in-clinica/2026-07-09monthly0.6 https://openbiodx.com/2022/09/01/keynote-564-update-confirms-adjuvant-pembrolizumab-benefit-in-renal-cell-carcino/2026-07-09monthly0.6 https://openbiodx.com/2022/08/31/clinical-trial-design-evolves-for-the-precision-oncology-era/2026-07-09monthly0.6 https://openbiodx.com/2022/08/27/circulating-tumour-cell-isolation-technologies-from-biomarker-dependent-to-charg/2026-07-09monthly0.6 https://openbiodx.com/2022/08/23/15-years-of-laboratory-test-appropriateness-cpoe-driven-strategies-that-reduced-/2026-07-09monthly0.6 https://openbiodx.com/2022/08/22/blood-based-tmb-fails-primary-endpoint-as-biomarker-for-atezolizumab-in-nsclc/2026-07-09monthly0.6 https://openbiodx.com/2022/08/15/personalized-neoantigen-vaccine-shows-promise-in-mss-colorectal-cancer-with-ctdn/2026-07-09monthly0.6 https://openbiodx.com/2022/08/04/histologic-evaluation-of-celiac-disease-current-best-practice-and-the-promise-of/2026-07-09monthly0.6 https://openbiodx.com/2022/08/02/modernising-antibiograms-updated-clsi-m39-guidance-for-the-stewardship-era/2026-07-09monthly0.6 https://openbiodx.com/2022/08/01/rethinking-histopathology-reporting-focus-on-what-changes-patient-management/2026-07-09monthly0.6 https://openbiodx.com/2022/08/01/breast-pathology-data-that-drives-treatment-a-clinical-utility-guide-for-reporti/2026-07-09monthly0.6 https://openbiodx.com/2022/08/01/how-gi-pathology-reports-drive-clinical-decisions-key-data-items-that-matter/2026-07-09monthly0.6 https://openbiodx.com/2022/08/01/when-pathology-data-items-matter-and-when-they-don-t-a-urological-cancer-perspec/2026-07-09monthly0.6 https://openbiodx.com/2022/08/01/intega-trial-nivolumab-trastuzumab-plus-folfox-outperforms-ipilimumab-arm-in-erb/2026-07-09monthly0.6 https://openbiodx.com/2022/08/01/beyond-blood-ctdna-from-urine-csf-and-body-fluids-offers-distinct-diagnostic-adv/2026-07-09monthly0.6 https://openbiodx.com/2022/08/01/chronos-trial-ctdna-guided-anti-egfr-rechallenge-shows-30-response-in-colorectal/2026-07-09monthly0.6 https://openbiodx.com/2022/07/31/scoping-review-maps-current-state-of-pharmacogenomic-clinical-decision-support/2026-07-09monthly0.6 https://openbiodx.com/2022/07/27/pharmvar-standardises-slco1b1-star-allele-nomenclature-for-statin-safety-testing/2026-07-09monthly0.6 https://openbiodx.com/2022/07/21/daxx-atrx-loss-and-alt-as-prognostic-biomarkers-in-pancreatic-neuroendocrine-tum/2026-07-09monthly0.6 https://openbiodx.com/2022/07/21/platelet-function-analyser-approaching-50-years-strengths-limits-and-clinical-ro/2026-07-09monthly0.6 https://openbiodx.com/2022/07/16/machine-learning-model-safely-reduces-unnecessary-blood-cultures-by-30-in-emerge/2026-07-09monthly0.6 https://openbiodx.com/2022/07/13/women-disadvantaged-in-fit-based-colorectal-screening-due-to-lower-faecal-haemog/2026-07-09monthly0.6 https://openbiodx.com/2022/07/12/pharmacogenomic-testing-reduces-drug-gene-interactions-in-depression-but-shows-m/2026-07-09monthly0.6 https://openbiodx.com/2022/07/06/temozolomide-priming-induces-mismatch-repair-deficiency-and-sensitises-colorecta/2026-07-09monthly0.6 https://openbiodx.com/2022/07/02/host-genomic-biomarkers-can-distinguish-bacterial-from-non-bacterial-infection/2026-07-09monthly0.6 https://openbiodx.com/2022/07/01/geparx-trial-denosumab-adds-no-benefit-to-neoadjuvant-chemotherapy-weekly-nab-pa/2026-07-09monthly0.6 https://openbiodx.com/2022/06/30/ai-in-lung-cancer-diagnostic-imaging-treatment-selection-and-prognostic-assessme/2026-07-09monthly0.6 https://openbiodx.com/2022/06/27/pre-analytical-pitfalls-in-high-sensitivity-troponin-testing-storage-interferenc/2026-07-09monthly0.6 https://openbiodx.com/2022/06/24/first-international-repository-of-precision-data-for-quantitative-autoantibody-a/2026-07-09monthly0.6 https://openbiodx.com/2022/06/23/redesigned-etest-fosfomycin-strip-validated-for-enterobacterales-enterococci-and/2026-07-09monthly0.6 https://openbiodx.com/2022/06/23/nano-omics-nanotechnology-enabled-multi-omics-analysis-of-the-blood-circulating-/2026-07-09monthly0.6 https://openbiodx.com/2022/06/21/circulating-lncrnas-as-blood-based-cancer-biomarkers-diagnostic-performance-and-/2026-07-09monthly0.6 https://openbiodx.com/2022/06/21/extracellular-vesicle-pd-l1-emerges-as-liquid-biopsy-biomarker-for-immunotherapy/2026-07-09monthly0.6 https://openbiodx.com/2022/06/20/ai-in-lung-digital-pathology-from-pd-l1-quantification-to-treatment-response-pre/2026-07-09monthly0.6 https://openbiodx.com/2022/06/16/hypertriglyceridaemia-genetic-diagnosis-and-the-role-of-ngs-in-lipid-disorders/2026-07-09monthly0.6 https://openbiodx.com/2022/06/14/bacteroides-fragilis-group-updated-taxonomy-resistance-trends-and-species-level-/2026-07-09monthly0.6 https://openbiodx.com/2022/06/14/msi-dmmr-testing-in-pancreatic-and-ampullary-carcinomas-prevalence-histotype-cor/2026-07-09monthly0.6 https://openbiodx.com/2022/06/14/hepatoid-tumors-of-the-gi-tract-immunohistochemical-and-molecular-profiles-for-d/2026-07-09monthly0.6 https://openbiodx.com/2022/06/13/comprehensive-review-of-antimicrobial-susceptibility-testing-methods-for-enteroc/2026-07-09monthly0.6 https://openbiodx.com/2022/06/12/dpyd-genotyping-before-fluoropyrimidine-chemotherapy-clinical-evidence-supports-/2026-07-09monthly0.6 https://openbiodx.com/2022/06/11/tert-promoter-mutations-present-in-60-80-of-bladder-cancers-detectable-via-liqui/2026-07-09monthly0.6 https://openbiodx.com/2022/06/08/high-throughput-whole-slide-scanning-strategies-for-building-large-scale-digital/2026-07-09monthly0.6 https://openbiodx.com/2022/06/04/expanded-ngs-biomarker-panel-identifies-pi3k-akt-pten-altered-breast-cancers-tha/2026-07-09monthly0.6 https://openbiodx.com/2022/06/04/dynamic-trial-ctdna-guided-therapy-halves-chemotherapy-use-in-stage-ii-colon-can/2026-07-09monthly0.6 https://openbiodx.com/2022/06/02/ngs-expands-the-genetic-landscape-of-inherited-thrombocytopenias-to-over-40-gene/2026-07-09monthly0.6 https://openbiodx.com/2022/05/31/asm-clinical-microbiology-open-charting-the-future-of-diagnostics-from-ngs-to-ai/2026-07-09monthly0.6 https://openbiodx.com/2022/05/28/advances-in-hiv-diagnostics-from-rapid-tests-to-ngs-for-ending-the-epidemic/2026-07-09monthly0.6 https://openbiodx.com/2022/05/28/risankizumab-shows-strong-induction-efficacy-in-crohn-s-disease-across-two-phase/2026-07-09monthly0.6 https://openbiodx.com/2022/05/28/risankizumab-maintains-remission-in-crohn-s-disease-in-phase-3-fortify-trial/2026-07-09monthly0.6 https://openbiodx.com/2022/05/26/tertiary-lymphoid-structures-predict-immunotherapy-response-in-soft-tissue-sarco/2026-07-09monthly0.6 https://openbiodx.com/2022/05/25/machine-learning-for-amr-prediction-promise-limitations-and-the-path-to-clinical/2026-07-09monthly0.6 https://openbiodx.com/2022/05/25/clinical-decision-support-in-cardiovascular-medicine-promise-barriers-and-regula/2026-07-09monthly0.6 https://openbiodx.com/2022/05/23/developing-practical-image-analysis-methods-for-digital-pathology-from-algorithm/2026-07-09monthly0.6 https://openbiodx.com/2022/05/17/cefazolin-inoculum-effect-present-in-nearly-one-fifth-of-north-american-mssa-iso/2026-07-09monthly0.6 https://openbiodx.com/2022/05/16/presepsin-emerges-as-a-promising-early-biomarker-for-perinatal-sepsis-detection/2026-07-09monthly0.6 https://openbiodx.com/2022/05/15/rapid-diagnostic-algorithms-using-high-sensitivity-troponin-from-evidence-to-imp/2026-07-09monthly0.6 https://openbiodx.com/2022/05/11/cmv-cell-mediated-immunity-assays-show-promise-for-personalizing-transplant-mana/2026-07-09monthly0.6 https://openbiodx.com/2022/05/10/radiotheranostics-enter-mainstream-oncology-a-clinical-pharmacology-primer/2026-07-09monthly0.6 https://openbiodx.com/2022/05/06/integrating-computational-pathology-and-proteomics-to-overcome-tumor-heterogenei/2026-07-09monthly0.6 https://openbiodx.com/2022/05/05/evidence-on-repeat-fit-testing-in-symptomatic-patients-remains-minimal-and-confl/2026-07-09monthly0.6 https://openbiodx.com/2022/05/01/erbb2-positive-metastatic-colorectal-cancer-diagnostic-methods-and-emerging-targ/2026-07-09monthly0.6 https://openbiodx.com/2022/04/29/real-world-data-and-evidence-are-reshaping-regulatory-decisions-for-ivd-diagnost/2026-07-09monthly0.6 https://openbiodx.com/2022/04/21/ai-predicts-genetic-alterations-from-h-e-slides-systematic-review-of-the-evidenc/2026-07-09monthly0.6 https://openbiodx.com/2022/04/19/early-cancer-detection-toward-risk-stratified-multi-modal-screening-paradigms/2026-07-09monthly0.6 https://openbiodx.com/2022/04/14/b-f1rst-trial-blood-based-tmb-shows-promise-but-needs-refinement-for-immunothera/2026-07-09monthly0.6 https://openbiodx.com/2022/04/11/h-pylori-diagnostics-comprehensive-guide-to-laboratory-methods-and-resistance-de/2026-07-09monthly0.6 https://openbiodx.com/2022/04/10/pax8-and-cdx2-can-stain-positive-in-breast-cancer-risking-misdiagnosis-of-tumor-/2026-07-09monthly0.6 https://openbiodx.com/2022/04/09/over-the-counter-strep-a-testing-opportunities-and-challenges-for-consumer-diagn/2026-07-09monthly0.6 https://openbiodx.com/2022/04/07/susceptibility-testing-for-new-beta-lactam-beta-lactamase-inhibitor-combinations/2026-07-09monthly0.6 https://openbiodx.com/2022/04/02/high-sensitivity-troponin-assays-enable-rapid-rule-out-in-acute-coronary-syndrom/2026-07-09monthly0.6 https://openbiodx.com/2022/04/01/korean-pan-cancer-sequencing-reveals-genomic-diversity-versus-western-cohorts/2026-07-09monthly0.6 https://openbiodx.com/2022/03/31/tutorial-statistical-methods-for-evaluating-diagnostic-test-accuracy-using-proca/2026-07-09monthly0.6 https://openbiodx.com/2022/03/31/nih-save-programme-defines-framework-for-real-time-sars-cov-2-variant-risk-asses/2026-07-09monthly0.6 https://openbiodx.com/2022/03/29/pharmvar-updates-cyp3a5-nomenclature-for-tacrolimus-dose-optimisation/2026-07-09monthly0.6 https://openbiodx.com/2022/03/24/molecular-testing-resolves-high-diagnostic-discrepancy-rates-in-endometrial-stro/2026-07-09monthly0.6 https://openbiodx.com/2022/03/24/ponte-di-legno-consortium-establishes-international-consensus-on-mrd-based-respo/2026-07-09monthly0.6 https://openbiodx.com/2022/03/23/prone-positioning-shows-no-benefit-for-non-critically-ill-hospitalised-covid-19-/2026-07-09monthly0.6 https://openbiodx.com/2022/03/23/precision-diagnostics-for-advanced-cutaneous-squamous-cell-carcinoma-liquid-biop/2026-07-09monthly0.6 https://openbiodx.com/2022/03/17/bridges-study-maps-tumor-pathology-across-nine-breast-cancer-susceptibility-gene/2026-07-09monthly0.6 https://openbiodx.com/2022/03/16/acuitas-amr-gene-panel-accurately-detects-28-resistance-markers-in-cultured-bact/2026-07-09monthly0.6 https://openbiodx.com/2022/03/14/simplexa-vzv-direct-assay-detects-varicella-zoster-virus-without-nucleic-acid-ex/2026-07-09monthly0.6 https://openbiodx.com/2022/03/11/cpic-guideline-for-slco1b1-abcg2-and-cyp2c9-genotypes-links-pharmacogenomics-to-/2026-07-09monthly0.6 https://openbiodx.com/2022/03/08/digital-pcr-for-sars-cov-2-lessons-for-future-pandemic-diagnostics/2026-07-09monthly0.6 https://openbiodx.com/2022/03/03/post-cardiac-surgery-troponin-thresholds-for-mortality-far-exceed-current-guidel/2026-07-09monthly0.6 https://openbiodx.com/2022/03/03/idiotype-vaccine-plus-adoptive-t-cell-transfer-shows-enhanced-immune-reconstitut/2026-07-09monthly0.6 https://openbiodx.com/2022/03/02/cancer-proteogenomics-integrates-protein-data-with-genomics-to-reveal-new-therap/2026-07-09monthly0.6 https://openbiodx.com/2022/03/01/comprehensive-guide-to-lc-ms-ms-method-development-for-clinical-diagnostic-assay/2026-07-09monthly0.6 https://openbiodx.com/2022/03/01/atezolizumab-shows-38-response-rate-in-tmb-high-tumors-across-multiple-cancer-ty/2026-07-09monthly0.6 https://openbiodx.com/2022/02/28/beyond-the-exome-a-guide-to-diagnosing-rare-and-undiagnosed-diseases/2026-07-09monthly0.6 https://openbiodx.com/2022/02/25/machine-learning-in-routine-laboratory-medicine-automation-utilisation-and-perso/2026-07-09monthly0.6 https://openbiodx.com/2022/02/22/crispr-in-cancer-from-functional-genomics-to-diagnostics-and-therapeutics/2026-07-09monthly0.6 https://openbiodx.com/2022/02/22/sublingual-dexmedetomidine-rapidly-reduces-acute-agitation-in-bipolar-disorder/2026-07-09monthly0.6 https://openbiodx.com/2022/02/16/whole-genome-sequencing-transforms-amr-surveillance-from-local-outbreaks-to-glob/2026-07-09monthly0.6 https://openbiodx.com/2022/02/15/acute-coronary-syndromes-high-sensitivity-troponin-transforms-rapid-diagnosis/2026-07-09monthly0.6 https://openbiodx.com/2022/02/14/scoring-system-for-poct-internal-quality-control-frequency-in-primary-care/2026-07-09monthly0.6 https://openbiodx.com/2022/02/09/bacillus-cereus-invasive-infections-in-preterm-neonates-underrecognised-and-pote/2026-07-09monthly0.6 https://openbiodx.com/2022/02/08/cpic-2022-update-cyp2c19-genotype-now-drives-broader-antiplatelet-therapy-recomm/2026-07-09monthly0.6 https://openbiodx.com/2022/02/02/stanford-lancet-commission-issues-comprehensive-recommendations-to-combat-the-op/2026-07-09monthly0.6 https://openbiodx.com/2022/02/02/flu-home-trial-tests-at-home-influenza-rdts-with-app-based-symptom-triggers/2026-07-09monthly0.6 https://openbiodx.com/2022/01/30/immunohistochemistry-for-infectious-disease-diagnosis-80-years-of-evolution-and-/2026-07-09monthly0.6 https://openbiodx.com/2022/01/29/schizophrenia-neuroimaging-and-biomarker-challenges-in-psychiatric-diagnosis/2026-07-09monthly0.6 https://openbiodx.com/2022/01/27/sustained-mrd-negativity-predicts-superior-pfs-in-transplant-ineligible-myeloma-/2026-07-09monthly0.6 https://openbiodx.com/2022/01/17/meta-analysis-confirms-adt-prolongation-improves-metastasis-free-survival-in-pro/2026-07-09monthly0.6 https://openbiodx.com/2022/01/11/jama-review-nucleic-acid-amplification-tests-transform-sti-diagnostics-with-near/2026-07-09monthly0.6 https://openbiodx.com/2022/01/06/genetic-and-epigenetic-landscape-of-cutaneous-t-cell-lymphoma-mapped-by-ngs/2026-07-09monthly0.6 https://openbiodx.com/2022/01/05/gut-microbiome-in-neurological-disorders-diagnostic-biomarkers-and-therapeutic-t/2026-07-09monthly0.6 https://openbiodx.com/2022/01/05/candida-auris-detection-from-sequencing-to-maldi-tof-and-rapid-molecular-tests/2026-07-09monthly0.6 https://openbiodx.com/2022/01/05/covid-19-pandemic-innovations-fuel-next-generation-of-infectious-disease-diagnos/2026-07-09monthly0.6 https://openbiodx.com/2021/12/30/ai-and-machine-learning-are-reshaping-infectious-disease-diagnostics/2026-07-09monthly0.6 https://openbiodx.com/2021/12/30/lateral-flow-assays-technology-advances-drive-new-era-in-infectious-disease-diag/2026-07-09monthly0.6 https://openbiodx.com/2021/12/30/rapid-antimicrobial-susceptibility-testing-where-technology-stands-and-what-is-s/2026-07-09monthly0.6 https://openbiodx.com/2021/12/30/eln-2021-mrd-consensus-introduces-ngs-specifications-and-integrative-assessment-/2026-07-09monthly0.6 https://openbiodx.com/2021/12/23/nejm-trial-decentralised-on-site-molecular-tb-testing-increases-diagnosis-and-sa/2026-07-09monthly0.6 https://openbiodx.com/2021/12/15/circular-rnas-emerge-as-cancer-biomarkers-detectable-in-liquid-biopsy/2026-07-09monthly0.6 https://openbiodx.com/2021/12/01/ctdna-minimal-residual-disease-emerges-as-a-transformative-biomarker-for-predict/2026-07-09monthly0.6 https://openbiodx.com/2021/11/26/blood-based-mass-spectrometry-mrd-rivals-bone-marrow-ngs-in-multiple-myeloma/2026-07-09monthly0.6 https://openbiodx.com/2021/11/25/preimplantation-genetic-testing-for-aneuploidy-does-not-improve-cumulative-ivf-l/2026-07-09monthly0.6 https://openbiodx.com/2021/11/24/ai-derived-stroma-infiltrating-lymphocyte-score-predicts-survival-in-head-and-ne/2026-07-09monthly0.6 https://openbiodx.com/2021/11/11/ctdna-genotyping-matches-tissue-testing-for-her2-amplified-colorectal-cancer-tre/2026-07-09monthly0.6 https://openbiodx.com/2021/11/10/etest-plazomicin-demonstrates-high-accuracy-for-enterobacterales-susceptibility-/2026-07-09monthly0.6 https://openbiodx.com/2021/11/01/neoadjuvant-therapy-in-early-stage-nsclc-biomarker-discovery-and-the-role-of-dig/2026-07-09monthly0.6 https://openbiodx.com/2021/11/01/pd-l1-positive-circulating-tumour-cells-emerge-as-prognostic-marker-in-advanced-/2026-07-09monthly0.6 https://openbiodx.com/2021/10/28/the-curse-of-dimensionality-why-high-dimensional-health-data-challenge-ai-genera/2026-07-09monthly0.6 https://openbiodx.com/2021/10/28/ticagrelor-beats-clopidogrel-in-cyp2c19-loss-of-function-carriers-after-minor-st/2026-07-09monthly0.6 https://openbiodx.com/2021/10/27/vitek-2-meropenem-vaborbactam-test-validated-for-enterobacterales-susceptibility/2026-07-09monthly0.6 https://openbiodx.com/2021/10/27/inflammation-downregulates-drug-metabolising-enzymes-implications-for-therapeuti/2026-07-09monthly0.6 https://openbiodx.com/2021/10/25/high-sensitivity-troponin-in-paediatric-populations-promise-limited-by-absent-re/2026-07-09monthly0.6 https://openbiodx.com/2021/10/21/nejm-review-establishes-point-of-care-ultrasound-as-essential-bedside-diagnostic/2026-07-09monthly0.6 https://openbiodx.com/2021/10/19/ai-models-for-gastric-cancer-diagnosis-and-prognosis-from-digital-pathology-imag/2026-07-09monthly0.6 https://openbiodx.com/2021/10/19/lynch-syndrome-carriers-with-msh2-msh6-mutations-show-higher-prostate-cancer-rat/2026-07-09monthly0.6 https://openbiodx.com/2021/10/18/multimodal-data-integration-for-precision-oncology-merging-genomics-imaging-and-/2026-07-09monthly0.6 https://openbiodx.com/2021/10/18/radiomics-and-ai-in-oncology-imaging-from-diagnosis-to-outcome-prediction/2026-07-09monthly0.6 https://openbiodx.com/2021/10/18/laboratory-biomarkers-for-multiple-sclerosis-from-oligoclonal-bands-to-neurofila/2026-07-09monthly0.6 https://openbiodx.com/2021/10/04/mendelian-randomisation-links-kidney-damage-to-brain-cortical-thinning/2026-07-09monthly0.6 https://openbiodx.com/2021/10/01/spirit-path-international-consensus-guidelines-for-pathology-content-in-clinical/2026-07-09monthly0.6 https://openbiodx.com/2021/10/01/single-fraction-sabr-non-inferior-to-multifraction-for-pulmonary-oligometastases/2026-07-09monthly0.6 https://openbiodx.com/2021/10/01/variant-classification-challenges-in-hereditary-hemochromatosis-diagnostics/2026-07-09monthly0.6 https://openbiodx.com/2021/09/27/deep-learning-in-oncology-from-digital-pathology-to-multi-omics-integration/2026-07-09monthly0.6 https://openbiodx.com/2021/09/23/mitotic-activity-assessment-in-breast-cancer-revisited-for-the-digital-pathology/2026-07-09monthly0.6 https://openbiodx.com/2021/09/23/treatment-landscape-for-malignant-pleural-mesothelioma-current-options-and-futur/2026-07-09monthly0.6 https://openbiodx.com/2021/09/22/clsi-m100-31st-edition-new-breakpoints-disk-diffusion-from-blood-cultures-and-re/2026-07-09monthly0.6 https://openbiodx.com/2021/09/21/procalcitonin-point-of-care-testing-reduces-antibiotic-prescribing-by-26-for-low/2026-07-09monthly0.6 https://openbiodx.com/2021/09/21/crp-point-of-care-testing-safely-reduces-antibiotic-prescribing-by-29-in-nursing/2026-07-09monthly0.6 https://openbiodx.com/2021/09/15/colorectal-cancer-screening-current-modalities-ai-assisted-detection-and-persist/2026-07-09monthly0.6 https://openbiodx.com/2021/09/10/tisagenlecleucel-demonstrates-durable-responses-at-40-month-follow-up-in-aggress/2026-07-09monthly0.6 https://openbiodx.com/2021/09/06/cancer-associated-fibroblasts-emerging-biomarker-and-therapeutic-target-in-the-t/2026-07-09monthly0.6 https://openbiodx.com/2021/09/01/aacc-expert-panel-issues-practical-recommendations-for-sars-cov-2-serologic-test/2026-07-09monthly0.6 https://openbiodx.com/2021/09/01/bmj-review-evidence-for-ai-in-breast-cancer-screening-remains-insufficient-for-c/2026-07-09monthly0.6 https://openbiodx.com/2021/09/01/carboplatin-improves-survival-in-high-risk-group-3-medulloblastoma/2026-07-09monthly0.6 https://openbiodx.com/2021/09/01/combining-type-i-and-type-ii-kit-inhibitors-shows-promise-in-refractory-gist-gui/2026-07-09monthly0.6 https://openbiodx.com/2021/08/29/tomahawk-trial-immediate-angiography-after-cardiac-arrest-without-st-elevation-s/2026-07-09monthly0.6 https://openbiodx.com/2021/08/29/how-to-guide-for-building-pharmacogenomic-clinical-decision-support-systems/2026-07-09monthly0.6 https://openbiodx.com/2021/08/27/whole-exome-sequencing-reveals-ciliary-gene-mutations-in-31-of-nonsyndromic-bili/2026-07-09monthly0.6 https://openbiodx.com/2021/08/21/digital-pathology-grading-of-renal-cell-carcinoma-is-non-inferior-to-glass-slide/2026-07-09monthly0.6 https://openbiodx.com/2021/08/18/genmark-eplex-gram-negative-blood-culture-panel-demonstrates-high-accuracy-acros/2026-07-09monthly0.6 https://openbiodx.com/2021/08/18/pharmacogenetics-of-antipsychotics-from-cyp2d6-dosing-to-tardive-dyskinesia-risk/2026-07-09monthly0.6 https://openbiodx.com/2021/08/13/point-of-care-placental-growth-factor-testing-does-not-reduce-maternal-morbidity/2026-07-09monthly0.6 https://openbiodx.com/2021/08/13/stockholm3-blood-test-plus-mri-outperforms-standard-psa-screening-for-prostate-c/2026-07-09monthly0.6 https://openbiodx.com/2021/08/10/teclistamab-bispecific-antibody-shows-65-response-rate-in-heavily-pretreated-mul/2026-07-09monthly0.6 https://openbiodx.com/2021/08/05/high-sensitivity-troponin-t-stratifies-covid-19-risk-a-single-value-below-6-ng-l/2026-07-09monthly0.6 https://openbiodx.com/2021/08/04/eucast-update-revised-s-i-r-definitions-and-rapid-ast-from-blood-culture-bottles/2026-07-09monthly0.6 https://openbiodx.com/2021/08/04/can-lab-tests-predict-sars-cov-2-infectivity-a-review-of-pcr-antigen-and-subgeno/2026-07-09monthly0.6 https://openbiodx.com/2021/07/29/race-conscious-pharmacogenomics-ancestry-specific-variants-and-equity-in-drug-re/2026-07-09monthly0.6 https://openbiodx.com/2021/07/29/postoperative-ctdna-predicts-recurrence-after-colorectal-cancer-liver-metastasis/2026-07-09monthly0.6 https://openbiodx.com/2021/07/27/large-phase-3-trial-shows-vincristine-dexamethasone-pulses-can-be-safely-omitted/2026-07-09monthly0.6 https://openbiodx.com/2021/07/22/bacterial-meningitis-conjugate-vaccines-reduce-incidence-but-diagnostic-challeng/2026-07-09monthly0.6 https://openbiodx.com/2021/07/21/sars-cov-2-antigen-rapid-tests-show-high-false-positive-rates-when-screening-asy/2026-07-09monthly0.6 https://openbiodx.com/2021/07/18/decade-of-pharmacogenomic-gwas-trends-discoveries-and-the-road-to-biobank-scale-/2026-07-09monthly0.6 https://openbiodx.com/2021/07/17/immunopharmacogenomics-mechanisms-behind-hla-linked-drug-hypersensitivity-reacti/2026-07-09monthly0.6 https://openbiodx.com/2021/07/14/blood-culture-diagnostic-stewardship-optimizing-when-and-how-to-collect/2026-07-09monthly0.6 https://openbiodx.com/2021/07/12/computational-pathology-risk-score-predicts-survival-and-benefit-from-adjuvant-c/2026-07-09monthly0.6 https://openbiodx.com/2021/07/12/pharmvar-catalogues-cyp2c9-star-alleles-critical-for-warfarin-and-nsaid-safety/2026-07-09monthly0.6 https://openbiodx.com/2021/07/10/pharmacogenomics-in-colorectal-cancer-from-dpyd-testing-to-companion-diagnostics/2026-07-09monthly0.6 https://openbiodx.com/2021/07/09/mri-targeted-biopsy-halves-clinically-insignificant-prostate-cancer-detection-in/2026-07-09monthly0.6 https://openbiodx.com/2021/07/07/pharmacogenetics-implementation-demands-broader-evidence-beyond-rcts/2026-07-09monthly0.6 https://openbiodx.com/2021/07/06/cardiac-biomarkers-in-pediatrics-an-undervalued-diagnostic-resource/2026-07-09monthly0.6 https://openbiodx.com/2021/07/04/mri-radiomics-plus-machine-learning-predicts-axillary-lymph-node-status-in-breas/2026-07-09monthly0.6 https://openbiodx.com/2021/06/26/qpcr-kit-outperforms-microscopy-for-early-detection-of-congenital-chagas-disease/2026-07-09monthly0.6 https://openbiodx.com/2021/06/25/pharmacogenetic-guided-antidepressant-prescribing-clinical-reality-and-implement/2026-07-09monthly0.6 https://openbiodx.com/2021/06/24/cilta-cel-car-t-cell-therapy-achieves-97-response-rate-in-heavily-pretreated-mul/2026-07-09monthly0.6 https://openbiodx.com/2021/06/21/procalcitonin-assay-harmonization-remains-incomplete-despite-growing-clinical-ad/2026-07-09monthly0.6 https://openbiodx.com/2021/06/20/cpic-guideline-mt-rnr1-genotyping-to-prevent-aminoglycoside-induced-hearing-loss/2026-07-09monthly0.6 https://openbiodx.com/2021/06/17/monthly-dihydroartemisinin-piperaquine-outperforms-sulfadoxine-pyrimethamine-for/2026-07-09monthly0.6 https://openbiodx.com/2021/06/16/nanopore-sequencing-for-tuberculosis-promise-and-gaps-in-current-evidence/2026-07-09monthly0.6 https://openbiodx.com/2021/06/16/ctdna-identifies-urothelial-cancer-patients-who-benefit-from-adjuvant-atezolizum/2026-07-09monthly0.6 https://openbiodx.com/2021/06/15/idh-mutations-as-a-therapeutic-target-across-multiple-cancer-types/2026-07-09monthly0.6 https://openbiodx.com/2021/06/11/ai-powered-biomarker-evaluation-for-personalised-treatment-in-breast-and-prostat/2026-07-09monthly0.6 https://openbiodx.com/2021/06/10/computational-tools-for-interpreting-rare-pharmacogenomic-variants-from-ngs-data/2026-07-09monthly0.6 https://openbiodx.com/2021/06/10/rare-vwf-gene-variants-predict-von-willebrand-factor-antigen-levels-beyond-known/2026-07-09monthly0.6 https://openbiodx.com/2021/06/10/tumour-educated-platelets-emerge-as-a-novel-liquid-biopsy-platform-for-early-can/2026-07-09monthly0.6 https://openbiodx.com/2021/06/10/tumor-educated-platelets-emerge-as-novel-liquid-biopsy-source-for-cancer-rna-bio/2026-07-09monthly0.6 https://openbiodx.com/2021/06/08/general-health-checks-do-not-reduce-mortality-but-boost-chronic-disease-detectio/2026-07-09monthly0.6 https://openbiodx.com/2021/06/04/kte-x19-car-t-achieves-71-complete-remission-with-97-mrd-negativity-in-adult-rel/2026-07-09monthly0.6 https://openbiodx.com/2021/06/03/circulating-mitochondrial-dna-identified-as-a-proinflammatory-damp-in-sickle-cel/2026-07-09monthly0.6 https://openbiodx.com/2021/06/02/practical-guidance-for-clinical-microbiology-laboratories-diagnosing-ocular-infe/2026-07-09monthly0.6 https://openbiodx.com/2021/05/31/eubivas-high-quality-biological-variation-data-for-80-laboratory-measurands/2026-07-09monthly0.6 https://openbiodx.com/2021/05/25/canadian-consensus-guidance-for-sars-cov-2-point-of-care-test-selection-and-qual/2026-07-09monthly0.6 https://openbiodx.com/2021/05/19/enovat-aims-to-harmonise-veterinary-antimicrobial-susceptibility-testing-across-/2026-07-09monthly0.6 https://openbiodx.com/2021/05/19/resolving-genotype-phenotype-discordance-in-rapid-molecular-ast-panels/2026-07-09monthly0.6 https://openbiodx.com/2021/05/19/67-of-msi-high-ras-braf-wild-type-colorectal-cancers-harbor-targetable-kinase-fu/2026-07-09monthly0.6 https://openbiodx.com/2021/05/18/permed-01-trial-extensive-molecular-profiling-finds-actionable-targets-in-71-of-/2026-07-09monthly0.6 https://openbiodx.com/2021/05/14/64-biomarker-panel-reveals-distinct-inflammatory-and-endothelial-pathways-drivin/2026-07-09monthly0.6 https://openbiodx.com/2021/05/14/deep-learning-in-histopathology-bridging-the-gap-between-proof-of-concept-and-cl/2026-07-09monthly0.6 https://openbiodx.com/2021/05/12/sars-cov-2-detection-technologies-from-pcr-to-point-of-care-biosensors/2026-07-09monthly0.6 https://openbiodx.com/2021/05/12/largest-ovarian-cancer-screening-trial-finds-no-mortality-benefit-after-16-years/2026-07-09monthly0.6 https://openbiodx.com/2021/05/11/pembrolizumab-cetuximab-combination-shows-45-response-rate-in-head-and-neck-canc/2026-07-09monthly0.6 https://openbiodx.com/2021/05/10/mdma-assisted-therapy-for-ptsd-phase-3-trial-and-implications-for-drug-testing-l/2026-07-09monthly0.6 https://openbiodx.com/2021/05/06/ai-enabled-ecg-screening-increases-early-diagnosis-of-low-ejection-fraction-in-p/2026-07-09monthly0.6 https://openbiodx.com/2021/04/23/procalcitonin-reference-values-established-for-term-pregnancy-and-early-postpart/2026-07-09monthly0.6 https://openbiodx.com/2021/04/22/emicizumab-maintains-low-bleed-rates-through-three-years-in-haemophilia-a-pooled/2026-07-09monthly0.6 https://openbiodx.com/2021/04/22/epigenetic-combination-therapy-highly-active-in-t-cell-lymphoma-ngs-identifies-m/2026-07-09monthly0.6 https://openbiodx.com/2021/04/20/poloxamer-188-fails-to-shorten-vaso-occlusive-episodes-in-sickle-cell-disease/2026-07-09monthly0.6 https://openbiodx.com/2021/04/20/abbott-realtime-and-alinity-m-sars-cov-2-assays-validated-with-head-to-head-plat/2026-07-09monthly0.6 https://openbiodx.com/2021/04/19/alk-and-ros1-rearrangement-testing-in-nsclc-ihc-fish-and-the-path-to-ngs/2026-07-09monthly0.6 https://openbiodx.com/2021/04/15/ctdna-based-pan-cancer-screening-tests-achieve-over-99-specificity-but-sensitivi/2026-07-09monthly0.6 https://openbiodx.com/2021/04/13/smad4-alteration-plus-low-mapk9-expression-predicts-erlotinib-benefit-in-resecte/2026-07-09monthly0.6 https://openbiodx.com/2021/04/13/novel-biomarkers-show-promise-for-monitoring-anti-tnf-therapy-in-ibd/2026-07-09monthly0.6 https://openbiodx.com/2021/04/12/patient-derived-organoids-as-predictive-biomarker-for-cancer-treatment-response/2026-07-09monthly0.6 https://openbiodx.com/2021/04/12/multi-site-benchmarking-study-defines-analytical-performance-boundaries-of-leadi/2026-07-09monthly0.6 https://openbiodx.com/2021/04/09/beyond-sequence-epigenomics-fragmentomics-and-topology-expand-cell-free-dna-anal/2026-07-09monthly0.6 https://openbiodx.com/2021/04/07/systematic-review-finds-high-but-heterogeneous-diagnostic-accuracy-for-deep-lear/2026-07-09monthly0.6 https://openbiodx.com/2021/04/06/antimicrobial-use-in-us-nursing-homes-a-national-point-prevalence-survey/2026-07-09monthly0.6 https://openbiodx.com/2021/04/05/patient-derived-models-reshape-biomarker-validation-in-colorectal-cancer/2026-07-09monthly0.6 https://openbiodx.com/2021/04/01/immunophenotype-and-proliferation-scores-independently-predict-pathologic-comple/2026-07-09monthly0.6 https://openbiodx.com/2021/04/01/ai-in-cancer-research-from-molecular-characterisation-to-treatment-prediction/2026-07-09monthly0.6 https://openbiodx.com/2021/04/01/synthetic-lethality-emerges-as-next-generation-strategy-for-targeting-undruggabl/2026-07-09monthly0.6 https://openbiodx.com/2021/04/01/tracerx-review-tracking-cancer-evolution-from-primary-disease-through-recurrence/2026-07-09monthly0.6 https://openbiodx.com/2021/04/01/liquid-biopsy-matures-a-framework-for-ctc-and-ctdna-clinical-applications/2026-07-09monthly0.6 https://openbiodx.com/2021/03/31/biomarker-targeted-therapy-landscape-in-gastric-cancer-expands-beyond-her2-msi-a/2026-07-09monthly0.6 https://openbiodx.com/2021/03/29/ntrk-fusions-across-solid-tumours-biology-prevalence-and-testing-strategies/2026-07-09monthly0.6 https://openbiodx.com/2021/03/26/multi-omics-pipelines-transform-diagnosis-of-mitochondrial-disease/2026-07-09monthly0.6 https://openbiodx.com/2021/03/19/ultrasensitive-diagnostics-target-the-hidden-reservoir-of-asymptomatic-malaria/2026-07-09monthly0.6 https://openbiodx.com/2021/03/15/esope-trial-profiling-first-metastatic-event-in-breast-cancer-reveals-actionable/2026-07-09monthly0.6 https://openbiodx.com/2021/03/11/pharmvar-catalogues-cyp2b6-variation-impacting-efavirenz-methadone-and-ketamine/2026-07-09monthly0.6 https://openbiodx.com/2021/03/10/pathogenesis-of-gram-negative-bacteremia-shared-and-unique-virulence-mechanisms-/2026-07-09monthly0.6 https://openbiodx.com/2021/03/10/mmp-7-reviewed-as-cancer-biomarker-and-therapeutic-target/2026-07-09monthly0.6 https://openbiodx.com/2021/03/02/biomarker-guided-individualization-of-antibiotic-therapy-from-crp-and-pct-to-pha/2026-07-09monthly0.6 https://openbiodx.com/2021/03/02/single-cell-meta-analysis-maps-sars-cov-2-entry-gene-expression-across-tissues-a/2026-07-09monthly0.6 https://openbiodx.com/2021/03/02/supar-combined-with-nt-probnp-and-heart-score-achieves-99-negative-predictive-va/2026-07-09monthly0.6 https://openbiodx.com/2021/03/02/blinatumomab-outperforms-chemotherapy-in-children-with-high-risk-first-relapse-b/2026-07-09monthly0.6 https://openbiodx.com/2021/02/28/global-variation-in-paediatric-beta-lactam-dosing-threatens-pharmacodynamic-targ/2026-07-09monthly0.6 https://openbiodx.com/2021/02/25/ide-cel-car-t-therapy-achieves-73-response-and-26-mrd-negativity-in-heavily-pret/2026-07-09monthly0.6 https://openbiodx.com/2021/02/23/clinical-chemistry-score-validated-for-ami-rule-out-troponin-combined-with-egfr-/2026-07-09monthly0.6 https://openbiodx.com/2021/02/19/high-sensitivity-troponin-assays-analytical-advances-clinical-benefits-and-ongoi/2026-07-09monthly0.6 https://openbiodx.com/2021/02/18/sherlock-and-detectr-crispr-cas-diagnostics-for-rapid-infectious-disease-detecti/2026-07-09monthly0.6 https://openbiodx.com/2021/02/18/unyvero-bal-panel-identifies-pneumonia-pathogens-and-resistance-markers-in-4-5-h/2026-07-09monthly0.6 https://openbiodx.com/2021/02/12/circulating-tumour-dna-validated-as-independent-prognostic-biomarker-in-braf-mut/2026-07-09monthly0.6 https://openbiodx.com/2021/02/12/pd-l1-immunohistochemistry-current-state-and-challenges-as-a-companion-diagnosti/2026-07-09monthly0.6 https://openbiodx.com/2021/02/11/anxiety-disorders-the-search-for-objective-diagnostic-biomarkers/2026-07-09monthly0.6 https://openbiodx.com/2021/02/11/burkitt-lymphoma-in-adults-genomic-landscape-and-treatment-challenges/2026-07-09monthly0.6 https://openbiodx.com/2021/02/10/cancer-epigenomics-proper-controls-and-the-road-to-clinical-translation/2026-07-09monthly0.6 https://openbiodx.com/2021/02/09/crispr-genome-editing-advances-next-generation-adoptive-cell-therapies-for-cance/2026-07-09monthly0.6 https://openbiodx.com/2021/02/09/cpic-opioid-guideline-cyp2d6-genotyping-recommended-for-codeine-and-tramadol-pre/2026-07-09monthly0.6 https://openbiodx.com/2021/02/08/glioma-intratumoral-heterogeneity-challenges-molecular-diagnostics-and-targeted-/2026-07-09monthly0.6 https://openbiodx.com/2021/02/01/universal-genetic-testing-in-cancer-patients-finds-6-more-actionable-variants-th/2026-07-09monthly0.6 https://openbiodx.com/2021/01/30/lancet-seminar-defines-the-diagnostic-and-mrd-landscape-of-multiple-myeloma/2026-07-09monthly0.6 https://openbiodx.com/2021/01/29/designing-rigorous-deep-learning-studies-in-cancer-diagnostics-protocol-and-vali/2026-07-09monthly0.6 https://openbiodx.com/2021/01/25/beyond-cytokine-storm-subacute-toxicities-and-long-term-monitoring-needs-in-paed/2026-07-09monthly0.6 https://openbiodx.com/2021/01/20/landmark-perspective-charts-the-path-from-approved-liquid-biopsy-assays-to-ctdna/2026-07-09monthly0.6 https://openbiodx.com/2021/01/15/eflm-consensus-provides-minimum-and-best-in-class-solutions-for-iso-15189-pre-an/2026-07-09monthly0.6 https://openbiodx.com/2021/01/14/ewing-sarcoma-molecular-pathogenesis-diagnosis-and-emerging-therapeutic-targets/2026-07-09monthly0.6 https://openbiodx.com/2021/01/12/non-reproducible-troponin-results-are-more-common-than-biotin-interference-and-c/2026-07-09monthly0.6 https://openbiodx.com/2021/01/09/crispr-based-sars-cov-2-diagnostics-rapid-alternatives-to-rt-qpcr/2026-07-09monthly0.6 https://openbiodx.com/2021/01/08/systematic-review-defines-optimal-high-sensitivity-troponin-strategies-for-early/2026-07-09monthly0.6 https://openbiodx.com/2021/01/08/atrial-fibrillation-modifies-the-prognostic-value-of-heart-failure-biomarkers/2026-07-09monthly0.6 https://openbiodx.com/2021/01/08/biological-variation-of-cardiac-troponins-meta-analysis-delivers-robust-referenc/2026-07-09monthly0.6 https://openbiodx.com/2021/01/08/type-2-myocardial-infarction-evolving-diagnostic-criteria-and-risk-stratificatio/2026-07-09monthly0.6 https://openbiodx.com/2021/01/08/biomarker-based-risk-scores-for-stroke-and-bleeding-in-atrial-fibrillation/2026-07-09monthly0.6 https://openbiodx.com/2021/01/08/esc-0-1-hour-algorithm-leads-the-field-in-rapid-troponin-based-mi-rule-out/2026-07-09monthly0.6 https://openbiodx.com/2021/01/08/cardiac-troponin-testing-strategies-in-covid-19-from-acute-care-to-long-term-sur/2026-07-09monthly0.6 https://openbiodx.com/2021/01/08/troponin-release-mechanisms-and-circulating-forms-toward-injury-specific-immunoa/2026-07-09monthly0.6 https://openbiodx.com/2021/01/08/bridging-high-sensitivity-and-point-of-care-troponin-testing-ifcc-practice-recom/2026-07-09monthly0.6 https://openbiodx.com/2021/01/08/cardiac-biomarkers-in-epidemiological-risk-prediction-from-troponin-to-emerging-/2026-07-09monthly0.6 https://openbiodx.com/2021/01/08/deep-learning-for-medical-computer-vision-a-decade-of-progress-across-clinical-d/2026-07-09monthly0.6 https://openbiodx.com/2021/01/01/deep-learning-predicts-microsatellite-instability-from-h-e-slides-outperforming-/2026-07-09monthly0.6 https://openbiodx.com/2021/01/01/afirma-vs-thyroseq-for-indeterminate-thyroid-nodules-randomized-head-to-head-tri/2026-07-09monthly0.6 https://openbiodx.com/2021/01/01/international-consensus-provides-clinical-toolbox-for-breast-surgery-after-neoad/2026-07-09monthly0.6 https://openbiodx.com/2020/12/25/novel-hk1-variant-identified-as-cause-of-hereditary-hemolytic-anemia-via-whole-e/2026-07-09monthly0.6 https://openbiodx.com/2020/12/17/cefiderocol-susceptibility-testing-requires-iron-depleted-media-practical-guidan/2026-07-09monthly0.6 https://openbiodx.com/2020/12/10/pd-l1-expression-predicts-avelumab-response-in-relapsed-nk-t-cell-lymphoma/2026-07-09monthly0.6 https://openbiodx.com/2020/12/07/cancer-of-unknown-primary-molecular-tissue-of-origin-tests-and-ngs-enter-the-dia/2026-07-09monthly0.6 https://openbiodx.com/2020/12/02/bladder-cancer-review-highlights-liquid-biopsy-and-mrd-advances/2026-07-09monthly0.6 https://openbiodx.com/2020/12/01/serial-ctdna-monitoring-predicts-treatment-response-in-kras-mutant-metastatic-co/2026-07-09monthly0.6 https://openbiodx.com/2020/12/01/meta-analysis-of-11-151-aml-patients-confirms-mrd-negativity-nearly-doubles-surv/2026-07-09monthly0.6 https://openbiodx.com/2020/11/29/cscc-publishes-quality-assurance-recommendations-for-hospital-and-community-poct/2026-07-09monthly0.6 https://openbiodx.com/2020/11/27/gene-therapy-nadofaragene-shows-53-complete-response-in-bcg-unresponsive-bladder/2026-07-09monthly0.6 https://openbiodx.com/2020/11/26/biological-variation-of-cardiac-troponin-why-it-matters-for-diagnostic-threshold/2026-07-09monthly0.6 https://openbiodx.com/2020/11/26/krd-plus-transplant-achieves-70-mrd-negativity-in-newly-diagnosed-multiple-myelo/2026-07-09monthly0.6 https://openbiodx.com/2020/11/20/early-onset-colorectal-cancer-rising-incidence-demands-new-screening-and-biomark/2026-07-09monthly0.6 https://openbiodx.com/2020/11/18/six-year-review-of-rickettsial-isolation-from-blood-using-mammalian-cell-culture/2026-07-09monthly0.6 https://openbiodx.com/2020/11/13/galactic-hf-omecamtiv-mecarbil-reduces-heart-failure-events-in-systolic-hf/2026-07-09monthly0.6 https://openbiodx.com/2020/11/01/clinical-metagenomic-sequencing-for-pathogen-detection-when-to-test-and-how-to-i/2026-07-09monthly0.6 https://openbiodx.com/2020/10/28/largest-genomic-study-of-low-grade-serous-ovarian-carcinoma-identifies-actionabl/2026-07-09monthly0.6 https://openbiodx.com/2020/10/28/culturing-the-uncultured-new-strategies-for-growing-human-microbiota-in-the-sequ/2026-07-09monthly0.6 https://openbiodx.com/2020/10/27/lung-map-master-protocol-delivers-biomarker-driven-results-in-squamous-nsclc/2026-07-09monthly0.6 https://openbiodx.com/2020/10/26/best-practices-for-variant-calling-in-clinical-next-generation-sequencing/2026-07-09monthly0.6 https://openbiodx.com/2020/10/25/what-lab-professionals-must-know-about-high-sensitivity-troponin-assay-performan/2026-07-09monthly0.6 https://openbiodx.com/2020/10/22/chemotherapy-free-dasatinib-blinatumomab-strategy-yields-60-molecular-response-i/2026-07-09monthly0.6 https://openbiodx.com/2020/10/19/personalised-tb-risk-predictor-outperforms-crude-group-based-approaches/2026-07-09monthly0.6 https://openbiodx.com/2020/10/14/clinically-applicable-53-gene-assay-predicts-survival-and-chemotherapy-benefit-i/2026-07-09monthly0.6 https://openbiodx.com/2020/10/12/neoadjuvant-durvalumab-plus-tremelimumab-achieves-37-5-pathological-complete-res/2026-07-09monthly0.6 https://openbiodx.com/2020/10/09/targeted-ngs-reveals-distinctive-mutational-profile-of-primary-cutaneous-follicl/2026-07-09monthly0.6 https://openbiodx.com/2020/10/06/tazemetostat-shows-durable-responses-in-ezh2-mutant-follicular-lymphoma/2026-07-09monthly0.6 https://openbiodx.com/2020/10/06/canadian-consensus-guidance-on-sars-cov-2-serology-testing-and-reporting/2026-07-09monthly0.6 https://openbiodx.com/2020/10/01/genomic-prediction-of-antimicrobial-resistance-moves-toward-clinical-laboratory-/2026-07-09monthly0.6 https://openbiodx.com/2020/09/29/mrna-1273-vaccine-elicits-strong-neutralising-antibody-responses-in-older-adults/2026-07-09monthly0.6 https://openbiodx.com/2020/09/28/procalcitonin-guided-stewardship-remains-effective-in-patients-with-impaired-kid/2026-07-09monthly0.6 https://openbiodx.com/2020/09/28/from-scanner-park-to-ai-integration-a-15-year-journey-to-full-digital-diagnostic/2026-07-09monthly0.6 https://openbiodx.com/2020/09/22/advances-in-molecular-diagnostics-for-tuberculosis-detection-and-drug-resistance/2026-07-09monthly0.6 https://openbiodx.com/2020/09/22/viral-load-testing-in-transplant-medicine-hampered-by-poor-assay-standardisation/2026-07-09monthly0.6 https://openbiodx.com/2020/09/22/upper-airway-surgery-beats-medical-management-for-moderate-to-severe-sleep-apnea/2026-07-09monthly0.6 https://openbiodx.com/2020/09/20/cpic-guideline-cyp2c19-genotype-guided-proton-pump-inhibitor-dosing/2026-07-09monthly0.6 https://openbiodx.com/2020/09/16/lung-microbiome-challenges-traditional-ventilator-associated-pneumonia-paradigms/2026-07-09monthly0.6 https://openbiodx.com/2020/09/15/digital-vs-light-microscopy-diagnostic-concordance-a-systematic-review-and-meta-/2026-07-09monthly0.6 https://openbiodx.com/2020/09/11/implementing-plasma-based-ctdna-genotyping-in-nsclc-clinical-practice/2026-07-09monthly0.6 https://openbiodx.com/2020/09/10/congenital-dyserythropoietic-anemias-ngs-transforms-diagnosis-of-rare-inherited-/2026-07-09monthly0.6 https://openbiodx.com/2020/09/10/keynote-158-validates-tumour-mutational-burden-as-a-pan-tumour-biomarker-for-pem/2026-07-09monthly0.6 https://openbiodx.com/2020/09/10/plasmamatch-ctdna-directed-therapy-platform-trial-validates-liquid-biopsy-for-br/2026-07-09monthly0.6 https://openbiodx.com/2020/09/09/16s-rrna-gene-sequencing-for-bacterial-identification-performance-limits-and-the/2026-07-09monthly0.6 https://openbiodx.com/2020/09/08/tumour-budding-validated-as-prognostic-biomarker-across-solid-cancers/2026-07-09monthly0.6 https://openbiodx.com/2020/09/01/i-spy2-trial-confirms-pcr-as-strong-prognostic-biomarker-across-breast-cancer-su/2026-07-09monthly0.6 https://openbiodx.com/2020/09/01/combined-ctdna-and-ctc-detection-after-neoadjuvant-chemotherapy-predicts-recurre/2026-07-09monthly0.6 https://openbiodx.com/2020/08/25/historical-controls-in-clinical-trials-promise-and-pharmacogenomic-pitfalls/2026-07-09monthly0.6 https://openbiodx.com/2020/08/25/tailor-pci-trial-genotype-guided-p2y12-inhibitor-selection-narrowly-misses-prima/2026-07-09monthly0.6 https://openbiodx.com/2020/08/25/m2bpgi-emerges-as-a-versatile-serum-marker-for-liver-fibrosis-and-hcc-risk/2026-07-09monthly0.6 https://openbiodx.com/2020/08/25/next-generation-sequencing-in-clinical-laboratory-medicine-a-comprehensive-revie/2026-07-09monthly0.6 https://openbiodx.com/2020/08/24/pcr-esi-ms-on-whole-blood-detects-bloodstream-pathogens-in-25-6-of-sepsis-cases-/2026-07-09monthly0.6 https://openbiodx.com/2020/08/24/xpert-carba-r-detects-carbapenemase-genes-directly-from-sputum-in-under-2-hours/2026-07-09monthly0.6 https://openbiodx.com/2020/08/22/sex-and-gender-differences-in-diagnostics-implications-for-laboratory-reference-/2026-07-09monthly0.6 https://openbiodx.com/2020/08/12/systematic-review-exposes-gaps-in-statistical-methods-for-paediatric-reference-i/2026-07-09monthly0.6 https://openbiodx.com/2020/08/11/sarcoma-epigenomics-chromatin-pathway-alterations-as-diagnostic-and-therapeutic-/2026-07-09monthly0.6 https://openbiodx.com/2020/08/11/ngs-and-flow-cytometry-reshape-treatment-paradigms-in-acute-myeloid-leukemia/2026-07-09monthly0.6 https://openbiodx.com/2020/08/06/ai-in-pathology-current-clinical-applications-and-the-road-to-precision-medicine/2026-07-09monthly0.6 https://openbiodx.com/2020/08/01/2019-isup-consensus-updates-prostate-cancer-grading-and-embraces-ai-and-cribrifo/2026-07-09monthly0.6 https://openbiodx.com/2020/08/01/hereditary-diffuse-gastric-cancer-updated-cdh1-genetic-testing-guidelines/2026-07-09monthly0.6 https://openbiodx.com/2020/08/01/heartbit-blood-based-gene-profiling-assay-validated-for-heart-transplant-rejecti/2026-07-09monthly0.6 https://openbiodx.com/2020/08/01/national-academies-workshop-best-practices-for-computational-methods-in-precisio/2026-07-09monthly0.6 https://openbiodx.com/2020/07/31/when-to-order-ngs-in-oncology-a-practical-guide-to-precision-medicine-in-clinica/2026-07-09monthly0.6 https://openbiodx.com/2020/07/28/jctlm-task-force-assesses-metrological-traceability-using-creatinine-as-a-model-/2026-07-09monthly0.6 https://openbiodx.com/2020/07/23/covid-19-coagulopathy-d-dimer-above-2-500-ng-ml-predicts-thrombosis-and-bleeding/2026-07-09monthly0.6 https://openbiodx.com/2020/07/23/practical-guide-to-verifying-eua-molecular-assays-for-sars-cov-2-detection/2026-07-09monthly0.6 https://openbiodx.com/2020/07/22/digital-pathology-during-covid-19-how-whole-slide-imaging-sustained-diagnostic-w/2026-07-09monthly0.6 https://openbiodx.com/2020/07/22/pharmvar-genefocus-cyp2c19-nomenclature-underpinning-clopidogrel-and-ppi-guideli/2026-07-09monthly0.6 https://openbiodx.com/2020/07/21/high-sensitivity-troponin-for-population-level-cardiovascular-risk-screening/2026-07-09monthly0.6 https://openbiodx.com/2020/07/20/diabetes-lowers-psa-levels-but-the-difference-is-too-small-to-affect-cancer-dete/2026-07-09monthly0.6 https://openbiodx.com/2020/07/14/mrna-1273-vaccine-phase-1-trial-demonstrates-robust-antibody-and-neutralisation-/2026-07-09monthly0.6 https://openbiodx.com/2020/07/09/whole-slide-imaging-for-distance-teaching-lessons-from-a-caribbean-canadian-path/2026-07-09monthly0.6 https://openbiodx.com/2020/07/07/in-vivo-functional-genomic-screens-crispr-transposons-and-rnai-for-cancer-gene-d/2026-07-09monthly0.6 https://openbiodx.com/2020/07/06/nci-whitepaper-defines-ctdna-applications-across-colorectal-cancer-management/2026-07-09monthly0.6 https://openbiodx.com/2020/07/03/digital-pathology-and-ai-as-critical-infrastructure-for-pathology-services-durin/2026-07-09monthly0.6 https://openbiodx.com/2020/07/02/genetics-of-mds-to-secondary-aml-progression-mapped-by-next-generation-sequencin/2026-07-09monthly0.6 https://openbiodx.com/2020/07/01/checkmate-143-nivolumab-does-not-improve-survival-over-bevacizumab-in-recurrent-/2026-07-09monthly0.6 https://openbiodx.com/2020/07/01/comprehensive-review-of-cannabinoid-analysis-across-biological-matrices-by-lc-ms/2026-07-09monthly0.6 https://openbiodx.com/2020/07/01/mass-spectrometry-outperforms-immunoassays-for-cortisol-in-cushing-s-syndrome-sc/2026-07-09monthly0.6 https://openbiodx.com/2020/06/25/mass-spectrometry-imaging-for-predicting-bone-fracture-healing-and-cartilage-rep/2026-07-09monthly0.6 https://openbiodx.com/2020/06/25/maldi-mass-spectrometry-from-principles-to-expanding-clinical-applications/2026-07-09monthly0.6 https://openbiodx.com/2020/06/25/in-house-vs-kit-based-lc-ms-ms-methods-a-practical-guide-for-clinical-laboratori/2026-07-09monthly0.6 https://openbiodx.com/2020/06/24/biofire-filmarray-pneumonia-panel-multiplex-detection-of-respiratory-pathogens-w/2026-07-09monthly0.6 https://openbiodx.com/2020/06/24/procalcitonin-as-a-sepsis-biomarker-in-children-diagnosis-prognosis-and-antibiot/2026-07-09monthly0.6 https://openbiodx.com/2020/06/24/revogene-strep-a-molecular-assay-delivers-98-sensitivity-in-multicenter-evaluati/2026-07-09monthly0.6 https://openbiodx.com/2020/06/24/covid-19-diagnostics-real-time-pcr-and-ngs-enable-early-pathogen-detection/2026-07-09monthly0.6 https://openbiodx.com/2020/06/21/combining-mri-and-gene-based-hypoxia-biomarkers-improves-chemoradiotherapy-failu/2026-07-09monthly0.6 https://openbiodx.com/2020/06/18/envision-consensus-calls-for-personalized-breast-cancer-screening-based-on-multi/2026-07-09monthly0.6 https://openbiodx.com/2020/06/16/patient-specific-physician-alerts-modestly-boost-colorectal-cancer-screening-upt/2026-07-09monthly0.6 https://openbiodx.com/2020/06/12/liquid-biopsy-in-gastrointestinal-cancer-from-ctcs-to-ctdna-and-extracellular-ve/2026-07-09monthly0.6 https://openbiodx.com/2020/06/11/prealbumin-as-a-nutritional-biomarker-clinical-value-and-analytical-challenges/2026-07-09monthly0.6 https://openbiodx.com/2020/06/08/met-dependent-solid-tumours-diagnostic-approaches-and-targeted-therapy-landscape/2026-07-09monthly0.6 https://openbiodx.com/2020/06/02/crp-guided-antibiotic-duration-for-gram-negative-bacteremia-noninferior-to-fixed/2026-07-09monthly0.6 https://openbiodx.com/2020/06/01/plasma-tumor-mutation-burden-identifies-colorectal-cancer-patients-benefiting-fr/2026-07-09monthly0.6 https://openbiodx.com/2020/05/29/tepotinib-achieves-46-response-rate-in-met-exon-14-skipping-nsclc-with-liquid-an/2026-07-09monthly0.6 https://openbiodx.com/2020/05/27/pooled-analysis-maps-laboratory-abnormalities-in-pediatric-covid-19-by-severity/2026-07-09monthly0.6 https://openbiodx.com/2020/05/26/molecular-point-of-care-tests-challenge-culture-based-strep-a-diagnosis-in-pedia/2026-07-09monthly0.6 https://openbiodx.com/2020/05/26/new-diagnostics-for-invasive-fungal-infections-from-antigen-testing-to-molecular/2026-07-09monthly0.6 https://openbiodx.com/2020/05/19/proteomic-mass-spectrometry-expands-its-role-across-pathology-and-laboratory-med/2026-07-09monthly0.6 https://openbiodx.com/2020/05/18/polygenic-risk-scores-promising-but-not-yet-ready-for-clinical-diagnostics/2026-07-09monthly0.6 https://openbiodx.com/2020/05/16/ai-and-global-health-from-tuberculosis-diagnostics-to-disease-surveillance-in-lo/2026-07-09monthly0.6 https://openbiodx.com/2020/05/14/clonal-hematopoiesis-complicates-mrd-assessment-in-acute-myeloid-leukemia/2026-07-09monthly0.6 https://openbiodx.com/2020/05/13/comprehensive-review-of-host-directed-antiviral-therapy-and-crispr-based-target-/2026-07-09monthly0.6 https://openbiodx.com/2020/05/13/covid-19-diagnostic-landscape-from-rt-pcr-to-point-of-care-and-serological-tests/2026-07-09monthly0.6 https://openbiodx.com/2020/05/01/brca1-2-germline-variants-predict-higher-pcr-rates-across-neoadjuvant-regimens-i/2026-07-09monthly0.6 https://openbiodx.com/2020/05/01/pre-salvage-psa-level-guides-hormone-therapy-benefit-after-prostatectomy-for-pro/2026-07-09monthly0.6 https://openbiodx.com/2020/04/30/epigenetic-mutations-in-crebbp-and-idh2-predict-poor-outcomes-in-peripheral-t-ce/2026-07-09monthly0.6 https://openbiodx.com/2020/04/28/cpic-guideline-cyp2c9-genotyping-for-safer-nsaid-prescribing/2026-07-09monthly0.6 https://openbiodx.com/2020/04/28/mass-spectrometry-reveals-how-gut-microbial-metabolites-drive-disease/2026-07-09monthly0.6 https://openbiodx.com/2020/04/27/first-in-human-trial-of-crispr-edited-pd-1-knockout-t-cells-in-lung-cancer/2026-07-09monthly0.6 https://openbiodx.com/2020/04/27/cardiac-troponin-in-covid-19-elevated-but-mostly-stable-not-acute-coronary-syndr/2026-07-09monthly0.6 https://openbiodx.com/2020/04/23/eplex-fungal-panel-identifies-15-fungal-pathogens-from-blood-cultures-with-up-to/2026-07-09monthly0.6 https://openbiodx.com/2020/04/23/pharmacy-based-clia-waived-testing-programmes-for-infectious-disease-management/2026-07-09monthly0.6 https://openbiodx.com/2020/04/23/bd-phoenix-cpo-detect-accurately-identifies-and-classifies-carbapenemases-during/2026-07-09monthly0.6 https://openbiodx.com/2020/04/23/st2-biomarker-predicts-non-relapse-mortality-after-stem-cell-transplant-in-child/2026-07-09monthly0.6 https://openbiodx.com/2020/04/21/favipiravir-pharmacokinetics-and-drug-interaction-concerns-for-covid-19-trials/2026-07-09monthly0.6 https://openbiodx.com/2020/04/16/molecular-diagnostics-and-targeted-therapy-transform-management-of-advanced-syst/2026-07-09monthly0.6 https://openbiodx.com/2020/04/14/deep-learning-detects-papilledema-from-fundus-photographs-with-auc-0-96-in-globa/2026-07-09monthly0.6 https://openbiodx.com/2020/04/07/phase-3-announce-trial-olaratumab-fails-to-confirm-survival-benefit-in-soft-tiss/2026-07-09monthly0.6 https://openbiodx.com/2020/04/01/annual-review-of-advances-in-pathology-digital-tools-biomarkers-genetics-and-the/2026-07-09monthly0.6 https://openbiodx.com/2020/03/25/digital-dispensing-enables-validated-aztreonam-avibactam-susceptibility-testing-/2026-07-09monthly0.6 https://openbiodx.com/2020/03/25/systematic-review-exposes-fundamental-design-and-reporting-flaws-in-deep-learnin/2026-07-09monthly0.6 https://openbiodx.com/2020/03/25/echonet-dynamic-video-based-deep-learning-outperforms-experts-in-cardiac-functio/2026-07-09monthly0.6 https://openbiodx.com/2020/03/25/stool-based-pcr-achieves-96-sensitivity-for-noninvasive-h-pylori-detection-and-c/2026-07-09monthly0.6 https://openbiodx.com/2020/03/25/eplex-blood-culture-id-gram-positive-panel-identifies-20-pathogens-and-4-resista/2026-07-09monthly0.6 https://openbiodx.com/2020/03/25/machine-learning-method-lung-clip-distinguishes-early-lung-cancer-from-controls-/2026-07-09monthly0.6 https://openbiodx.com/2020/03/23/neuroimaging-biomarker-for-striatal-dysfunction-distinguishes-schizophrenia-with/2026-07-09monthly0.6 https://openbiodx.com/2020/03/22/supar-predicts-non-cardiac-mortality-after-primary-pci-for-stemi/2026-07-09monthly0.6 https://openbiodx.com/2020/03/21/mass-spectrometry-advances-as-the-gold-standard-for-sex-hormone-measurement/2026-07-09monthly0.6 https://openbiodx.com/2020/03/19/circulating-tumour-cells-from-metastatic-biology-to-clinical-liquid-biopsy-appli/2026-07-09monthly0.6 https://openbiodx.com/2020/03/15/lc-ms-ms-matures-into-routine-clinical-diagnostics-after-a-decade-of-growth/2026-07-09monthly0.6 https://openbiodx.com/2020/03/09/folate-receptor-alpha-emerges-as-a-versatile-oncology-target-and-predictive-biom/2026-07-09monthly0.6 https://openbiodx.com/2020/03/04/switch-blocker-pcr-platform-achieves-93-96-concordance-with-tissue-biopsy-for-eg/2026-07-09monthly0.6 https://openbiodx.com/2020/03/01/genomic-risk-stratification-could-transform-smoldering-myeloma-management/2026-07-09monthly0.6 https://openbiodx.com/2020/03/01/t-vec-plus-pembrolizumab-achieves-35-response-rate-in-advanced-sarcoma/2026-07-09monthly0.6 https://openbiodx.com/2020/03/01/mass-spectrometry-methods-transform-m-protein-detection-and-mrd-monitoring-in-my/2026-07-09monthly0.6 https://openbiodx.com/2020/02/27/pre-transplant-molecular-mrd-strongly-predicts-outcome-in-npm1-mutated-aml/2026-07-09monthly0.6 https://openbiodx.com/2020/02/26/lab-consolidation-enables-ai-driven-genomics-and-transformative-diagnostic-platf/2026-07-09monthly0.6 https://openbiodx.com/2020/02/25/eflm-guidance-on-risk-based-method-validation-and-verification-under-iso-15189/2026-07-09monthly0.6 https://openbiodx.com/2020/02/25/software-assisted-decision-support-in-digital-histopathology-from-biomarker-scor/2026-07-09monthly0.6 https://openbiodx.com/2020/02/24/rapid-immunochromatographic-test-detects-and-serogroups-n-meningitidis-from-csf-/2026-07-09monthly0.6 https://openbiodx.com/2020/02/22/exercise-induced-cardiac-biomarker-elevation-physiological-response-or-pathologi/2026-07-09monthly0.6 https://openbiodx.com/2020/02/13/immunotherapy-in-small-cell-lung-cancer-biomarker-strategies-remain-elusive/2026-07-09monthly0.6 https://openbiodx.com/2020/02/12/diagnostic-strategies-for-differentiating-cellulitis-from-other-causes-of-red-le/2026-07-09monthly0.6 https://openbiodx.com/2020/02/11/camera2-trial-beta-lactam-addition-to-standard-mrsa-bacteremia-therapy-shows-no-/2026-07-09monthly0.6 https://openbiodx.com/2020/02/06/first-in-human-trial-of-multiplex-crispr-cas9-edited-t-cells-shows-safety-and-du/2026-07-09monthly0.6 https://openbiodx.com/2020/02/01/pathologists-need-consensus-on-cd30-detection-and-reporting-in-lymphoma/2026-07-09monthly0.6 https://openbiodx.com/2020/02/01/deep-learning-on-h-e-slides-predicts-colorectal-cancer-outcome-in-large-validati/2026-07-09monthly0.6 https://openbiodx.com/2020/01/30/breast-cancer-immunoassays-shift-toward-electrochemiluminescence-and-automation/2026-07-09monthly0.6 https://openbiodx.com/2020/01/28/aptima-naat-assays-outperform-clinician-diagnosis-for-bacterial-vaginosis-candid/2026-07-09monthly0.6 https://openbiodx.com/2020/01/28/revogene-c-difficile-test-demonstrates-85-sensitivity-for-toxin-b-gene-detection/2026-07-09monthly0.6 https://openbiodx.com/2020/01/28/circulating-tumour-dna-in-molecular-oncology-clinical-applications-and-pre-analy/2026-07-09monthly0.6 https://openbiodx.com/2020/01/14/molecular-profiling-for-precision-oncology-from-ngs-panels-to-liquid-biopsies/2026-07-09monthly0.6 https://openbiodx.com/2020/01/11/red-blood-cell-distribution-width-as-a-prognostic-marker-in-sepsis/2026-07-09monthly0.6 https://openbiodx.com/2020/01/08/automated-deep-learning-system-for-gleason-grading-outperforms-most-pathologists/2026-07-09monthly0.6 https://openbiodx.com/2020/01/01/molecular-poc-testing-in-microbiology-matching-lab-sensitivity-at-the-bedside/2026-07-09monthly0.6 https://openbiodx.com/2020/01/01/digital-pcr-in-clinical-microbiology-advantages-limitations-and-practical-consid/2026-07-09monthly0.6 https://openbiodx.com/2020/01/01/policy-challenges-in-genomic-medicine-reimbursement-fda-oversight-and-gene-paten/2026-07-09monthly0.6 https://openbiodx.com/2020/01/01/circulating-tumour-cells-move-beyond-counting-to-multi-omic-characterisation/2026-07-09monthly0.6 https://openbiodx.com/2020/01/01/epigenomic-approaches-for-cancer-detection-using-tissue-and-cell-free-dna/2026-07-09monthly0.6 https://openbiodx.com/2020/01/01/liquid-biopsy-enters-the-phenotypic-era-with-single-cell-ctc-profiling/2026-07-09monthly0.6 https://openbiodx.com/2019/12/18/presepsin-as-a-diagnostic-biomarker-across-clinical-settings-from-icu-sepsis-to-/2026-07-09monthly0.6 https://openbiodx.com/2019/12/18/systematic-review-delivers-updated-biological-variation-estimates-for-20-haemato/2026-07-09monthly0.6 https://openbiodx.com/2019/12/18/konica-minolta-validates-a-high-sensitivity-point-of-care-cardiac-troponin-i-sys/2026-07-09monthly0.6 https://openbiodx.com/2019/12/09/pharmvar-genefocus-cyp2d6-star-allele-nomenclature-for-the-most-tested-pharmacog/2026-07-09monthly0.6 https://openbiodx.com/2019/12/05/typhoid-conjugate-vaccine-shows-81-6-efficacy-in-phase-3-nepal-trial/2026-07-09monthly0.6 https://openbiodx.com/2019/12/05/non-driver-mutations-in-tp53-and-splicing-genes-predict-disease-transformation-i/2026-07-09monthly0.6 https://openbiodx.com/2019/12/02/toparp-b-validates-olaparib-activity-in-prostate-cancer-with-dna-repair-defects/2026-07-09monthly0.6 https://openbiodx.com/2019/12/01/post-surgery-and-post-chemotherapy-ctdna-predicts-recurrence-risk-in-stage-iii-c/2026-07-09monthly0.6 https://openbiodx.com/2019/11/29/training-and-validation-protocol-for-primary-diagnosis-with-digital-pathology-th/2026-07-09monthly0.6 https://openbiodx.com/2019/11/25/ultra-deep-cfdna-sequencing-reveals-clonal-haematopoiesis-as-the-dominant-source/2026-07-09monthly0.6 https://openbiodx.com/2019/11/19/ai-in-clinical-and-genomic-diagnostics-from-variant-calling-to-phenotype-genotyp/2026-07-09monthly0.6 https://openbiodx.com/2019/11/13/laboratory-diagnosis-of-human-brucellosis-culture-serology-and-molecular-methods/2026-07-09monthly0.6 https://openbiodx.com/2019/11/12/whole-slide-imaging-outperforms-robotic-microscopy-for-intraoperative-frozen-sec/2026-07-09monthly0.6 https://openbiodx.com/2019/11/05/clinical-mass-spectrometry-expands-across-pathology-disciplines/2026-07-09monthly0.6 https://openbiodx.com/2019/10/31/molecular-classification-of-cns-tumors-recurrent-genetic-alterations-since-who-2/2026-07-09monthly0.6 https://openbiodx.com/2019/10/30/blood-culture-contamination-evidence-based-interventions-reduce-false-positive-r/2026-07-09monthly0.6 https://openbiodx.com/2019/10/24/targeted-ngs-panel-validates-tmb-as-predictor-of-checkpoint-inhibitor-response-i/2026-07-09monthly0.6 https://openbiodx.com/2019/10/23/first-fda-cleared-mycoplasma-genitalium-naat-validated-in-3-361-subject-us-multi/2026-07-09monthly0.6 https://openbiodx.com/2019/10/23/first-us-surveillance-finds-7-5-macrolide-resistant-mycoplasma-pneumoniae-with-r/2026-07-09monthly0.6 https://openbiodx.com/2019/10/23/novel-pcr-assay-simultaneously-detects-m-genitalium-and-fluoroquinolone-resistan/2026-07-09monthly0.6 https://openbiodx.com/2019/10/23/keratin-17-identified-as-negative-prognostic-marker-in-high-grade-endometrial-ca/2026-07-09monthly0.6 https://openbiodx.com/2019/10/15/procalcitonin-underperforms-crp-and-il-6-for-pneumonia-diagnosis-in-dyspnoea-pat/2026-07-09monthly0.6 https://openbiodx.com/2019/10/08/16-gene-panel-characterizes-mutational-landscape-of-breast-fibroepithelial-lesio/2026-07-09monthly0.6 https://openbiodx.com/2019/10/04/graids-real-time-ai-system-matches-expert-endoscopists-for-upper-gi-cancer-detec/2026-07-09monthly0.6 https://openbiodx.com/2019/10/02/bmj-guideline-fit-sigmoidoscopy-and-colonoscopy-all-offer-similar-colorectal-can/2026-07-09monthly0.6 https://openbiodx.com/2019/10/02/single-cell-profiling-of-circulating-tumour-cells-advances-liquid-biopsy-beyond-/2026-07-09monthly0.6 https://openbiodx.com/2019/10/01/personalised-ctdna-assays-detect-breast-cancer-molecular-relapse-10-7-months-bef/2026-07-09monthly0.6 https://openbiodx.com/2019/09/30/new-vitros-high-sensitivity-troponin-i-assay-matches-established-hs-ctn-platform/2026-07-09monthly0.6 https://openbiodx.com/2019/09/24/clsi-guided-susceptibility-testing-for-nontuberculous-mycobacteria-methods-and-e/2026-07-09monthly0.6 https://openbiodx.com/2019/09/14/lancet-review-drug-resistant-tuberculosis-management-requires-rapid-genotypic-an/2026-07-09monthly0.6 https://openbiodx.com/2019/09/03/digital-pathology-association-white-paper-defines-best-practices-and-regulatory-/2026-07-09monthly0.6 https://openbiodx.com/2019/09/03/popular-genetics-trial-validates-cyp2c19-guided-antiplatelet-selection-after-pri/2026-07-09monthly0.6 https://openbiodx.com/2019/08/29/best-practice-workflow-for-mitigating-biotin-interference-in-laboratory-immunoas/2026-07-09monthly0.6 https://openbiodx.com/2019/08/28/best-practices-for-neoantigen-prediction-in-personalised-cancer-vaccines/2026-07-09monthly0.6 https://openbiodx.com/2019/08/27/international-expert-consensus-simplifies-procalcitonin-guided-antibiotic-stewar/2026-07-09monthly0.6 https://openbiodx.com/2019/08/27/faecal-calprotectin-in-ibd-meta-analyses-reveal-strengths-and-assay-interchangea/2026-07-09monthly0.6 https://openbiodx.com/2019/08/27/single-cell-ctc-profiling-reveals-tumour-heterogeneity-beyond-what-ctdna-can-cap/2026-07-09monthly0.6 https://openbiodx.com/2019/08/26/making-the-case-for-advanced-microbiology-tests-a-framework-for-demonstrating-cl/2026-07-09monthly0.6 https://openbiodx.com/2019/08/17/albumin-rna-in-situ-hybridization-distinguishes-intrahepatic-cholangiocarcinoma-/2026-07-09monthly0.6 https://openbiodx.com/2019/08/09/ai-powered-digital-pathology-new-biomarker-discovery-tools-for-precision-oncolog/2026-07-09monthly0.6 https://openbiodx.com/2019/08/06/molecular-targets-in-endometrial-cancer-from-histological-to-genomic-subtyping/2026-07-09monthly0.6 https://openbiodx.com/2019/08/05/lancet-genomic-medicine-series-pharmacogenomics-for-individualizing-drug-therapy/2026-07-09monthly0.6 https://openbiodx.com/2019/08/05/building-the-evidence-base-for-genomic-medicine-in-routine-clinical-care/2026-07-09monthly0.6 https://openbiodx.com/2019/08/05/caribbean-cancer-control-hampered-by-weak-surveillance-limited-diagnostics-and-a/2026-07-09monthly0.6 https://openbiodx.com/2019/08/05/pacific-island-nations-face-triple-cancer-burden-with-fragmented-screening-and-p/2026-07-09monthly0.6 https://openbiodx.com/2019/08/01/ai-enabled-ecg-detects-atrial-fibrillation-during-sinus-rhythm-landmark-mayo-cli/2026-07-09monthly0.6 https://openbiodx.com/2019/07/31/8-aminoquinoline-therapy-for-latent-malaria-g6pd-testing-remains-the-critical-bo/2026-07-09monthly0.6 https://openbiodx.com/2019/07/26/sequencing-historical-bacterial-genomes-illuminates-pathogen-evolution-and-amr-o/2026-07-09monthly0.6 https://openbiodx.com/2019/07/26/composite-tma-reference-standard-enables-clinical-validation-of-first-mycoplasma/2026-07-09monthly0.6 https://openbiodx.com/2019/07/24/hyperprogression-on-immunotherapy-identifying-patients-whose-tumours-accelerate-/2026-07-09monthly0.6 https://openbiodx.com/2019/07/23/metabolomics-enters-clinical-pharmacology-biomarker-discovery-to-drug-response-p/2026-07-09monthly0.6 https://openbiodx.com/2019/07/23/copd-drug-development-new-biomarkers-and-regulatory-guidance-reshape-clinical-tr/2026-07-09monthly0.6 https://openbiodx.com/2019/07/18/ai-in-digital-pathology-a-uk-roadmap-from-development-to-regulatory-approval-and/2026-07-09monthly0.6 https://openbiodx.com/2019/07/15/maldi-imaging-mass-spectrometry-poised-to-complement-ihc-in-pathology-workflows/2026-07-09monthly0.6 https://openbiodx.com/2019/07/11/nejm-pace-trial-crp-point-of-care-testing-safely-cuts-antibiotic-prescribing-in-/2026-07-09monthly0.6 https://openbiodx.com/2019/07/10/international-consensus-criteria-standardise-t-pll-diagnosis-and-response-assess/2026-07-09monthly0.6 https://openbiodx.com/2019/07/01/pantel-and-alix-panabieres-define-liquid-biopsy-technologies-for-minimal-residua/2026-07-09monthly0.6 https://openbiodx.com/2019/06/27/nejm-landmark-high-sensitivity-troponin-risk-assessment-tool-validated-across-22/2026-07-09monthly0.6 https://openbiodx.com/2019/06/27/perch-study-maps-pneumonia-aetiology-in-children-using-multiplex-pcr-across-seve/2026-07-09monthly0.6 https://openbiodx.com/2019/06/26/mitotic-figure-detection-across-microscopy-and-multiple-whole-slide-scanners-a-m/2026-07-09monthly0.6 https://openbiodx.com/2019/06/25/sr-bi-p376l-variant-linked-to-dysfunctional-hdl-and-increased-cardiovascular-ris/2026-07-09monthly0.6 https://openbiodx.com/2019/06/24/plasma-mirna-extraction-method-strongly-influences-biomarker-discovery-results-m/2026-07-09monthly0.6 https://openbiodx.com/2019/06/21/multicenter-study-validates-cobas-crp-point-of-care-test-for-primary-care-use/2026-07-09monthly0.6 https://openbiodx.com/2019/06/21/off-label-predictive-biomarkers-in-gi-cancers-when-should-pathologists-say-yes/2026-07-09monthly0.6 https://openbiodx.com/2019/06/13/metagenomic-ngs-of-cerebrospinal-fluid-improves-diagnosis-of-meningitis-and-ence/2026-07-09monthly0.6 https://openbiodx.com/2019/06/08/practical-guide-to-iso-15189-accreditation-for-digital-pathology-in-clinical-lab/2026-07-09monthly0.6 https://openbiodx.com/2019/06/03/cassiopeia-trial-establishes-daratumumab-vtd-as-standard-induction-for-transplan/2026-07-09monthly0.6 https://openbiodx.com/2019/06/01/imwg-consensus-standardises-imaging-for-bone-disease-and-mrd-detection-in-myelom/2026-07-09monthly0.6 https://openbiodx.com/2019/05/24/navigating-clsi-breakpoint-revisions-a-practical-guide-for-clinical-laboratories/2026-07-09monthly0.6 https://openbiodx.com/2019/05/23/ethical-framework-for-returning-epigenetic-research-results-to-participants/2026-07-09monthly0.6 https://openbiodx.com/2019/05/15/point-of-care-hiv-viral-load-testing-essential-for-sustainable-global-treatment-/2026-07-09monthly0.6 https://openbiodx.com/2019/05/03/imp3-plus-l1cam-immunohistochemistry-optimises-grading-of-endometrial-carcinomas/2026-07-09monthly0.6 https://openbiodx.com/2019/05/01/digital-pathology-and-ai-advancing-computer-aided-diagnosis-beyond-the-microscop/2026-07-09monthly0.6 https://openbiodx.com/2019/05/01/crispr-cas-as-a-versatile-platform-for-cancer-research-screening-and-therapeutic/2026-07-09monthly0.6 https://openbiodx.com/2019/05/01/high-dose-vitamin-c-targets-redox-imbalance-epigenetics-and-oxygen-sensing-in-ca/2026-07-09monthly0.6 https://openbiodx.com/2019/04/26/mass-spectrometry-serum-disaccharide-assay-shows-promise-as-panfungal-diagnostic/2026-07-09monthly0.6 https://openbiodx.com/2019/04/26/multiplex-pcr-tracks-rapid-emergence-of-fluoroquinolone-resistant-e-coli-st1193-/2026-07-09monthly0.6 https://openbiodx.com/2019/04/26/false-positives-plague-widely-used-dientamoeba-fragilis-pcr-assay-across-multipl/2026-07-09monthly0.6 https://openbiodx.com/2019/04/24/sphingomyelin-profiling-predicts-short-term-outcomes-in-lower-respiratory-tract-/2026-07-09monthly0.6 https://openbiodx.com/2019/04/24/pilot-ring-trial-for-plasma-ctdna-egfr-mutation-testing-using-cobas-platform/2026-07-09monthly0.6 https://openbiodx.com/2019/04/22/winther-trial-shows-combined-dna-and-rna-profiling-improves-precision-oncology-m/2026-07-09monthly0.6 https://openbiodx.com/2019/04/19/designing-ctdna-based-interventional-clinical-trials-a-framework-for-oncology/2026-07-09monthly0.6 https://openbiodx.com/2019/04/01/proteogenomics-adds-clinical-value-beyond-genomics-only-cancer-profiling/2026-07-09monthly0.6 https://openbiodx.com/2019/04/01/somatic-and-germline-genomics-reshape-childhood-all-classification-and-risk-stra/2026-07-09monthly0.6 https://openbiodx.com/2019/03/28/polymyxin-susceptibility-testing-remains-technically-challenging-despite-growing/2026-07-09monthly0.6 https://openbiodx.com/2019/03/28/crispr-cas-biology-and-emerging-applications-in-infectious-disease-diagnostics-a/2026-07-09monthly0.6 https://openbiodx.com/2019/03/28/rapid-respiratory-virus-pcr-cuts-hospital-stay-by-21-hours-and-reduces-unnecessa/2026-07-09monthly0.6 https://openbiodx.com/2019/03/28/multiplex-rt-pcr-distinguishes-wild-type-measles-from-vaccine-strains-in-a-singl/2026-07-09monthly0.6 https://openbiodx.com/2019/03/28/multiplex-pcr-for-shigella-flexneri-serotyping-validated-across-seven-internatio/2026-07-09monthly0.6 https://openbiodx.com/2019/03/26/host-response-proteomic-biomarkers-for-bacterial-respiratory-infections-procalci/2026-07-09monthly0.6 https://openbiodx.com/2019/03/26/real-time-pcr-for-tuberculous-meningitis-high-specificity-but-limited-sensitivit/2026-07-09monthly0.6 https://openbiodx.com/2019/03/26/aberrant-glycosylation-as-a-source-of-cancer-biomarkers-analytical-advances-and-/2026-07-09monthly0.6 https://openbiodx.com/2019/03/19/apolipoprotein-profiling-by-mass-spectrometry-enables-precision-cardiovascular-r/2026-07-09monthly0.6 https://openbiodx.com/2019/03/14/single-cell-genomics-from-research-tool-to-clinical-laboratory-reality/2026-07-09monthly0.6 https://openbiodx.com/2019/03/06/the-microbiome-as-a-modulator-of-cancer-therapy-response/2026-07-09monthly0.6 https://openbiodx.com/2019/03/04/tumor-educated-platelets-emerge-as-a-distinct-liquid-biopsy-analyte/2026-07-09monthly0.6 https://openbiodx.com/2019/03/01/diagnostic-management-teams-a-strategy-to-reduce-diagnostic-errors-and-laborator/2026-07-09monthly0.6 https://openbiodx.com/2019/03/01/framework-for-developing-anti-metastatic-agents-from-biology-to-clinical-strateg/2026-07-09monthly0.6 https://openbiodx.com/2019/03/01/avelumab-shows-modest-activity-in-heavily-pretreated-ovarian-cancer-pd-l1-status/2026-07-09monthly0.6 https://openbiodx.com/2019/03/01/ctdna-screening-selects-patients-for-successful-anti-egfr-rechallenge-in-colorec/2026-07-09monthly0.6 https://openbiodx.com/2019/02/27/alternative-medicine-labs-sell-unvalidated-tests-with-misleading-interpretations/2026-07-09monthly0.6 https://openbiodx.com/2019/02/25/molecular-markers-of-regulated-necrosis-enable-pathological-detection-of-targeta/2026-07-09monthly0.6 https://openbiodx.com/2019/02/21/preanalytical-guidelines-for-circulating-cell-free-dna-analysis-a-systematic-rev/2026-07-09monthly0.6 https://openbiodx.com/2019/02/14/full-digitisation-of-clinical-immunohistochemistry-validation-across-1-480-slide/2026-07-09monthly0.6 https://openbiodx.com/2019/02/02/tp53-mutation-screening-in-cll-ngs-detects-clinically-relevant-subclonal-mutatio/2026-07-09monthly0.6 https://openbiodx.com/2019/02/01/dna-damage-response-biomarkers-guide-synthetic-lethal-cancer-therapy-beyond-brca/2026-07-09monthly0.6 https://openbiodx.com/2019/01/31/page-study-prenatal-exome-sequencing-identifies-genetic-diagnoses-in-8-5-of-feta/2026-07-09monthly0.6 https://openbiodx.com/2019/01/30/neumodx-gbs-assay-matches-cdc-culture-method-with-96-9-sensitivity-for-antepartu/2026-07-09monthly0.6 https://openbiodx.com/2019/01/24/epilepsy-diagnostics-from-eeg-to-genomic-testing-and-pharmacogenomics/2026-07-09monthly0.6 https://openbiodx.com/2019/01/23/three-generations-of-poc-inr-devices-compared-across-extended-anticoagulation-ra/2026-07-09monthly0.6 https://openbiodx.com/2019/01/22/current-landscape-of-mds-treatment-from-hypomethylating-agents-to-novel-targets/2026-07-09monthly0.6 https://openbiodx.com/2019/01/22/genomic-landscape-of-myelodysplastic-syndromes-a-comprehensive-review/2026-07-09monthly0.6 https://openbiodx.com/2019/01/20/cpic-guideline-tpmt-and-nudt15-genotyping-essential-for-safe-thiopurine-dosing-a/2026-07-09monthly0.6 https://openbiodx.com/2019/01/15/jama-review-penicillin-allergy-evaluation-is-critical-for-antimicrobial-stewards/2026-07-09monthly0.6 https://openbiodx.com/2019/01/10/acute-infections-as-triggers-for-myocardial-infarction-mechanisms-and-clinical-i/2026-07-09monthly0.6 https://openbiodx.com/2019/01/08/fusion-sarcomas-diagnostic-markers-and-detection-methods-for-newly-defined-entit/2026-07-09monthly0.6 https://openbiodx.com/2019/01/07/patient-privacy-in-the-era-of-medical-big-data-and-ai-legal-and-ethical-challeng/2026-07-09monthly0.6 https://openbiodx.com/2019/01/07/deep-learning-in-healthcare-a-technical-guide-spanning-imaging-nlp-and-genomics/2026-07-09monthly0.6 https://openbiodx.com/2019/01/02/who-international-standards-for-nucleic-acid-testing-two-decades-of-global-stand/2026-07-09monthly0.6 https://openbiodx.com/2019/01/02/cryptococcal-antigen-lateral-flow-assay-enables-pre-symptomatic-screening-in-hiv/2026-07-09monthly0.6 https://openbiodx.com/2019/01/02/triplex-pcr-algorithm-validated-for-rapid-bordetella-species-identification-in-p/2026-07-09monthly0.6 https://openbiodx.com/2019/01/01/best-practices-for-reporting-pharmacogenomics-studies-a-pharmgkb-perspective/2026-07-09monthly0.6 https://openbiodx.com/2019/01/01/automated-urinalysis-advances-from-flow-cytometry-to-maldi-tof-pathogen-id/2026-07-09monthly0.6 https://openbiodx.com/2019/01/01/thyroid-laboratory-testing-a-practical-guide-to-pitfalls-and-clinical-interpreta/2026-07-09monthly0.6 https://openbiodx.com/2019/01/01/lung-tumor-microenvironment-as-a-source-of-prognostic-biomarkers-and-therapeutic/2026-07-09monthly0.6 https://openbiodx.com/2019/01/01/circulating-tumour-cells-in-prostate-cancer-from-enumeration-to-precision-oncolo/2026-07-09monthly0.6 https://openbiodx.com/2018/12/28/mxa-protein-a-specific-host-biomarker-for-viral-infection-that-complements-crp-a/2026-07-09monthly0.6 https://openbiodx.com/2018/12/19/norway-s-noklus-model-25-years-of-harmonizing-point-of-care-testing-quality/2026-07-09monthly0.6 https://openbiodx.com/2018/12/19/personalized-neoantigen-vaccine-generates-intratumoral-t-cell-responses-in-gliob/2026-07-09monthly0.6 https://openbiodx.com/2018/12/19/csf-ctdna-clearance-correlates-with-sustained-response-in-cns-lymphoma-combinati/2026-07-09monthly0.6 https://openbiodx.com/2018/12/11/plasma-dna-analysis-in-prostate-cancer-opportunities-across-the-disease-spectrum/2026-07-09monthly0.6 https://openbiodx.com/2018/12/05/two-decades-of-hba1c-standardisation-how-ngsp-transformed-diabetes-diagnostics/2026-07-09monthly0.6 https://openbiodx.com/2018/12/05/pace-framework-aims-to-make-preemptive-pharmacogenomics-testing-routine/2026-07-09monthly0.6 https://openbiodx.com/2018/12/04/immunogenomics-of-glioblastoma-molecular-subtyping-reveals-distinct-immune-evasi/2026-07-09monthly0.6 https://openbiodx.com/2018/12/01/whole-exome-sequencing-reveals-wnt-pathway-mutations-in-biliary-papillary-neopla/2026-07-09monthly0.6 https://openbiodx.com/2018/12/01/molecular-biomarkers-for-guiding-bladder-preservation-therapy-in-muscle-invasive/2026-07-09monthly0.6 https://openbiodx.com/2018/12/01/ntrk-fusions-in-cancer-detection-strategies-and-targeted-trk-inhibitor-therapy/2026-07-09monthly0.6 https://openbiodx.com/2018/11/28/hiv-diagnostics-from-serologic-assays-to-molecular-poc-testing-for-epidemic-cont/2026-07-09monthly0.6 https://openbiodx.com/2018/11/27/filmarray-blood-culture-id-panel-enables-rapid-candida-species-identification-fr/2026-07-09monthly0.6 https://openbiodx.com/2018/11/19/epa-and-aspirin-fail-to-reduce-colorectal-adenoma-rates-in-high-risk-screening-p/2026-07-09monthly0.6 https://openbiodx.com/2018/11/08/neuregulin-1-mrna-levels-downregulated-in-autism-spectrum-disorder-and-linked-to/2026-07-09monthly0.6 https://openbiodx.com/2018/11/01/nejm-review-establishes-clinical-framework-for-cell-free-dna-analysis-in-cancer-/2026-07-09monthly0.6 https://openbiodx.com/2018/10/29/universal-cancer-screening-via-multi-analyte-blood-tests-a-conceptual-framework/2026-07-09monthly0.6 https://openbiodx.com/2018/10/26/hiv-tb-coinfection-in-children-and-pregnant-women-pharmacogenomic-and-drug-inter/2026-07-09monthly0.6 https://openbiodx.com/2018/10/25/hba1c-and-non-glycaemic-variables-what-lab-professionals-need-to-know/2026-07-09monthly0.6 https://openbiodx.com/2018/10/25/phenotypic-assays-for-carbapenemase-detection-a-practical-laboratory-review/2026-07-09monthly0.6 https://openbiodx.com/2018/10/23/ngs-applications-in-biodefense-biosurveillance-forensics-and-biothreat-diagnosti/2026-07-09monthly0.6 https://openbiodx.com/2018/10/22/serum-setd7-emerges-as-novel-diagnostic-biomarker-for-colorectal-cancer/2026-07-09monthly0.6 https://openbiodx.com/2018/10/19/dpyd-genotype-guided-fluoropyrimidine-dosing-improves-safety-in-cancer-patients/2026-07-09monthly0.6 https://openbiodx.com/2018/10/17/bnp-based-staging-system-for-al-amyloidosis-validated-as-alternative-to-nt-probn/2026-07-09monthly0.6 https://openbiodx.com/2018/10/16/the-digital-scribe-ai-powered-clinical-documentation-from-dictation-to-intellige/2026-07-09monthly0.6 https://openbiodx.com/2018/10/11/deep-learning-accurately-detects-critical-head-ct-findings-enabling-automated-tr/2026-07-09monthly0.6 https://openbiodx.com/2018/10/10/fentanyl-analog-detection-analytical-challenges-in-the-synthetic-opioid-epidemic/2026-07-09monthly0.6 https://openbiodx.com/2018/10/04/nejm-review-next-generation-sequencing-for-diagnosing-suspected-genetic-disorder/2026-07-09monthly0.6 https://openbiodx.com/2018/10/01/mgmt-methylation-independently-predicts-outcomes-in-low-grade-glioma-treated-wit/2026-07-09monthly0.6 https://openbiodx.com/2018/10/01/ctdna-as-a-biomarker-for-immunotherapy-response-monitoring-pseudoprogression-and/2026-07-09monthly0.6 https://openbiodx.com/2018/09/27/machine-learning-in-medicine-bridging-ai-driven-diagnostics-and-medical-educatio/2026-07-09monthly0.6 https://openbiodx.com/2018/09/25/algorithm-based-therapy-for-staphylococcal-bacteremia-achieves-noninferior-outco/2026-07-09monthly0.6 https://openbiodx.com/2018/09/24/deep-sequencing-mrd-negativity-confirmed-as-major-prognostic-factor-in-multiple-/2026-07-09monthly0.6 https://openbiodx.com/2018/09/24/hair-cortisol-analysis-offers-a-unique-window-into-long-term-stress-hormones/2026-07-09monthly0.6 https://openbiodx.com/2018/09/20/standard-clinical-chemistry-validation-protocols-successfully-applied-to-ddpcr-l/2026-07-09monthly0.6 https://openbiodx.com/2018/09/17/point-of-care-hba1c-device-matches-lab-methods-for-diabetes-diagnosis/2026-07-09monthly0.6 https://openbiodx.com/2018/09/12/comprehensive-review-mrsa-molecular-characterization-sccmec-evolution-and-typing/2026-07-09monthly0.6 https://openbiodx.com/2018/09/12/vivo-method-validates-crispr-in-vivo-editing-with-no-detectable-off-target-mutat/2026-07-09monthly0.6 https://openbiodx.com/2018/09/11/paloma-3-ctdna-analysis-maps-resistance-evolution-to-palbociclib-plus-fulvestran/2026-07-09monthly0.6 https://openbiodx.com/2018/09/10/laboratory-testing-and-monitoring-of-direct-oral-anticoagulants-current-state-an/2026-07-09monthly0.6 https://openbiodx.com/2018/09/05/bmj-guideline-recommends-against-routine-psa-screening-for-prostate-cancer/2026-07-09monthly0.6 https://openbiodx.com/2018/09/05/meta-analysis-questions-mortality-benefit-of-psa-based-prostate-cancer-screening/2026-07-09monthly0.6 https://openbiodx.com/2018/09/05/circulating-tumor-dna-as-a-cancer-biomarker-advantages-over-tissue-and-protein-m/2026-07-09monthly0.6 https://openbiodx.com/2018/09/01/circulating-non-coding-rnas-as-cancer-biomarkers-from-mirnas-to-xeno-mirnas/2026-07-09monthly0.6 https://openbiodx.com/2018/09/01/ctdna-shows-promise-for-early-nsclc-screening-and-post-surgical-mrd-detection-de/2026-07-09monthly0.6 https://openbiodx.com/2018/08/31/dna-writers-and-molecular-recorders-emerging-tools-for-in-vivo-genetic-informati/2026-07-09monthly0.6 https://openbiodx.com/2018/08/31/crispr-cas-systems-from-genome-editing-to-programmable-diagnostics/2026-07-09monthly0.6 https://openbiodx.com/2018/08/28/salivary-biomarkers-for-cardiovascular-disease-a-systematic-review-of-non-invasi/2026-07-09monthly0.6 https://openbiodx.com/2018/08/28/jama-review-pharmacogenetics-not-yet-ready-for-personalizing-alcohol-use-disorde/2026-07-09monthly0.6 https://openbiodx.com/2018/08/27/population-structure-of-canine-uropathogenic-e-coli-reveals-cross-species-strain/2026-07-09monthly0.6 https://openbiodx.com/2018/08/27/icubate-ic-gpc-assay-achieves-95-5-agreement-for-gram-positive-bloodstream-patho/2026-07-09monthly0.6 https://openbiodx.com/2018/08/27/subpopulation-primer-strategy-achieves-exhaustive-h5-avian-influenza-detection-b/2026-07-09monthly0.6 https://openbiodx.com/2018/08/27/molecular-diagnosis-of-bacterial-vaginosis-objective-testing-beyond-microscopy/2026-07-09monthly0.6 https://openbiodx.com/2018/08/14/ct-radiomics-signature-predicts-cd8-cell-infiltration-and-immunotherapy-response/2026-07-09monthly0.6 https://openbiodx.com/2018/08/02/prenatal-cell-free-dna-testing-how-genomic-screening-transformed-prenatal-care/2026-07-09monthly0.6 https://openbiodx.com/2018/08/01/diagnostic-error-rates-of-3-9-in-anatomical-pathology-highlight-value-of-structu/2026-07-09monthly0.6 https://openbiodx.com/2018/08/01/ai-in-radiology-deep-learning-methods-for-quantitative-medical-image-analysis/2026-07-09monthly0.6 https://openbiodx.com/2018/07/26/procalcitonin-guided-antibiotic-stewardship-reduces-treatment-duration-in-lower-/2026-07-09monthly0.6 https://openbiodx.com/2018/07/26/expert-consensus-endorses-procalcitonin-for-antibiotic-de-escalation-but-not-as-/2026-07-09monthly0.6 https://openbiodx.com/2018/07/26/hcp1-based-rapid-immunochromatography-test-offers-improved-point-of-care-diagnos/2026-07-09monthly0.6 https://openbiodx.com/2018/07/26/point-of-care-troponin-i-test-shows-diagnostic-promise-for-acute-mi-in-emergency/2026-07-09monthly0.6 https://openbiodx.com/2018/07/26/luminex-aries-gbs-assay-achieves-96-sensitivity-with-minimal-hands-on-time/2026-07-09monthly0.6 https://openbiodx.com/2018/07/26/rickettsioses-diagnostics-evolve-beyond-serology-with-molecular-and-ms-based-met/2026-07-09monthly0.6 https://openbiodx.com/2018/07/16/ctdna-and-msi-ebv-status-predict-dramatic-responses-to-pembrolizumab-in-metastat/2026-07-09monthly0.6 https://openbiodx.com/2018/07/03/infective-endocarditis-management-from-blood-cultures-and-echocardiography-to-em/2026-07-09monthly0.6 https://openbiodx.com/2018/07/01/pan-trk-immunohistochemistry-is-97-sensitive-and-98-specific-for-ntrk-fusions-in/2026-07-09monthly0.6 https://openbiodx.com/2018/07/01/genetic-counseling-faces-new-complexity-in-the-ngs-era/2026-07-09monthly0.6 https://openbiodx.com/2018/06/30/subjective-functional-assessment-unreliable-before-major-surgery-dasi-score-outp/2026-07-09monthly0.6 https://openbiodx.com/2018/06/27/multicenter-ngs-validation-of-ce-ivd-cftr-gene-scanning-kit-achieves-over-99-acc/2026-07-09monthly0.6 https://openbiodx.com/2018/06/25/comprehensive-review-of-high-sensitivity-troponin-algorithms-and-accelerated-dia/2026-07-09monthly0.6 https://openbiodx.com/2018/06/25/filmarray-meningitis-panel-detects-enterovirus-in-25-of-young-infants-evaluated-/2026-07-09monthly0.6 https://openbiodx.com/2018/06/18/multi-omics-approaches-open-new-avenues-for-alzheimer-s-disease-biomarker-discov/2026-07-09monthly0.6 https://openbiodx.com/2018/06/08/point-of-care-testing-trends-from-wearables-and-microfluidics-to-mass-spectromet/2026-07-09monthly0.6 https://openbiodx.com/2018/06/01/ngs-identifies-recurrent-targetable-mutations-in-cervical-small-cell-neuroendocr/2026-07-09monthly0.6 https://openbiodx.com/2018/06/01/clinical-genomics-in-oncology-from-targeted-therapy-to-mutational-load-and-vacci/2026-07-09monthly0.6 https://openbiodx.com/2018/06/01/dasatinib-shows-activity-in-imatinib-resistant-gist-psrc-may-identify-responders/2026-07-09monthly0.6 https://openbiodx.com/2018/05/30/molecular-rapid-diagnostics-with-stewardship-are-cost-effective-for-bloodstream-/2026-07-09monthly0.6 https://openbiodx.com/2018/05/29/sex-specific-troponin-thresholds-women-need-lower-cut-offs-to-avoid-missed-myoca/2026-07-09monthly0.6 https://openbiodx.com/2018/05/24/hcv-core-antigen-testing-matures-into-a-practical-alternative-to-rna-detection/2026-07-09monthly0.6 https://openbiodx.com/2018/05/21/meta-analysis-poc-natriuretic-peptide-tests-show-high-sensitivity-for-heart-fail/2026-07-09monthly0.6 https://openbiodx.com/2018/05/20/proact-trial-procalcitonin-guidance-did-not-reduce-antibiotic-use-in-u-s-emergen/2026-07-09monthly0.6 https://openbiodx.com/2018/05/18/experimental-design-randomisation-and-validation-foundations-for-reliable-biomar/2026-07-09monthly0.6 https://openbiodx.com/2018/05/08/top-down-measurement-uncertainty-for-tacrolimus-by-uhplc-ms-ms-two-approaches-co/2026-07-09monthly0.6 https://openbiodx.com/2018/05/08/uspstf-evidence-review-psa-screening-reduces-mortality-but-carries-substantial-o/2026-07-09monthly0.6 https://openbiodx.com/2018/05/01/ezh1-mutations-help-classify-follicular-thyroid-tumours-as-likely-benign/2026-07-09monthly0.6 https://openbiodx.com/2018/04/30/tnt-trial-brca1-2-mutation-status-predicts-carboplatin-response-in-triple-negati/2026-07-09monthly0.6 https://openbiodx.com/2018/04/28/chairing-an-academic-pathology-department-navigating-clinical-service-research-a/2026-07-09monthly0.6 https://openbiodx.com/2018/04/25/multiple-blood-cultures-required-to-detect-m-tuberculosis-bacteremia-in-hiv-posi/2026-07-09monthly0.6 https://openbiodx.com/2018/04/25/gstp1-methylation-as-a-liquid-biopsy-biomarker-systematic-review-across-cancer-t/2026-07-09monthly0.6 https://openbiodx.com/2018/04/24/heart-type-fatty-acid-binding-protein-falls-short-as-a-biomarker-for-acute-coron/2026-07-09monthly0.6 https://openbiodx.com/2018/04/24/crispr-cas-systems-as-rapid-nucleic-acid-detection-tools-for-pathogen-diagnostic/2026-07-09monthly0.6 https://openbiodx.com/2018/04/23/28-gene-hypoxia-signature-validated-as-prognostic-biomarker-in-localized-prostat/2026-07-09monthly0.6 https://openbiodx.com/2018/04/21/venous-blood-draw-order-varies-widely-across-danish-laboratories-despite-interna/2026-07-09monthly0.6 https://openbiodx.com/2018/04/17/pathogenesis-of-t-cell-lymphomas-revealed-by-ngs-and-gene-expression-profiling/2026-07-09monthly0.6 https://openbiodx.com/2018/04/16/checkmate-227-tumour-mutational-burden-validated-as-biomarker-for-immunotherapy-/2026-07-09monthly0.6 https://openbiodx.com/2018/04/10/smart-therapy-reduces-asthma-exacerbations-systematic-review-and-meta-analysis/2026-07-09monthly0.6 https://openbiodx.com/2018/04/09/whole-exome-sequencing-uncovers-diverse-genetic-mechanisms-beyond-familial-hlh-g/2026-07-09monthly0.6 https://openbiodx.com/2018/04/01/her3-mrna-expression-predicts-panitumumab-benefit-in-ras-wild-type-colorectal-ca/2026-07-09monthly0.6 https://openbiodx.com/2018/03/30/european-dpwg-guidelines-advance-pharmacogenomic-implementation-across-the-conti/2026-07-09monthly0.6 https://openbiodx.com/2018/03/26/sensitest-colistin-broth-microdilution-panels-validated-including-mcr-1-positive/2026-07-09monthly0.6 https://openbiodx.com/2018/03/26/clsi-best-practices-for-evaluating-antimicrobial-susceptibility-tests/2026-07-09monthly0.6 https://openbiodx.com/2018/03/26/t2-magnetic-resonance-outperforms-blood-culture-for-monitoring-candidemia-cleara/2026-07-09monthly0.6 https://openbiodx.com/2018/03/26/accelerate-pheno-system-delivers-pathogen-id-in-90-minutes-and-phenotypic-ast-in/2026-07-09monthly0.6 https://openbiodx.com/2018/03/26/meta-analysis-confirms-strong-performance-of-xpert-hiv-1-viral-load-at-point-of-/2026-07-09monthly0.6 https://openbiodx.com/2018/03/26/quantiferon-cmv-assay-predicts-post-transplant-cmv-infection-risk-in-heart-recip/2026-07-09monthly0.6 https://openbiodx.com/2018/03/26/cobas-cdiff-pcr-validated-for-active-surveillance-of-asymptomatic-c-difficile-ca/2026-07-09monthly0.6 https://openbiodx.com/2018/03/15/lancet-series-calls-for-national-lab-plans-and-4-health-spending-on-pathology-in/2026-07-09monthly0.6 https://openbiodx.com/2018/03/15/lancet-roadmap-fixing-pathology-and-lab-medicine-in-low-and-middle-income-countr/2026-07-09monthly0.6 https://openbiodx.com/2018/03/14/ai-powers-digital-medicine-from-diagnosis-to-treatment-decision-support/2026-07-09monthly0.6 https://openbiodx.com/2018/03/14/pulmonary-arterial-hypertension-biomarkers-from-bnp-to-molecular-subtypes/2026-07-09monthly0.6 https://openbiodx.com/2018/03/13/preemptive-pharmacogenomic-testing-shows-clinical-benefit-when-linked-to-ehr-dec/2026-07-09monthly0.6 https://openbiodx.com/2018/03/12/cell-free-dna-across-body-fluids-clinical-applications-and-preanalytical-conside/2026-07-09monthly0.6 https://openbiodx.com/2018/03/06/single-psa-test-does-not-reduce-prostate-cancer-deaths-in-uk-cap-trial-at-10-yea/2026-07-09monthly0.6 https://openbiodx.com/2018/03/01/bcor-internal-tandem-duplication-defines-a-new-subtype-of-high-grade-uterine-sar/2026-07-09monthly0.6 https://openbiodx.com/2018/03/01/mrd-testing-in-cll-evolves-from-chemoimmunotherapy-to-novel-targeted-agents/2026-07-09monthly0.6 https://openbiodx.com/2018/02/28/emerging-molecular-technologies-for-sepsis-diagnosis-toward-the-1-to-3-hour-idea/2026-07-09monthly0.6 https://openbiodx.com/2018/02/22/tcga-pancancer-atlas-untapped-potential-of-digital-pathology-archives-for-comput/2026-07-09monthly0.6 https://openbiodx.com/2018/02/22/alere-i-rsv-assay-delivers-98-6-sensitivity-in-under-13-minutes-at-point-of-care/2026-07-09monthly0.6 https://openbiodx.com/2018/02/22/alere-i-molecular-test-outperforms-bd-veritor-antigen-assay-for-rapid-strep-a-de/2026-07-09monthly0.6 https://openbiodx.com/2018/02/16/tumor-normal-sequencing-uncovers-secondary-germline-findings-in-cancer-patients/2026-07-09monthly0.6 https://openbiodx.com/2018/02/14/proteomic-methods-unlock-tumour-heterogeneity-analysis-in-archival-ffpe-tissues/2026-07-09monthly0.6 https://openbiodx.com/2018/02/13/multicentre-audit-reveals-high-interobserver-variability-in-breast-fibroepitheli/2026-07-09monthly0.6 https://openbiodx.com/2018/02/13/uspstf-review-confirms-no-mortality-benefit-from-ovarian-cancer-screening-in-ave/2026-07-09monthly0.6 https://openbiodx.com/2018/02/10/the-cancer-genome-as-biomarker-dna-repair-deficiency-and-parp-inhibitor-response/2026-07-09monthly0.6 https://openbiodx.com/2018/02/09/external-quality-assessment-in-the-traceability-era-metrological-requirements-fo/2026-07-09monthly0.6 https://openbiodx.com/2018/02/05/multiplexed-fluorescence-ihc-quantifies-compartment-specific-immune-infiltrates-/2026-07-09monthly0.6 https://openbiodx.com/2018/02/05/triple-braf-egfr-mek-inhibition-achieves-21-response-in-braf-v600e-colorectal-ca/2026-07-09monthly0.6 https://openbiodx.com/2018/02/03/nucleotyping-pan-cancer-chromatin-biomarker-validated-across-seven-tumour-types/2026-07-09monthly0.6 https://openbiodx.com/2018/02/02/how-measurement-uncertainty-should-be-communicated-to-clinicians-on-laboratory-r/2026-07-09monthly0.6 https://openbiodx.com/2018/02/01/canadian-society-of-clinical-chemists-issues-consensus-position-on-point-of-care/2026-07-09monthly0.6 https://openbiodx.com/2018/02/01/dual-pet-ct-imaging-reveals-prognostic-tumour-heterogeneity-in-castration-resist/2026-07-09monthly0.6 https://openbiodx.com/2018/02/01/tisagenlecleucel-car-t-therapy-achieves-81-remission-in-paediatric-relapsed-all/2026-07-09monthly0.6 https://openbiodx.com/2018/01/31/preoperative-nt-probnp-improves-risk-prediction-beyond-euroscore-ii-in-cardiac-s/2026-07-09monthly0.6 https://openbiodx.com/2018/01/29/targeting-minimal-residual-disease-emerges-as-a-viable-path-toward-cancer-cure/2026-07-09monthly0.6 https://openbiodx.com/2018/01/24/cepheid-xpert-flu-rsv-rapid-pcr-assay-validated-for-clia-waived-point-of-care-se/2026-07-09monthly0.6 https://openbiodx.com/2018/01/24/deepmelt-assay-detects-0-01-isoniazid-resistant-tb-mutants-through-selective-wil/2026-07-09monthly0.6 https://openbiodx.com/2018/01/24/combined-bal-fractions-essential-for-optimal-aspergillus-and-mucorales-pcr-sensi/2026-07-09monthly0.6 https://openbiodx.com/2018/01/24/multiplex-pcr-identifies-meningitis-pathogens-in-culture-negative-csf-within-hou/2026-07-09monthly0.6 https://openbiodx.com/2018/01/24/cartridge-based-pcr-achieves-100-sensitivity-for-coccidioides-in-lower-respirato/2026-07-09monthly0.6 https://openbiodx.com/2018/01/24/real-time-pcr-assay-for-candida-auris-surveillance-cuts-detection-time-from-14-d/2026-07-09monthly0.6 https://openbiodx.com/2018/01/22/blinatumomab-achieves-78-complete-mrd-response-in-adults-with-mrd-positive-all/2026-07-09monthly0.6 https://openbiodx.com/2018/01/19/nivolumab-plus-ipilimumab-shows-promise-in-specific-sarcoma-subtypes/2026-07-09monthly0.6 https://openbiodx.com/2018/01/08/population-pharmacokinetics-of-polymyxin-b-characterised-by-lc-ms-ms/2026-07-09monthly0.6 https://openbiodx.com/2018/01/01/landmark-pivotal-study-whole-slide-imaging-is-non-inferior-to-microscopy-for-pri/2026-07-09monthly0.6 https://openbiodx.com/2018/01/01/cell-free-dna-assays-move-from-research-to-routine-clinical-oncology/2026-07-09monthly0.6 https://openbiodx.com/2018/01/01/leptomeningeal-metastases-in-nsclc-advances-in-csf-liquid-biopsy-and-cns-penetra/2026-07-09monthly0.6 https://openbiodx.com/2017/12/26/nocardia-identification-challenges-taxonomy-complexity-demands-molecular-methods/2026-07-09monthly0.6 https://openbiodx.com/2017/12/22/serum-dna-methylation-marker-efc-93-detects-lethal-breast-cancer-months-before-d/2026-07-09monthly0.6 https://openbiodx.com/2017/12/20/cobas-h232-point-of-care-nt-probnp-test-proves-accurate-and-practice-changing-in/2026-07-09monthly0.6 https://openbiodx.com/2017/12/20/companion-diagnostics-in-oncology-20-years-of-fda-approved-assays-reviewed/2026-07-09monthly0.6 https://openbiodx.com/2017/12/16/optimizing-high-sensitivity-cardiac-troponin-use-in-suspected-myocardial-infarct/2026-07-09monthly0.6 https://openbiodx.com/2017/12/16/95-gene-expression-classifier-identifies-primary-tumor-origin-in-metastatic-canc/2026-07-09monthly0.6 https://openbiodx.com/2017/12/16/ngs-reveals-recurrent-med12-mutations-in-breast-fibroadenomas-aiding-phyllodes-t/2026-07-09monthly0.6 https://openbiodx.com/2017/12/12/deep-learning-system-validated-for-diabetic-retinopathy-screening-across-multiet/2026-07-09monthly0.6 https://openbiodx.com/2017/12/12/daratumumab-vmp-nearly-halves-disease-progression-in-transplant-ineligible-myelo/2026-07-09monthly0.6 https://openbiodx.com/2017/12/06/rapid-diagnostic-test-for-second-stage-sleeping-sickness-shows-100-sensitivity-i/2026-07-09monthly0.6 https://openbiodx.com/2017/12/01/beyond-brca-founders-panel-sequencing-uncovers-additional-cancer-risk-in-ashkena/2026-07-09monthly0.6 https://openbiodx.com/2017/12/01/whole-body-mri-detects-localized-cancers-in-7-of-li-fraumeni-patients-at-baselin/2026-07-09monthly0.6 https://openbiodx.com/2017/11/29/carrion-s-disease-an-expanding-neglected-bartonellosis-with-emerging-resistance-/2026-07-09monthly0.6 https://openbiodx.com/2017/11/29/dried-blood-spots-cover-over-2-000-analytes-across-all-major-analytical-platform/2026-07-09monthly0.6 https://openbiodx.com/2017/11/27/procalcitonin-guidance-halves-antibiotic-prescriptions-in-upper-respiratory-trac/2026-07-09monthly0.6 https://openbiodx.com/2017/11/27/alpha-defensin-poc-test-for-prosthetic-joint-infection-needs-laboratory-oversigh/2026-07-09monthly0.6 https://openbiodx.com/2017/11/27/de-novo-mutations-in-neurodevelopmental-disorders-patterns-databases-and-clinica/2026-07-09monthly0.6 https://openbiodx.com/2017/11/21/high-sensitivity-troponin-i-below-5-ng-l-safely-rules-out-myocardial-infarction-/2026-07-09monthly0.6 https://openbiodx.com/2017/11/20/cpic-guideline-update-dpyd-genotyping-before-fluoropyrimidine-chemotherapy-to-pr/2026-07-09monthly0.6 https://openbiodx.com/2017/11/16/bevacizumab-plus-lomustine-fails-to-improve-overall-survival-in-recurrent-gliobl/2026-07-09monthly0.6 https://openbiodx.com/2017/11/15/syndromic-multiplex-panels-reshape-clinical-microbiology-practice/2026-07-09monthly0.6 https://openbiodx.com/2017/11/09/foxp1-protein-expression-predicts-outcome-in-rituximab-treated-follicular-lympho/2026-07-09monthly0.6 https://openbiodx.com/2017/11/08/adding-bnp-to-high-sensitivity-troponin-i-does-not-improve-detection-of-exercise/2026-07-09monthly0.6 https://openbiodx.com/2017/11/08/tumour-heterogeneity-drives-resistance-implications-for-liquid-biopsy-monitoring/2026-07-09monthly0.6 https://openbiodx.com/2017/11/02/neuropeptides-as-biomarkers-and-drug-targets-in-obesity-from-bench-to-bedside/2026-07-09monthly0.6 https://openbiodx.com/2017/11/02/biochemistry-of-the-menopause-diagnostic-assays-and-hormone-reference-intervals/2026-07-09monthly0.6 https://openbiodx.com/2017/11/01/maldi-tof-mass-spectrometry-in-clinical-microbiology-progress-and-remaining-chal/2026-07-09monthly0.6 https://openbiodx.com/2017/10/26/defining-the-99th-percentile-for-cardiac-troponin-methodological-challenges-and-/2026-07-09monthly0.6 https://openbiodx.com/2017/10/26/card11-mutations-predict-ibrutinib-resistance-in-relapsed-follicular-lymphoma/2026-07-09monthly0.6 https://openbiodx.com/2017/10/20/umbrella-basket-and-platform-trials-what-oncology-has-learned-from-new-biomarker/2026-07-09monthly0.6 https://openbiodx.com/2017/10/17/liquid-biopsies-for-early-cancer-detection-promise-and-biological-challenges/2026-07-09monthly0.6 https://openbiodx.com/2017/10/16/aurora-a-snp-at-codon-57-predicts-response-to-alisertib-in-advanced-solid-tumors/2026-07-09monthly0.6 https://openbiodx.com/2017/10/16/oncometabolites-bridge-inborn-errors-of-metabolism-and-cancer-diagnostics/2026-07-09monthly0.6 https://openbiodx.com/2017/10/13/maf-amplification-predicts-zoledronic-acid-benefit-in-breast-cancer-potential-co/2026-07-09monthly0.6 https://openbiodx.com/2017/10/11/the-early-development-of-cardiac-troponin-i-assays-a-historical-perspective-on-b/2026-07-09monthly0.6 https://openbiodx.com/2017/09/28/vi-tetanus-toxoid-conjugate-vaccine-achieves-54-6-efficacy-against-typhoid-in-hu/2026-07-09monthly0.6 https://openbiodx.com/2017/09/13/dengue-point-of-care-diagnostics-progress-toward-multiplexed-rapid-testing/2026-07-09monthly0.6 https://openbiodx.com/2017/09/13/ros1-fusions-in-nsclc-detection-methods-for-the-clinical-laboratory/2026-07-09monthly0.6 https://openbiodx.com/2017/09/06/citrate-anticoagulant-improves-sensitivity-of-borrelia-burgdorferi-blood-culture/2026-07-09monthly0.6 https://openbiodx.com/2017/09/06/bd-max-extended-enteric-panel-validated-for-yersinia-etec-vibrio-and-plesiomonas/2026-07-09monthly0.6 https://openbiodx.com/2017/09/05/gp-notification-of-non-adherent-patients-increases-fit-screening-participation/2026-07-09monthly0.6 https://openbiodx.com/2017/09/05/colonoscopy-outreach-outperforms-mailed-fit-for-completing-cancer-screening-proc/2026-07-09monthly0.6 https://openbiodx.com/2017/09/01/metaplasia-as-a-precursor-to-dysplasia-and-cancer-mechanisms-and-screening-impli/2026-07-09monthly0.6 https://openbiodx.com/2017/08/30/maldi-tof-ms-for-positive-blood-cultures-methods-performance-and-clinical-impact/2026-07-09monthly0.6 https://openbiodx.com/2017/08/28/deto2x-ami-routine-oxygen-in-non-hypoxaemic-mi-does-not-reduce-one-year-mortalit/2026-07-09monthly0.6 https://openbiodx.com/2017/08/28/translating-epigenetic-biomarkers-from-discovery-to-clinical-diagnostics-challen/2026-07-09monthly0.6 https://openbiodx.com/2017/08/27/anti-inflammatory-drug-canakinumab-slashes-lung-cancer-incidence-in-cantos-trial/2026-07-09monthly0.6 https://openbiodx.com/2017/08/23/hypothesis-free-molecular-microbiology-the-case-for-a-universal-sequencing-based/2026-07-09monthly0.6 https://openbiodx.com/2017/08/23/egfrviii-vaccine-rindopepimut-fails-to-improve-survival-in-glioblastoma-despite-/2026-07-09monthly0.6 https://openbiodx.com/2017/08/17/precision-medicine-in-biliary-tract-cancers-actionable-mutations-and-emerging-ta/2026-07-09monthly0.6 https://openbiodx.com/2017/08/16/multiplex-pcr-simultaneously-identifies-n-gonorrhoeae-and-predicts-ciprofloxacin/2026-07-09monthly0.6 https://openbiodx.com/2017/08/10/aqt90-flex-point-of-care-troponin-i-matches-central-lab-performance-but-troponin/2026-07-09monthly0.6 https://openbiodx.com/2017/08/05/future-proofing-pathology-strategic-case-for-clinical-adoption-of-digital-pathol/2026-07-09monthly0.6 https://openbiodx.com/2017/08/01/her2-positive-breast-cancer-lacks-validated-predictive-biomarkers-beyond-her2-it/2026-07-09monthly0.6 https://openbiodx.com/2017/07/13/meta-analysis-confirms-strong-prognostic-value-of-mrd-negativity-in-pediatric-an/2026-07-09monthly0.6 https://openbiodx.com/2017/07/12/neopins-trial-procalcitonin-guided-decision-making-safely-reduces-neonatal-antib/2026-07-09monthly0.6 https://openbiodx.com/2017/07/01/topical-antibacterials-and-antiseptics-mechanisms-resistance-epidemiology-and-em/2026-07-09monthly0.6 https://openbiodx.com/2017/07/01/bartonella-endocarditis-an-underdiagnosed-cause-of-culture-negative-disease/2026-07-09monthly0.6 https://openbiodx.com/2017/07/01/genotyping-strategies-for-medically-important-fungi-mlst-microsatellites-and-ngs/2026-07-09monthly0.6 https://openbiodx.com/2017/06/28/laboratory-algorithm-for-diagnosing-infective-endocarditis-from-blood-cultures-t/2026-07-09monthly0.6 https://openbiodx.com/2017/06/28/gbs-detection-modernised-with-maldi-tof-molecular-assays-and-chromogenic-media/2026-07-09monthly0.6 https://openbiodx.com/2017/06/27/quality-control-materials-for-pharmacogenomic-testing-current-sources-and-future/2026-07-09monthly0.6 https://openbiodx.com/2017/06/23/serum-troponin-t-as-a-prognostic-marker-in-unstable-angina-a-historical-perspect/2026-07-09monthly0.6 https://openbiodx.com/2017/06/21/daratumumab-plus-pomalidomide-dexamethasone-deep-mrd-responses-in-heavily-treate/2026-07-09monthly0.6 https://openbiodx.com/2017/06/19/sex-specific-cardiac-troponin-cutoffs-biological-rationale-versus-clinical-evide/2026-07-09monthly0.6 https://openbiodx.com/2017/06/19/computer-aided-diagnosis-system-using-triple-ihc-markers-classifies-breast-epith/2026-07-09monthly0.6 https://openbiodx.com/2017/06/09/genome-wide-vs-panel-vs-single-gene-testing-choosing-the-right-approach-in-hemat/2026-07-09monthly0.6 https://openbiodx.com/2017/06/09/high-throughput-sequencing-enables-sensitive-noninvasive-mrd-detection-across-he/2026-07-09monthly0.6 https://openbiodx.com/2017/06/07/clia-compliant-whole-genome-sequencing-validated-for-public-health-microbiology-/2026-07-09monthly0.6 https://openbiodx.com/2017/05/31/gene-expression-signatures-in-early-breast-cancer-comparing-oncotype-dx-mammapri/2026-07-09monthly0.6 https://openbiodx.com/2017/05/24/bact-alert-virtuo-blood-culture-system-detects-pathogens-nearly-2-hours-faster-t/2026-07-09monthly0.6 https://openbiodx.com/2017/05/24/poc-diagnostics-for-infectious-disease-from-lateral-flow-to-molecular-platforms/2026-07-09monthly0.6 https://openbiodx.com/2017/05/24/ep-cam-meta-analysis-high-diagnostic-accuracy-and-prognostic-value-in-colorectal/2026-07-09monthly0.6 https://openbiodx.com/2017/05/23/harmonising-interpretive-comments-on-lab-results-still-a-long-way-to-go/2026-07-09monthly0.6 https://openbiodx.com/2017/05/22/seven-molecular-subgroups-of-medulloblastoma-refine-risk-stratification-beyond-s/2026-07-09monthly0.6 https://openbiodx.com/2017/05/17/response-tailored-hcv-treatment-using-on-treatment-pcr-monitoring-proves-non-inf/2026-07-09monthly0.6 https://openbiodx.com/2017/05/01/circulating-micrornas-as-cardiovascular-biomarkers-from-diagnosis-to-therapy/2026-07-09monthly0.6 https://openbiodx.com/2017/05/01/inr-point-of-care-testing-cost-effective-self-monitoring-for-anticoagulation-the/2026-07-09monthly0.6 https://openbiodx.com/2017/05/01/measuring-vitamin-k-in-blood-hplc-and-lc-ms-ms-methods-compared/2026-07-09monthly0.6 https://openbiodx.com/2017/05/01/mirna-assays-for-clinical-diagnostics-detection-technologies-workflows-and-autom/2026-07-09monthly0.6 https://openbiodx.com/2017/04/28/returning-germline-findings-from-cancer-genomics-research-lessons-from-the-austr/2026-07-09monthly0.6 https://openbiodx.com/2017/04/26/galectin-3-as-a-prognostic-biomarker-in-acute-coronary-syndrome/2026-07-09monthly0.6 https://openbiodx.com/2017/04/19/european-multicenter-evaluation-validates-analytical-performance-of-veris-hiv-1-/2026-07-09monthly0.6 https://openbiodx.com/2017/04/19/preanalytical-best-practices-for-lc-ms-analysis-of-blood-specimens/2026-07-09monthly0.6 https://openbiodx.com/2017/04/18/cpic-guideline-links-cyp2c19-genotype-to-voriconazole-dosing/2026-07-09monthly0.6 https://openbiodx.com/2017/04/12/clostridioides-difficile-resistance-mechanisms-and-susceptibility-testing-an-upd/2026-07-09monthly0.6 https://openbiodx.com/2017/04/12/preanalytical-factors-affect-hemocue-hemoglobin-measurements-differently-between/2026-07-09monthly0.6 https://openbiodx.com/2017/04/12/taqman-array-card-tests-csf-for-21-meningitis-pathogens-in-a-single-2-5-hour-run/2026-07-09monthly0.6 https://openbiodx.com/2017/04/06/ifm-2009-trial-confirms-transplant-advantage-over-rvd-alone-with-mrd-as-key-disc/2026-07-09monthly0.6 https://openbiodx.com/2017/04/04/cpic-updates-warfarin-dosing-guideline-with-cyp4f2-and-ancestry-specific-recomme/2026-07-09monthly0.6 https://openbiodx.com/2017/04/04/c-met-inhibition-in-gi-cancers-biomarker-stratification-remains-the-key-challeng/2026-07-09monthly0.6 https://openbiodx.com/2017/04/01/chromogenic-culture-media-a-decade-of-innovation-alongside-molecular-diagnostics/2026-07-09monthly0.6 https://openbiodx.com/2017/04/01/biological-age-predictors-epigenetic-clocks-lead-the-multi-omics-race/2026-07-09monthly0.6 https://openbiodx.com/2017/04/01/kras-variant-germline-mutation-predicts-cetuximab-benefit-in-head-and-neck-cance/2026-07-09monthly0.6 https://openbiodx.com/2017/04/01/imwg-consensus-defines-role-of-pet-ct-for-mrd-assessment-and-response-monitoring/2026-07-09monthly0.6 https://openbiodx.com/2017/03/30/tp53-and-smad4-inactivation-are-late-events-in-pancreatic-cancer-progression/2026-07-09monthly0.6 https://openbiodx.com/2017/03/16/cortisol-measurement-across-matrices-immunoassay-limitations-and-the-lc-ms-ms-ad/2026-07-09monthly0.6 https://openbiodx.com/2017/03/15/free-web-based-immunoratio-tool-reliably-automates-ki-67-scoring-in-breast-cance/2026-07-09monthly0.6 https://openbiodx.com/2017/03/15/digital-pcr-enters-the-clinical-microbiology-lab-advantages-over-qpcr/2026-07-09monthly0.6 https://openbiodx.com/2017/03/15/dna-methylation-profiling-outperforms-who-grading-for-meningioma-prognosis/2026-07-09monthly0.6 https://openbiodx.com/2017/03/14/idylla-automated-pcr-platform-shows-100-concordance-with-ngs-for-colorectal-canc/2026-07-09monthly0.6 https://openbiodx.com/2017/03/03/outlier-removal-methods-dramatically-alter-cardiac-troponin-99th-percentile-refe/2026-07-09monthly0.6 https://openbiodx.com/2017/03/02/integrating-liquid-biopsies-into-cancer-management-a-clinical-roadmap-for-ctdna/2026-07-09monthly0.6 https://openbiodx.com/2017/03/01/europe-s-u-pgx-consortium-launches-landmark-multi-gene-pharmacogenomics-implemen/2026-07-09monthly0.6 https://openbiodx.com/2017/02/25/lancet-seminar-peptic-ulcer-disease-in-the-era-of-declining-h-pylori-and-rising-/2026-07-09monthly0.6 https://openbiodx.com/2017/02/24/landmark-review-charts-the-path-from-ctdna-research-to-clinical-liquid-biopsy/2026-07-09monthly0.6 https://openbiodx.com/2017/02/22/ngs-and-gwas-reshape-the-genetic-landscape-of-dilated-cardiomyopathy-and-heart-f/2026-07-09monthly0.6 https://openbiodx.com/2017/02/15/toxoplasma-elite-mgb-commercial-pcr-kit-shows-89-sensitivity-but-extraction-meth/2026-07-09monthly0.6 https://openbiodx.com/2017/02/13/cpic-updates-guideline-for-cyp2d6-cyp2c19-guided-tricyclic-antidepressant-dosing/2026-07-09monthly0.6 https://openbiodx.com/2017/02/10/line-1-retrotransposon-as-an-emerging-cancer-biomarker-methylation-rna-and-prote/2026-07-09monthly0.6 https://openbiodx.com/2017/02/03/blood-based-protein-signatures-could-enable-early-cancer-detection/2026-07-09monthly0.6 https://openbiodx.com/2017/02/01/troponin-levels-diverge-between-type-1-and-type-2-mi-but-mortality-runs-in-the-o/2026-07-09monthly0.6 https://openbiodx.com/2017/01/25/deep-learning-matches-dermatologist-accuracy-in-skin-cancer-classification-from-/2026-07-09monthly0.6 https://openbiodx.com/2017/01/25/portrait-staph-id-r-panel-achieves-99-4-agreement-for-rapid-staphylococcus-ident/2026-07-09monthly0.6 https://openbiodx.com/2017/01/25/roche-hcv-rna-assays-on-cobas-6800-8800-show-excellent-sensitivity-and-cross-pla/2026-07-09monthly0.6 https://openbiodx.com/2017/01/23/immunophenotypic-and-genetic-profiling-essential-for-risk-stratification-in-adul/2026-07-09monthly0.6 https://openbiodx.com/2017/01/18/novel-multiplex-pcr-enables-rapid-screening-for-multidrug-resistant-e-coli-st648/2026-07-09monthly0.6 https://openbiodx.com/2017/01/10/heart-pathway-performs-equally-well-with-high-sensitivity-troponin-i-as-with-con/2026-07-09monthly0.6 https://openbiodx.com/2017/01/04/glasgow-blatchford-score-best-at-predicting-need-for-intervention-in-upper-gi-bl/2026-07-09monthly0.6 https://openbiodx.com/2017/01/01/eflm-position-paper-reaffirms-importance-of-blood-draw-order-to-prevent-sample-c/2026-07-09monthly0.6 https://openbiodx.com/2017/01/01/biomarkers-for-type-2-diabetes-from-glycemic-indices-to-cardiac-risk-stratificat/2026-07-09monthly0.6 https://openbiodx.com/2017/01/01/genetics-and-pathology-convergence-integrating-genomic-analysis-with-disease-mec/2026-07-09monthly0.6 https://openbiodx.com/2017/01/01/ciliopathies-reclassified-from-clinical-syndromes-to-functional-modules-of-the-c/2026-07-09monthly0.6 https://openbiodx.com/2017/01/01/meta-analysis-confirms-mrd-negativity-predicts-superior-survival-in-multiple-mye/2026-07-09monthly0.6 https://openbiodx.com/2016/12/29/molecular-genetics-of-gliomas-drives-new-classification-and-therapy-paradigm/2026-07-09monthly0.6 https://openbiodx.com/2016/12/28/cdc-advanced-molecular-detection-initiative-integrates-genomics-into-public-heal/2026-07-09monthly0.6 https://openbiodx.com/2016/12/28/pivotal-trial-validates-a-non-invasive-urine-based-malaria-rapid-diagnostic-test/2026-07-09monthly0.6 https://openbiodx.com/2016/12/23/clinical-ngs-in-pediatric-oncology-yields-actionable-findings-in-two-thirds-of-h/2026-07-09monthly0.6 https://openbiodx.com/2016/12/14/how-microbiology-labs-can-drive-antimicrobial-stewardship-programmes/2026-07-09monthly0.6 https://openbiodx.com/2016/12/14/new-antibiotics-for-skin-infections-address-growing-resistance-challenges/2026-07-09monthly0.6 https://openbiodx.com/2016/12/13/deep-learning-achieves-0-99-auc-for-automated-diabetic-retinopathy-detection-in-/2026-07-09monthly0.6 https://openbiodx.com/2016/12/13/brca-testing-must-expand-beyond-family-history-to-guide-parp-inhibitor-therapy-i/2026-07-09monthly0.6 https://openbiodx.com/2016/12/09/bone-turnover-markers-add-prognostic-value-but-preanalytic-pitfalls-persist/2026-07-09monthly0.6 https://openbiodx.com/2016/12/09/timps-as-extracellular-regulators-of-cancer-from-tumour-biology-to-liquid-biopsy/2026-07-09monthly0.6 https://openbiodx.com/2016/12/07/sybr-green-qpcr-on-noninvasive-swabs-matches-biopsy-accuracy-for-leishmaniasis-d/2026-07-09monthly0.6 https://openbiodx.com/2016/12/06/tumour-heterogeneity-reshapes-precision-treatment-in-colorectal-cancer/2026-07-09monthly0.6 https://openbiodx.com/2016/12/01/predictive-biomarkers-for-checkpoint-immunotherapy-beyond-pd-l1-alone/2026-07-09monthly0.6 https://openbiodx.com/2016/11/30/euroflow-standardised-8-colour-flow-cytometry-achieves-10-5-mrd-sensitivity-in-b/2026-07-09monthly0.6 https://openbiodx.com/2016/11/29/ngs-uncovers-new-pathogenic-mechanisms-in-tuberous-sclerosis-complex-tumours/2026-07-09monthly0.6 https://openbiodx.com/2016/11/29/genomic-loss-of-heterozygosity-by-ngs-predicts-parp-inhibitor-response-in-ovaria/2026-07-09monthly0.6 https://openbiodx.com/2016/11/28/eln-2017-recommendations-establish-genomic-risk-classification-and-mrd-framework/2026-07-09monthly0.6 https://openbiodx.com/2016/11/27/genomic-evolution-of-ductal-carcinoma-in-situ-clonal-models-of-invasion/2026-07-09monthly0.6 https://openbiodx.com/2016/11/23/chronic-kidney-disease-laboratory-diagnostics-from-gfr-estimation-to-novel-bioma/2026-07-09monthly0.6 https://openbiodx.com/2016/11/22/coronary-artery-calcium-found-in-one-third-of-low-risk-women-predicts-cardiovasc/2026-07-09monthly0.6 https://openbiodx.com/2016/11/18/pharmacogenomics-of-cardiovascular-drugs-statins-p2y12-inhibitors-and-anticoagul/2026-07-09monthly0.6 https://openbiodx.com/2016/11/18/decoding-cancer-evolution-through-genomic-analysis-of-tumour-clonal-dynamics/2026-07-09monthly0.6 https://openbiodx.com/2016/11/16/crowdsourced-dream-challenge-produces-superior-prognostic-model-for-metastatic-p/2026-07-09monthly0.6 https://openbiodx.com/2016/11/15/defining-procedural-myocardial-infarction-after-pci-the-evolving-consensus/2026-07-09monthly0.6 https://openbiodx.com/2016/11/04/circulating-biomarkers-for-risk-stratification-in-stable-ischemic-heart-disease/2026-07-09monthly0.6 https://openbiodx.com/2016/11/03/troponin-t-and-the-redefinition-of-the-myocardial-infarction-gold-standard/2026-07-09monthly0.6 https://openbiodx.com/2016/11/03/biomarkers-for-risk-stratification-and-treatment-optimization-in-atrial-fibrilla/2026-07-09monthly0.6 https://openbiodx.com/2016/11/03/interpreting-cardiac-troponin-and-natriuretic-peptides-in-chronic-kidney-disease/2026-07-09monthly0.6 https://openbiodx.com/2016/11/02/maldi-tof-ms-revolutionises-identification-of-clinically-important-molds/2026-07-09monthly0.6 https://openbiodx.com/2016/11/02/ngs-drives-gene-discovery-in-mitochondrial-disease-over-250-genes-now-implicated/2026-07-09monthly0.6 https://openbiodx.com/2016/11/01/pro-adrenomedullin-and-pro-anp-predict-quality-of-life-decline-after-community-a/2026-07-09monthly0.6 https://openbiodx.com/2016/11/01/reference-materials-for-genetic-testing-the-get-rm-programme-and-genome-in-a-bot/2026-07-09monthly0.6 https://openbiodx.com/2016/10/26/technological-considerations-for-clinical-cancer-genome-profiling-from-ffpe-to-l/2026-07-09monthly0.6 https://openbiodx.com/2016/10/25/gdf-15-an-emerging-multi-domain-cardiovascular-biomarker/2026-07-09monthly0.6 https://openbiodx.com/2016/10/19/biomarker-guided-risk-stratification-in-pulmonary-embolism-troponin-bnp-and-beyo/2026-07-09monthly0.6 https://openbiodx.com/2016/10/18/conservative-oxygen-therapy-halves-icu-mortality-the-oxygen-icu-trial/2026-07-09monthly0.6 https://openbiodx.com/2016/10/17/blood-collection-tubes-as-unrecognised-ivd-variables-a-framework-for-laboratory-/2026-07-09monthly0.6 https://openbiodx.com/2016/10/10/type-2-myocardial-infarction-and-myocardial-injury-definitions-diagnosis-and-cli/2026-07-09monthly0.6 https://openbiodx.com/2016/10/10/understanding-cardiac-troponin-assay-characteristics-a-guide-for-laboratorians-a/2026-07-09monthly0.6 https://openbiodx.com/2016/10/10/accelerated-rule-out-and-rule-in-strategies-for-myocardial-infarction-in-the-eme/2026-07-09monthly0.6 https://openbiodx.com/2016/10/10/cardiac-troponin-beyond-acs-prognostic-value-across-heart-failure-myocarditis-an/2026-07-09monthly0.6 https://openbiodx.com/2016/10/08/ventana-pd-l1-sp263-assay-validated-for-nsclc-and-head-and-neck-cancer-diagnosti/2026-07-09monthly0.6 https://openbiodx.com/2016/10/06/daratumumab-added-to-lenalidomide-dexamethasone-significantly-improves-mrd-negat/2026-07-09monthly0.6 https://openbiodx.com/2016/10/05/chlorhexidine-and-iodine-tincture-show-equivalent-blood-culture-contamination-ra/2026-07-09monthly0.6 https://openbiodx.com/2016/10/05/high-sensitivity-troponin-t-exhibits-a-diurnal-rhythm-that-troponin-i-does-not/2026-07-09monthly0.6 https://openbiodx.com/2016/10/05/systematic-review-of-preanalytical-error-collection-methods-recommends-lims-base/2026-07-09monthly0.6 https://openbiodx.com/2016/09/29/cannabidiol-for-drug-resistant-epilepsy-early-evidence-of-anticonvulsant-efficac/2026-07-09monthly0.6 https://openbiodx.com/2016/09/08/cord-blood-transplants-yield-lower-relapse-rates-than-unrelated-donors-in-mrd-po/2026-07-09monthly0.6 https://openbiodx.com/2016/09/01/digital-pcr-outperforms-qpcr-for-viral-load-quantification-without-calibration-c/2026-07-09monthly0.6 https://openbiodx.com/2016/09/01/molecular-testing-challenges-in-advanced-nsclc-from-egfr-to-pdl1-and-beyond/2026-07-09monthly0.6 https://openbiodx.com/2016/09/01/pd-l1-testing-in-lung-cancer-multiple-assays-and-no-consensus-create-a-biomarker/2026-07-09monthly0.6 https://openbiodx.com/2016/08/25/mindact-trial-70-gene-signature-spares-46-of-high-clinical-risk-breast-cancer-pa/2026-07-09monthly0.6 https://openbiodx.com/2016/08/17/bd-max-enteric-parasite-pcr-panel-matches-or-exceeds-microscopy-for-giardia-cryp/2026-07-09monthly0.6 https://openbiodx.com/2016/08/09/mass-mosquito-trapping-with-odour-baited-solar-traps-reduces-malaria-prevalence-/2026-07-09monthly0.6 https://openbiodx.com/2016/08/01/plasma-ddpcr-detects-egfr-and-kras-mutations-in-lung-cancer-with-100-positive-pr/2026-07-09monthly0.6 https://openbiodx.com/2016/08/01/brazil-charts-a-path-for-companion-diagnostics-amid-complex-health-system-challe/2026-07-09monthly0.6 https://openbiodx.com/2016/08/01/imwg-consensus-criteria-define-mrd-negativity-as-new-response-endpoint-in-multip/2026-07-09monthly0.6 https://openbiodx.com/2016/07/28/nejm-study-point-of-care-hemostasis-test-detects-aortic-regurgitation-during-tav/2026-07-09monthly0.6 https://openbiodx.com/2016/07/21/fia-ms-ms-method-validated-for-dried-blood-spot-amino-acid-monitoring-in-phenylk/2026-07-09monthly0.6 https://openbiodx.com/2016/07/19/metabolic-imaging-biomarkers-offer-a-non-invasive-window-into-brain-tumor-biolog/2026-07-09monthly0.6 https://openbiodx.com/2016/07/06/systematic-review-maps-788-blood-based-biomarkers-for-early-cancer-detection/2026-07-09monthly0.6 https://openbiodx.com/2016/07/05/cyp2c19-loss-of-function-alleles-eliminate-clopidogrel-aspirin-benefit-after-min/2026-07-09monthly0.6 https://openbiodx.com/2016/07/05/deutetrabenazine-rct-shows-significant-chorea-reduction-in-huntington-disease/2026-07-09monthly0.6 https://openbiodx.com/2016/07/04/nhs-implementation-study-shows-nipt-for-down-syndrome-reduces-invasive-testing-b/2026-07-09monthly0.6 https://openbiodx.com/2016/07/01/point-of-care-microbiology-labs-bringing-rapid-pcr-diagnostics-closer-to-patient/2026-07-09monthly0.6 https://openbiodx.com/2016/07/01/meta-analysis-finds-2-propsa-accuracy-for-prostate-cancer-remains-uncertain/2026-07-09monthly0.6 https://openbiodx.com/2016/07/01/cdk4-inhibitor-palbociclib-shows-favorable-pfs-in-cdk4-amplified-liposarcoma/2026-07-09monthly0.6 https://openbiodx.com/2016/06/28/persistent-diarrhoea-how-multiplex-pcr-is-changing-diagnostic-workup/2026-07-09monthly0.6 https://openbiodx.com/2016/06/24/digital-e-training-matches-live-training-for-pathologists-learning-companion-dia/2026-07-09monthly0.6 https://openbiodx.com/2016/06/14/spag5-identified-as-amplified-prognostic-and-chemotherapy-predictive-biomarker-i/2026-07-09monthly0.6 https://openbiodx.com/2016/06/14/genetic-counselling-framework-proposed-for-moderate-penetrance-cancer-mutations/2026-07-09monthly0.6 https://openbiodx.com/2016/06/12/inotuzumab-ozogamicin-achieves-81-remission-with-superior-mrd-clearance-in-relap/2026-07-09monthly0.6 https://openbiodx.com/2016/06/02/acute-bacterial-meningitis-in-adults-multiplex-pcr-and-novel-platforms-accelerat/2026-07-09monthly0.6 https://openbiodx.com/2016/06/01/serum-free-light-chain-testing-in-al-amyloidosis-diagnosis-monitoring-and-progno/2026-07-09monthly0.6 https://openbiodx.com/2016/06/01/measuring-monoclonal-proteins-from-electrophoresis-limitations-to-lc-ms-ms-preci/2026-07-09monthly0.6 https://openbiodx.com/2016/06/01/mass-spectrometry-and-free-light-chain-assays-transform-monoclonal-gammopathy-de/2026-07-09monthly0.6 https://openbiodx.com/2016/05/25/real-time-pcr-with-high-resolution-melting-detects-gonorrhoea-resistance-markers/2026-07-09monthly0.6 https://openbiodx.com/2016/05/12/dried-blood-spot-analysis-by-mass-spectrometry-for-therapeutic-drug-monitoring/2026-07-09monthly0.6 https://openbiodx.com/2016/05/06/lc-ms-ms-in-therapeutic-drug-monitoring-current-status-and-future-directions/2026-07-09monthly0.6 https://openbiodx.com/2016/05/05/perioperative-rosuvastatin-fails-to-prevent-atrial-fibrillation-or-myocardial-in/2026-07-09monthly0.6 https://openbiodx.com/2016/04/21/tumor-associated-b-cells-linked-to-better-survival-in-primary-melanoma/2026-07-09monthly0.6 https://openbiodx.com/2016/04/15/uk-guidelines-for-post-vasectomy-semen-analysis-under-iso-15189-accreditation/2026-07-09monthly0.6 https://openbiodx.com/2016/04/13/laboratory-diagnosis-of-sexually-transmitted-infections-methods-guidelines-and-e/2026-07-09monthly0.6 https://openbiodx.com/2016/04/13/newer-line-probe-assays-prove-non-inferior-for-rapid-mdr-tb-detection/2026-07-09monthly0.6 https://openbiodx.com/2016/04/11/2016-who-classification-of-myeloid-neoplasms-and-acute-leukemia-key-revisions/2026-07-09monthly0.6 https://openbiodx.com/2016/04/06/diagnosing-urinary-tract-infections-in-children-laboratory-challenges-and-best-p/2026-07-09monthly0.6 https://openbiodx.com/2016/04/01/point-of-care-procalcitonin-test-matches-central-lab-accuracy-with-two-hour-fast/2026-07-09monthly0.6 https://openbiodx.com/2016/04/01/eflm-survey-maps-iso-15189-accreditation-progress-across-29-european-countries/2026-07-09monthly0.6 https://openbiodx.com/2016/04/01/lynch-syndrome-screening-in-gynecologic-cancers-current-algorithms-and-future-di/2026-07-09monthly0.6 https://openbiodx.com/2016/03/23/bd-max-open-system-validated-for-multiplex-mycobacterial-detection-directly-from/2026-07-09monthly0.6 https://openbiodx.com/2016/03/16/laboratory-diagnosis-of-paediatric-tuberculosis-remains-a-major-challenge-despit/2026-07-09monthly0.6 https://openbiodx.com/2016/03/08/seven-gene-transcriptomic-score-quantifies-immune-dysregulation-in-sepsis-on-a-p/2026-07-09monthly0.6 https://openbiodx.com/2016/02/28/circulating-micrornas-as-blood-based-cancer-biomarkers-diagnostic-and-screening-/2026-07-09monthly0.6 https://openbiodx.com/2016/02/19/beyond-epcam-non-epithelial-methods-for-capturing-circulating-tumor-cells/2026-07-09monthly0.6 https://openbiodx.com/2016/02/04/personalised-thrombosis-medicine-genomics-has-not-yet-replaced-functional-coagul/2026-07-09monthly0.6 https://openbiodx.com/2016/01/27/optimizing-blood-culture-collection-in-pediatric-patients-volume-timing-and-rapi/2026-07-09monthly0.6 https://openbiodx.com/2016/01/27/consolidating-antibiotic-resistance-gene-databases-for-clinical-microbiology/2026-07-09monthly0.6 https://openbiodx.com/2016/01/27/trpv6-shows-sex-dependent-prognostic-value-in-esophageal-squamous-cell-carcinoma/2026-07-09monthly0.6 https://openbiodx.com/2016/01/20/npm1-mutation-tracking-by-rt-qpcr-is-the-strongest-prognostic-factor-in-standard/2026-07-09monthly0.6 https://openbiodx.com/2016/01/01/rapid-blood-culture-diagnostics-with-direct-communication-reduce-time-to-targete/2026-07-09monthly0.6 https://openbiodx.com/2016/01/01/soluble-st2-an-emerging-cardiac-biomarker-for-heart-failure-prognosis/2026-07-09monthly0.6 https://openbiodx.com/2016/01/01/biomarker-based-poc-tests-for-preeclampsia-could-transform-maternal-care-in-low-/2026-07-09monthly0.6 https://openbiodx.com/2016/01/01/detecting-intestinal-carriage-of-carbapenemase-producers-culture-vs-molecular-me/2026-07-09monthly0.6 https://openbiodx.com/2015/12/21/systemic-amyloidosis-advances-in-mass-spectrometry-typing-and-diagnostic-imaging/2026-07-09monthly0.6 https://openbiodx.com/2015/12/17/ukctocs-multimodal-ovarian-cancer-screening-shows-20-mortality-reduction-when-pr/2026-07-09monthly0.6 https://openbiodx.com/2015/12/10/ngs-guided-targeted-therapies-reshape-the-treatment-landscape-for-acute-myeloid-/2026-07-09monthly0.6 https://openbiodx.com/2015/12/09/enhanced-reminder-letters-reduce-socioeconomic-gradient-in-bowel-cancer-screenin/2026-07-09monthly0.6 https://openbiodx.com/2015/12/04/four-perioperative-samples-on-three-culture-media-suffice-for-prosthetic-joint-i/2026-07-09monthly0.6 https://openbiodx.com/2015/11/28/pips-trial-bifidobacterium-breve-probiotic-shows-no-benefit-in-very-preterm-infa/2026-07-09monthly0.6 https://openbiodx.com/2015/11/28/crispr-engineered-pig-models-for-neurodegenerative-disease-research/2026-07-09monthly0.6 https://openbiodx.com/2015/11/25/precision-oncology-trials-need-standardised-biomarker-reporting-to-unlock-their-/2026-07-09monthly0.6 https://openbiodx.com/2015/11/19/ion-mobility-spectrometry-emerges-as-rapid-bedside-screening-tool-for-clinical-l/2026-07-09monthly0.6 https://openbiodx.com/2015/11/19/maldi-tof-ms-set-to-expand-beyond-microbiology-into-broader-clinical-chemistry/2026-07-09monthly0.6 https://openbiodx.com/2015/11/18/lancet-review-understanding-antimicrobial-resistance-mechanisms-across-healthcar/2026-07-09monthly0.6 https://openbiodx.com/2015/11/17/mass-spectrometry-of-exhaled-breath-nonvolatiles-an-emerging-biomarker-source/2026-07-09monthly0.6 https://openbiodx.com/2015/11/17/eliminating-mrd-as-a-therapeutic-endpoint-could-move-cll-treatment-toward-cure/2026-07-09monthly0.6 https://openbiodx.com/2015/11/10/ambient-ionization-mass-spectrometry-for-real-time-cancer-diagnosis-and-surgical/2026-07-09monthly0.6 https://openbiodx.com/2015/11/10/mass-spectrometry-as-a-phenotypic-complement-to-pharmacogenomics-in-precision-me/2026-07-09monthly0.6 https://openbiodx.com/2015/11/09/fda-outlines-regulatory-path-for-clinical-mass-spectrometry-devices/2026-07-09monthly0.6 https://openbiodx.com/2015/11/09/mass-spectrometry-delivers-cost-effective-solutions-across-expanding-clinical-ap/2026-07-09monthly0.6 https://openbiodx.com/2015/10/28/rapid-detection-of-c-difficile-bi-nap1-027-useful-for-infection-control-but-spec/2026-07-09monthly0.6 https://openbiodx.com/2015/10/21/anyplex-multiplex-pcr-validated-for-rapid-tb-detection-and-isoniazid-resistance-/2026-07-09monthly0.6 https://openbiodx.com/2015/10/20/internal-quality-control-for-poct-devices-where-is-the-evidence/2026-07-09monthly0.6 https://openbiodx.com/2015/10/14/ambient-ionization-mass-spectrometry-targets-point-of-care-diagnostics/2026-07-09monthly0.6 https://openbiodx.com/2015/09/30/digital-whole-slide-imaging-validated-for-preimplantation-kidney-biopsy-assessme/2026-07-09monthly0.6 https://openbiodx.com/2015/09/07/pre-trial-molecular-validation-across-two-laboratories-ensures-reliable-patient-/2026-07-09monthly0.6 https://openbiodx.com/2015/08/17/ihc4-c-breast-cancer-recurrence-score-robust-to-staining-and-scoring-variation/2026-07-09monthly0.6 https://openbiodx.com/2015/07/06/sigma-metric-quality-control-a-practical-framework-from-westgard-for-scientifica/2026-07-09monthly0.6